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ABSTRACT 
Background: Military personnel are occupationally exposed to chemical mixtures at 
domestic locations and in theater.  
At military bases, a chemical hazard of concern is JP-8 jet fuel, the largest 
chemical exposure in the United States Air Force (USAF). We examined blood 
concentrations of JP-8 constituents as biomarkers of exposure and determined if workday 
exposure is associated with diminished balance control. 
Veterans of the 1990–1991 Gulf War (GW) were exposed to mixtures of 
chemicals in theater and about a third of GW veterans developed GW illness (GWI) on 
return from deployment. We identified health symptom profiles in the GWI literature and 
examined longitudinal exposure-symptom relationships in a subset of GW veterans. 
Methods: In USAF personnel, personal air, urine, and blood samples were analyzed for 
components of JP-8. Separate multivariate linear regression analyses were conducted to 
examine relationships between personal air and post-shift blood volatile organic 
compounds (VOCs) and between JP-8 exposure and postural sway. 
Meta-analytic techniques were conducted to determine pooled prevalence and 
vii	
combined odds ratios of symptoms comparing GW and GW-era control veterans. 
Repeated logistic regression models stratified by sex examined the association of GW 
exposures and symptoms. 
Results: Blood VOC concentrations were higher among participants with work-shift JP-8 
exposure and breathing zone total hydrocarbons significantly predicted VOC blood 
levels. Postural sway outcomes were associated with personal variables and task 
difficulty but not JP-8 exposure. 
GW veterans had higher odds of reporting all analyzed symptoms compared to 
GW-era controls, with 20% excess prevalence for fatigue, memory problems, and joint 
pain. Men had more significant associations between GW exposures and symptoms 
compared to women. Specific exposures were significantly associated with higher 
symptom reporting over time. 
Conclusion: In USAF personnel, blood VOC concentrations reflected work-shift 
exposure to jet fuel, supporting their use as biomarkers of JP-8 exposure. Work-shift 
exposure to JP-8 did not diminish balance control. 
Health symptoms evaluated through meta-analysis with the largest summary odds 
ratios were consistent with the symptom clusters reported in case definitions of GWI. The 
associations between GW exposure and longitudinal symptom reporting differed between 
men and women. 
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CHAPTER ONE. INTRODUCTION 
Over 2.4 million people serve in the United States Armed Forces, including 
Active Duty Armed Forces, Coast Guard, and DoD Ready Reserve (Office of the Deputy 
Assistant Secretary of Defense for Military Community and Family 2016). These 
individuals represent an occupational group distinct from the civilian workforce both 
during their time in the service and as veterans following their separation from the 
military. First, personnel in the US Armed Forces are, on average, younger than the 
civilian workforce and more physically fit than their civilian counterparts because of 
regular physical training and combat readiness requirements (Proctor 2008; Sulsky 2003). 
One-half of the Active Duty enlisted personnel and one-third of Reserve personnel are 
younger than 25 years old (Office of the Deputy Assistant Secretary of Defense for 
Military Community and Family 2016), while just 15% of civilian workforce in 2016 is 
younger than 24 (Bureau of Labor Statistics 2016). Second, an analysis comparing 
military occupational specialty codes to department of labor statistics showed that 
approximately 30% of military jobs do not have a civilian counterpart, leading to unique 
occupational health and safety needs for military occupations (Sulsky 2003). Finally, the 
life-cycle of a military career is often a combination of garrison and deployment stations, 
each with its own mission requirements and potential hazards (Gaydos 2011; Proctor 
2008). 
This research focuses on two groups of military personnel who experienced 
exposure to complex mixtures of chemicals, one during occupational activities in garrison 
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and the other in a deployment zone. In Chapters 2 and 3, we use a standard exposure-
related disease framework to explore methods for characterizing exposure to JP-8 and 
nervous system effects of JP-8 in a group of United States Air Force (USAF) jet fuel 
workers from the Occupational JP-8 Exposure Neuroepidemiology Study (OJENES) 
(Figure 1.1). Following this traditional framework is more challenging in a deployment 
zone where standard occupational health and monitoring procedures are not always 
possible. In the third and fourth studies, we focus on veterans of the 1990–1991 Gulf War 
(GW). The research and medical communities have identified health problems that 
emerged after return from deployment, requiring retrospective identification of relevant 
exposures and causal links. In Chapters 4 and 5, we investigate symptom profiles and 
exposure-related health complaints among GW veterans exposed to complex mixtures of 
chemicals and other hazards during deployment. 
Figure 1.1 
Source: http://sphweb.bumc.bu.edu/otlt/mph-modules/exposureassessment/exposureassessment_print.html 
JP-8 exposures and their effects 
Jet propulsion fuel-8 is the only fuel used in the US Air Force and widely used in 
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the other branches of the US Armed Forces and NATO militaries (NRC 2003). It is a 
kerosene-based fuel with over 200 aliphatic and aromatic hydrocarbons and can be used 
to fuel ground vehicles, generators, heaters, and other fuel-driven equipment (NRC 
2003). For military aircraft, specific performance objectives are met by enhancing the 
base JP-8 formula with additives, including corrosion inhibitors, static inhibitors, 
biocides, and thermal stability improvers (ATSDR 2017; Ritchie et al. 2003). JP-8 is a 
complex mixture and there is no current standard industrial hygiene method for 
quantifying occupational jet fuel exposure. Previous studies have used several different 
techniques to measure exposure to components of JP-8 as surrogate measures of jet fuel 
exposure, including total hydrocarbons (THC) and volatile organic compounds (VOCs) 
(e.g., naphthalene, benzene, toluene, and xylenes) in personal breathing zone, dermal skin 
samples, and exhaled breath, in addition to the urinary biomarkers 1- and 2-naphthol, 
which are metabolites of the parent compound naphthalene (Chao et al. 2005; Chao et al. 
2006; Egeghy et al. 2003; Merchant-Borna et al. 2012; Puhala et al. 1997; Rodrigues et 
al. 2014; Serdar et al. 2003; Serdar et al. 2004; Smith et al. 2010; Smith et al. 2012; Tu et 
al. 2004). VOCs measured in blood provide an estimate of total absorbed dose and a 
more biologically relevant measure of VOCs that could reach target organs; however, 
very few studies have utilized this biomarker (Blount 2006; Kirman 2012). 
 The OJENES study recruited 74 Active Duty personnel from three USAF bases 
based on job activities with a range of potential occupational jet fuel exposure. Personnel 
categorized as low JP-8 exposed worked in administrative office jobs, and high JP-8 
exposed personnel worked in aircraft and fuel cell maintenance and fuel handling. Over 
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the course of a work shift, JP-8 exposure was assessed by self-reported jet fuel contact 
and by measuring components of JP-8 in personal air, urine and blood samples. Blood 
samples from 69 OJENES participants were analyzed for toluene, ethylbenzene, m/p-
xylene, and o-xylene . The research summarized in Chapter 2 aimed to characterize 
blood biomarkers of JP-8 exposure and to establish the validity of blood VOCs as 
indicators of exposure to jet fuel. To address these aims, we compared VOC blood levels 
in USAF personnel with and without self-reported JP-8 contact. We used multiple linear 
regression models to examine the relationship between VOC levels in blood and a well-
characterized JP-8 exposure measure, personal breathing zone levels of total 
hydrocarbons in air (Maule et al. 2016).  
Components of JP-8 are known to be neurotoxic, though the mechanisms of 
toxicity of VOC constituents in JP-8 depend on their specific structures and the exposure 
dose (White and Proctor 1997). Due to the possible neurotoxicity of JP-8 components, 
central (CNS) and peripheral nervous system (PNS) effects of exposure are a concern. As 
a benchmark for protection of personnel health, the USAF adopted the 2013 American 
Conference of Governmental Industrial Hygienists (ACGIH) threshold level value set 
over an 8-hour time weighted average (TWA) of 200 mg/m3 for jet fuel in air (ATSDR 
2017).   
Balance control involves functional aspects of both the CNS and PNS and has 
been evaluated using posturography, a technique for measuring postural sway, in many 
occupational settings where workers are exposed to organic solvents (Hegeman et al. 
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2007; Kuo et al. 1996; Kurikawa et al. 2002; Vouriot et al. 2005; Yokoyama et al. 1997). 
Less efficient balance, or increased postural sway, has been noted in adhesive 
manufacturing, shipbuilding, and sewage treatment workers (Herpin et al. 2009; Ledin et 
al. 1989; Kuo et al. 1996). In two previous studies of USAF jet fuel workers, as exposure 
to personal air levels of JP-8 constituents (e.g., benzene, xylenes, naphthalene) increased, 
postural sway during the most difficult balance task (i.e., standing on two legs with eyes 
closed on a foam support) was significantly increased, indicating dysfunction among JP-8 
exposed USAF personnel (Bhattacharya 2001; Smith et al. 1997). 
Thirty-seven OJENES participants, whose JP-8 exposure was categorized as high 
or low based on job activities, completed four balance tasks before and after a work shift. 
The high exposure group was comprised of 23 personnel and the low group of 14 
personnel. Diminished balance control was quantified for each of the balance tasks by 
increased sway area and increased sway velocity. JP-8 exposure was measured using 
THC and naphthalene levels in personal breathing zone air and urinary 1- and 2-naphthol 
concentrations. The research in Chapter 3 aimed to determine the relationship between 
acute JP-8 exposure and postural sway performance at the end of a work shift. We 
compared sway area and velocity measurements from four balance tasks in the high and 
low JP-8 exposed USAF personnel. Multiple linear regression models were used to 
evaluate the association between JP-8 exposure (i.e., THC and naphthalene levels in 
personal air and urinary naphthol concentrations) and postural sway (Maule et al. 2013). 
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Health effects of service in the 1991 Gulf War 
Beginning in 1990 through early 1991, approximately 700,000 US troops were 
deployed to the Persian Gulf in support of Operations Desert Shield and Desert Storm, 
collectively known as the Gulf War (GW) (RAC-GWVI 2008). These two operations 
resulted in a 6-week intensive air-strike in the region and a four-day ground war. During 
the GW, women were 7% of the deployed force, the largest group of women to deploy to 
a war-zone up to that time (Coughlin 2016).  
There were fewer combat casualties and fatalities among American military 
personnel during the course of these two operations compared to previous wars and the 
most recent conflicts in Iraq and Afghanistan. However, during their GW deployment, 
US troops were exposed to a combination environmental and physical hazards, including 
petrochemicals, oil well fire smoke, depleted uranium, pesticides, pharmaceuticals agents 
and chemical warfare agents (RAC-GWVI 2008). 
Exposure to raw petrochemicals was widespread because it was used as a sand 
suppressant during the high wind season, and petrochemicals were used to fuel aircraft, 
ground vehicles and other equipment including tent heaters. The tent heaters were often 
unvented, exposing troops to high levels of fuel combustion products in their living 
quarters (RAC-GWVI 2008). In February 1991, as the Iraqi Army retreated from Kuwait, 
Iraqi troops set fire to over 600 Kuwaiti oil wells. The last oil well fire was extinguished 
on November 6, 1991 (Smith et al. 2002). Large smoke plumes from these fires contained 
particulates and gases exposing military personnel to a mixture of carbon dioxide, carbon 
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monoxide, sulfur dioxide, nitrogen oxides, volatile organic compounds, ozone, polycyclic 
aromatic hydrocarbons, heavy metals, and soot (Kelsall et al 2004a; Petruccelli et al. 
1999; Spektor 1998). Troops stationed in Kuwait and Saudi Arabia were exposed to these 
toxicants. During the GW, the US used depleted uranium (DU) ordinance and armor-
plating for the first time, and US troops were often unaware that they were handling DU 
munitions (RAC-GWVI 2008). There was also widespread use of pesticides in the desert 
environment during the GW to control insects carrying vector-borne illnesses such a sand 
flies, sand fleas and mosquitoes. Organophosphate and carbamate pesticides were used in 
area spraying or fogging to protect living and eating quarters as well as work spaces, 
while permethrin and DEET were issued for personal use (Fricker et al. 2000; 
Winkenwerder 2003). DEET was applied directly to the skin and permethrin was applied 
to uniforms, bedding, and bed nets. Finally, several prophylactic pharmaceuticals were 
given to US and other allied troops during GW deployment, including anthrax and 
botulinum toxin vaccines and pyridostigmine bromide (PB pills), which were given for 
the first time in a military operation in the hopes that they would protect troops from 
chemical warfare agents (RAC-GWVI 2008). No accurate records were kept that would 
identify which troops received the anthrax vaccine, and PB pills were distributed without 
tracking their use by individual soldiers.  
Prior to and during the GW, it was known that the Iraqi Army had chemical 
weapons. Troops were given devices that were designed to detect the presence of 
chemical warfare agents, and there were widespread reports of chemical alerts/alarms 
sounding in theater. However, only one incident of chemical warfare exposure of US 
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troops has been confirmed by the Department of Defense (DoD). This incident occurred 
following the ceasefire agreement at the end of February 1991, at which time US military 
personnel moved into the Khamisiyah area of southeastern Iraq (Winkenwerder 2002a). 
The operational goal was to destroy munitions and weapons being held at an Iraqi storage 
facility in Khamisiyah. Demolition of the facility, which contained thousands of 
munitions and chemical warfare agents, occurred in March and April 1991. In June 1996, 
the DoD publicly announced that chemical weapons were stored at the Khamisiyah 
facility, and during the demolition of the facility, sarin and cyclosarin nerve gas agents 
were released into the environment, resulting in exposure for approximately 100,000 US 
troops. 
 Shortly after returning from deployment, GW veterans began to report persistent 
health problems. These reports were seen in troops across all US service components, 
service branches, and unit locations in the Persian Gulf theater and were also documented 
in troops from allied militaries that deployed to the Gulf as part of the coalition of 30 
countries engaged in the conflict against Iraq. These included the United Kingdom, 
Canada, Australia, France, and Denmark (Cherry et al. 2001a; Doebbeling et al. 2000; 
Fukuda et al. 1998; Goss Gilroy Inc. 1998; Gray et al. 2002; Ishoy et al. 1999; Kang et al. 
2000; Kelsall et al. 2004b; Proctor et al. 1998; Salamon et al. 2006; Steele 2000; Unwin 
et al. 1999; Unwin et al. 2002). In research attempts to understand the patterns and 
etiologies of the chronic health symptoms reported by GW veterans, researchers spent 
many years identifying GW veteran symptom profiles and defining the illness through 
self-report and medical evaluations. The most commonly reported symptoms include a 
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combination of cognitive dysfunction, chronic headaches, widespread pain, unexplained 
fatigue, chronic diarrhea, skin rashes and respiratory problems (Fukuda et al. 1998; IOM 
2014; RAC-GWVI 2008; RAC-GWVI 2014; Steele 2000). A combination of these 
symptoms in an individual veteran can be used to diagnose GW illness (GWI), a disorder 
prevalent in 25–32% of GW veterans (Fukuda et al. 1998; RAC-GWVI 2008; RAC-
GWVI 2014; Steele 2000; IOM 2014). The two most widely accepted case definitions are 
the Centers for Disease Control (CDC) chronic multisymptom illness (CMI) and the 
Kansas case definition (Fukuda et al. 1998; IOM 2014; Steele 2000). According to the 
CDC CMI case definition, a veteran is diagnosed with GWI if s/he reports one or more 
symptoms that last for at least six months in two of three categories: fatigue, pain, and 
mood/cognition (Fukuda et al. 1998). Depending on the population studied, the case 
definition includes between 29–60% of the GW veteran population (Fukuda et al. 1998; 
IOM 2014). The Kansas definition requires moderate levels of self-reported symptoms in 
three out of six categories: fatigue/sleep, pain, neurological/cognition/mood, 
gastrointestinal, respiratory and skin (Steele 2000). In the study that established the 
Kansas criteria, the prevalence of GWI was 34%; however, veterans with certain medical 
or psychiatric conditions were excluded from the diagnosis (IOM 2014; Steele 2000). 
The Haley criteria are a third set of symptoms that have been used to define GWI in 
research (Haley et al. 1997). The criteria were devised by assessing a specific military 
unit of US Navy Seabees and include three syndromes that are based on factor analysis of 
symptoms reported by study participants: impaired cognition (Syndrome 1), 
confusion/ataxia (Syndrome 2), and neuropathic pain (Syndrome 3). The Seabee Unit 
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showed a 20% prevalence of GWI (Haley et al. 1997). Uncertainty remains about the 
sensitivity and specificity of these case definitions because of differences in the study 
populations and the methods used to ask about health outcomes.  
The research in Chapter 4 aimed to identify the symptoms most commonly 
reported in the GWI literature by deployed GW veterans and the non-deployed controls 
used in each study. To address this aim, we evaluated published data on self-reported 
symptoms using meta-analytic techniques to pool data from 18 unique veteran 
populations. Our goal was to determine the excess prevalence and the combined odds 
ratios of individual symptoms among deployed GW veterans compared to their controls. 
A secondary aim of our study was to examine differences in pooled symptom reporting 
between population-based and military-unit based GW cohorts. Some military-units in 
the GW theater experienced specific deployment exposures (e.g., forward-deployed 
personnel, US Navy Seabees) (Haley et al. 1997; Haley and Tuite 2013; Ismail et al. 
2000; Spencer et al. 2001; Steele et al. 2012). To examine the differences in GW 
exposures experienced by some military-units compared to the whole population of 
deployed GW veterans and its effect on symptom reporting, we re-evaluated symptoms 
using a meta-analysis stratified by the study sampling strategy (population-based versus 
military-unit). 
Researchers have focused on chemical, pharmaceutical, climatic, stress and other 
theater-specific exposures as the cause of GWI and as predictors of other objective 
measures of health outcomes in GW veterans. The challenge in this field of research is 
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that records of exposures to individual hazards and objective measurements of 
environmental and pharmaceutical exposures present in the GW theater are almost non-
existent. Using historical data and modeling techniques, exposure models have been 
developed for oil well fire smoke plumes and for sarin/cyclosarin exposure following the 
demolition of the Khamisiyah munitions facility. For oil well fire smoke exposure 
models, the US Army Center for Health Promotion and Preventive Medicine combined 
troop location data with a National Oceanic and Atmospheric Administration model that 
spatially and temporally predicted oil fire smoke using satellite imagery, ground station 
air-monitoring data, oil well emission rates, and Kuwaiti crude oil composition data 
(Cowan et al. 2002; Smith et al. 2002). In 2000, the DoD and the CIA modeled 
sarin/cyclosarin exposure at Khamisiyah to determine which US troops who had been 
exposed to nerve gas agents there (Winkenwerder 2002a; Winkenwerder 2002b). The 
exposure plume was modeled for four days (March 10–13, 1991) using available global 
and regional meteorological data; estimates of atmospheric transport, diffusion, and 
removal; and estimates of the types and numbers of sarin/cyclosarin-containing weapons 
present at the bunker. The exposure models determined the geographic areas surrounding 
the Khamisiyah demolition in which sarin/cyclosarin was likely present at levels above 
the general population limit (GPL=0.01296 mg min/m3 per day) each day for a 4-day 
exposure period. The GPL was set by the US Army and the CDC and represents the 
maximum exposure where no adverse health effects would be expected for an individual 
exposed to sarin 24-hours a day over 70 years (CDC 1988; McNamara and Leitnaker 
1971). Exposure models were combined with troop location data using a database of GW 
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unit locations to determine which US troops were in the modeled exposure plume area. 
Due to lack of objective modeling data, most of the epidemiological research on 
effects of GW theater exposures has, by necessity, relied heavily on self-reported 
exposures to evaluate relationships between specific exposures and health effects. 
Review of the literature suggests that exposures to pesticides and consumption of PB pills 
have consistently been linked to the diagnosis of GWI in health outcome studies (RAC-
GWVI 2008; RAC-GWVI 2014; Steele et al. 2012, White et al. 2016). In cross-sectional 
studies, GW veterans with self-reported exposure to pesticides and PB pills were also 
more likely than unexposed veterans to report specific symptoms such as cognitive 
dysfunction, depressive symptomatology and neurological complaints; similar complaints 
were also seen in GW veterans reporting exposure to smoke from oil well fires, debris 
from SCUD missiles, and chemical weapon alerts (The Iowa Persian Gulf Study Group 
1997; Kelsall et al. 2005; Proctor et al. 1998; Steele et al. 2012; White et al. 2001). 
Among GW veterans exposed to oil well fire and tent heater emissions, pulmonary 
symptoms were more likely to be reported compared to unexposed GW veterans (Cowan 
et al. 2002; Petruccelli et al. 1999; Proctor et al. 1998). GW exposures have been linked 
to objectively measured health outcomes as well. Exposure to smoke from oil well fires 
has been linked to respiratory disease and increased mortality from brain cancer. (Cowan 
et al. 2002; Barth et al. 2009; Kelsall et al. 2004a). GW veterans with sarin exposure have 
been found to show significant differences in brain structure (Chao et al. 2011; Heaton et 
al. 2007), demonstrate cognitive dysfunction (Chao et al. 2010; Proctor et al. 2006; 
Toomey at al. 2009) and have increased mortality due to brain cancer (Barth et al. 2009; 
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Bullman et al. 2005) compared to unexposed veterans who were deployed to the Gulf 
theater.   
The Fort Devens Cohort is a population of former US Army Active, Reserve, and 
National Guard GW veterans who have been followed prospectively through a series of 
surveys since immediately after their return from deployment to the Persian Gulf in 1991 
(Wolfe et al. 1998; Proctor et al. 1998; White et al. 2001; Wolfe et al. 2002; Proctor et al. 
2006; Heaton et al. 2006). Follow-up questionnaires were distributed from Winter 1992–
Spring 1993 (Follow-up 1), Spring 1994–Fall 1996 (Follow-up 2), and Spring 1997–
Spring 1998 (Follow-up 3). A subset of the Fort Devens Cohort (n=117) completed 
health symptom questionnaires on all three follow-up surveys. Participants self-reported 
whether they thought they had heard chemical weapons alerts, took PB pills, and/or had 
been exposed to exhaust from tent heaters, pesticides, smoke from oil well fires, debris 
from SCUD missiles at Follow-up 2. Information from the DoD regarding which cohort 
members had been notified of sarin nerve gas exposure based on the 2000 DoD/CIA 
plume model was also available to us. The research in Chapter 5 aimed to examine the 
relationship between modeled and self-reported GW deployment exposures and health 
symptoms, with a particular focus on sex differences, using longitudinal data from the 
three health symptom surveys conducted over a 7-year follow-up period. We used 
repeated logistic regression models stratified by sex to determine associations between 
individual GW exposures and health symptoms over time.  
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ABSTRACT 
Objective: This study aimed to evaluate blood VOC levels as biomarkers of occupational 
JP-8 exposure while controlling for smoking.  
Methods: Among 69 Air Force personnel, post-shift blood samples were analyzed for 
components of JP-8, including ethylbenzene, toluene, o-xylene, and m/p-xylene, and for 
the smoking biomarker, 2,5-dimethylfuran. JP-8 exposure was characterized based on 
self-report and measured work shift levels of total hydrocarbons in personal air. 
Multivariate regression was used to evaluate the relationship between JP-8 exposure and 
post-shift blood VOCs while controlling for potential confounding from smoking.  
Results: Blood VOC concentrations were higher among USAF personnel who reported 
JP-8 exposure and work shift smoking. Breathing zone total hydrocarbons was a 
significant predictor of VOC blood levels, after controlling for smoking.  
Conclusions: These findings support the use of blood VOCs as a biomarker of 
occupational JP-8 exposure. 
 
INTRODUCTION 
 Jet propulsion fuel 8 (JP-8) is a complex, kerosene-based chemical mixture 
composed of more than 200 aliphatic and aromatic hydrocarbons (NRC 2003). More than 
five billion gallons of JP-8 are used every year by U.S. and North Atlantic Treaty 
Organization (NATO) militaries for fueling aircraft, ground vehicles, and support 
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equipment, making it potentially the single largest source of chemical exposure for 
military personnel. Personal exposure assessment has proved challenging because of the 
complex composition of JP-8, and has focused on using surrogate measures of exposure 
including self-reported exposure and biomarkers of exposure (Chao et al. 2005; Chao et 
al. 2006; Merchant-Borna et al. 2012; Pleil et al. 2000; Puhala et al. 1997; Rodrigues et 
al. 2014; Serdar et al. 2003; Serdar et al. 2004; Smith et al. 2010; Smith et al. 2012; Tu et 
al. 2004). These studies have shown a wide range in the levels of exposure to JP-8 among 
U.S. Air Force (USAF) personnel, with the highest occurring among those who report 
routine occupational exposure to jet fuel.  
Self-reported exposure to JP-8 was found to be associated with total hydrocarbons 
(THCs) in personal breathing zone air samples (Merchant-Borna et al. 2012; Smith et al. 
2010). Similarly, previous studies have demonstrated that THCs in personal air samples 
were associated with other biomarkers of JP-8 exposure, including levels of volatile 
organic compounds (VOCs) in exhaled breath and 1- and 2-napthols in urine (Chao et al. 
2006; Pleil et al. 2000; Rodrigues et al. 2014; Serdar et al. 2003; Serdar et al. 2004; Smith 
et al. 2012; Tu et al. 2004). Although these exposure assessment methods are 
noninvasive, certain methods only monitor a single route of exposure, and differences 
among individuals and dynamic environmental factors only permit approximating body 
burden of VOCs and their metabolites. 
The National Health and Nutrition Examination Survey (NHANES) monitors 
levels of VOCs in blood collected from a representative sample of the U.S. population 
(Chambers et al. 2011; Kirman et al. 2012). Measuring VOC exposure levels in blood is 
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important because it provides an estimate of total absorbed dose from multiple routes of 
exposure (i.e., dermal, inhalation) and a biologically relevant measure of VOCs that 
potentially can reach target organs such as the brain, liver, and kidneys (Kirman et al. 
2012). Most half-lives for VOCs in blood are bi-phasic and on the time course of hours; 
however, half-life increases in repeated exposure scenarios such as occupational exposure 
(Ashley et al. 1996a). To date, no studies have characterized blood VOCs in USAF 
personnel with occupational exposure to jet fuel or assessed their relationship with 
personal measures of JP-8 exposure (e.g., THC in personal air samples).  
Certain VOCs that make up fuel such as JP-8 are also abundant in cigarette 
smoke, gasoline and other organic solvents, which also can affect levels of VOCs in 
blood (Ashley et al. 1994; Chambers et al. 2008; Chambers et al. 2011; Polzin et al. 
2007). In a U.S. Department of Defense health behavior study, approximately one-third 
of U.S. service members reported any cigarette use in the past month (Bray et al. 2010). 
In many of the studies examining USAF personnel JP-8 exposure, smoking also has been 
significantly associated with measured levels of JP-8 constituents in personal air and 
urine biomarkers, confounding the association between JP-8 exposure and blood VOC 
levels in active duty military personnel exposed to JP-8 (Chao et al. 2006; Rodrigues et 
al. 2014; Serdar et al. 2003; Serdar et al. 2004; Smith et al. 2012).  
The overall goal of this study was to evaluate VOCs in blood as a biomarker for 
characterizing exposure to JP-8. Specifically, the objectives were to characterize VOCs in 
blood among a population of USAF personnel exposed to JP-8, evaluate self-reported 
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work shift JP-8 exposure and measured personal exposure to THC as predictors of VOCs 
in blood, while for controlling for the effect of smoking on VOC levels in blood.  
 
METHODS 
We recruited 74 active duty personnel who served at least six months in the 
USAF from three bases according to their Air Force Specialty Code (AFSC) and current 
job tasks (i.e., administrative, aircraft structural maintenance, fuel systems maintenance) 
such that some participants were expected to have higher exposure to JP-8 and other 
participants were expected to have lower exposure to JP-8. Persons with a self-reported 
history of loss of consciousness >20 min or known neurological or psychological 
disorder(s) were excluded from the study. The parent study included a six-day protocol 
designed to assess JP-8 exposure and central nervous system functioning in active duty 
USAF personnel (Proctor et al. 2011). Blood samples were only collected at the end of 
shift on day 5 (Thursday) of the week-long sampling investigation and were available for 
69 of the 74 participants. Accordingly, this investigation focuses on the 69 workers who 
provided a blood sample on day 5. The study protocol was approved by institutional 
review boards at the U.S. Army Research Institute of Environmental Medicine, USAF 
Research Laboratory at Wright Patterson Air Force Base and Boston University, and was 
in compliance with human subjects review procedure at the Centers for Disease Control 
and Prevention. Written informed consent was obtained from all participants.  
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Personal air samples  
Personal air samples were collected and extracted in accordance with National 
Institute for Occupational Safety and Health Method 1550 for THC (NIOSH 1994). 
Methods for personal air sampling and laboratory analysis are described in detail by 
Merchant-Borna et al. (2012) and Smith et al. (2010). In brief, participants wore a battery 
operated personal air sampling pump (Casella Apex Pro IS; Casella USA, Amherst, NH) 
that was attached to a two-section (100/50 mg) coconut shell charcoal tube (Anasorb; 
SKC Inc., Eight Four, PA, USA) clipped to the lapel of each subject near their breathing 
zone (flow rate = 0.2 l/min). The personal air-sampling pump was turned off and sealed 
during breaks from job tasks when the participant left the work area (e.g., during lunch 
and cigarette breaks), and when participants were required to put on respirators to 
perform certain job tasks. Samples were analyzed for THC at the Organic Chemistry 
Analytical Laboratory (Harvard School of Public Health, Boston, MA) using gas 
chromatography with flame ionization detection (NIOSH 1994). THC concentrations 
determined to be below the limit of detection (LOD), calculated as three times the 
standard deviation of the field blanks, were replaced with a value of half the LOD. Air 
concentrations of THC are reported as eight-hour (8-h) time-weighted averages (TWAs) 
in mg/m3 to account for difference in work shift length. 
A data logger (HOBO; Onset Computer Corporation, Bourne, MA, USA) was 
attached to each worker to obtain air temperature and relative humidity measurements in 
15-min intervals through the duration of each work shift. Air temperature and relative 
humidity measurements were averaged across an 8-h work shift. 
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Blood VOCs  
After the same work shift in which air samples were collected, a trained 
phlebotomist obtained a blood sample (≤20 ml total) from each worker. Samples were 
collected in specially prepared BD Vacutainer tubes (Becton, Dickinson and Company, 
Franklin Lakes, NJ, USA) and sent to the Centers for Disease Control and Prevention 
laboratory for analysis. Using automated solid-phase microextraction coupled with 
capillary gas chromatography and quadrupole mass spectrometry, blood samples were 
analyzed for trace level amounts of the following 11 VOCs: n-hexane, n-heptane, n-
octane, benzene, 1,4-dicholorobenzene, ethylbenzene, methyl tert-butyl ether, styrene, 
toluene, o-xylene, and m/p-xylene (Chambers et al. 2006; Chambers et al. 2008). Blood 
samples were also analyzed for 2,5-dimethylfuran, a highly specific combustion 
biomarker of cigarette smoke exposure for daily smokers or nonsmokers exposed to 
environmental tobacco smoke (ETS), using the same method (Ashley et al. 1996b; 
Chambers et al. 2011). Concentrations of blood analytes are reported in µg/l. 
 
Questionnaires 
Participants completed a baseline questionnaire providing information about 
demographics and smoking, as well as occupational, military, and health history. Before 
starting the work shift, participants completed a brief questionnaire asking about 
chemical exposures from the previous evening and the morning. The pre-shift survey 
asked “Since we last saw you have you been to the gas station and filled up your car 
(self-service)?” (yes/no). 
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At the end of the work shift, participants completed another brief questionnaire 
which included a section for participants whose “job involved direct exposure to JP-8 
during the work shift.” If participants completed this section, this was considered self-
reported work shift JP-8 exposure. The post-shift questionnaire also asked about contact 
with other solvents and chemicals, use of protective equipment, and tobacco use during 
the work shift. On this survey, participants were asked to report if they had worked with 
gasoline, cutting or lubricating oils, coolants or antifreeze, degreasers or other cleaners, 
organic solvents, mineral spirits, and/or epoxy or adhesives (yes/no). The questionnaire 
also asked, “How many cigarettes have you had during today’s work shift?” Response 
options included “none,” “quarter-pack,” “half-pack,” “1 pack,” “1+ to 2 packs,” and “2+ 
packs.” Because of the lack of diversity in responses and the small number who smoked a 
half pack or more, we lacked statistical power for an analysis of the influence of 
fractional pack. Of the 23 persons who reported smoking during their work shift, 20 
indicated that they had smoked a quarter-pack and three indicated they had smoked a 
half-pack of cigarettes during the work shift. Responses were dichotomized according to 
yes/no responses for smoking during the work shift for the data analysis.  
 
Data analysis 
Statistical analyses focused on five VOCs that were detected above the LOD in 
≥50% of the blood samples for both self-reported exposure groups: 2,5-dimethylfuran, 
ethylbenzene, toluene, o-xylene, and m/p-xylene. Blood VOC concentrations below the 
analytical LOD were replaced with a calculated value of the LOD/SQRT(2). Distribution 
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of personal air and blood concentrations were right-skewed, so the data were transformed 
with the natural log function before statistical analyses. THCs in personal air and VOCs 
in blood were analyzed using descriptive statistics, and Student’s t-test compared mean 
concentrations between workers who reported JP-8 exposure and those who reported no 
exposure. Blood VOCs also were compared between USAF personnel who smoked 
during the work shift and those who did not using the same method. 
Air concentrations were natural log-transformed to reduce skewness for the 
correlation analysis and blood concentrations were natural log-transformed for both 
correlation and regression analyses. Pearson correlations were used to estimate the 
strength of the relationship between THC concentrations in air and VOC concentrations 
in blood. Multiple linear regression models examined the association between blood 
VOC levels and two surrogate measures of JP-8 exposure: categorical self-reported work 
shift jet fuel exposure (yes/no) and 8-h TWA THC (mg/m3). To control for cigarette 
smoking, two variables were considered in separate models: categorical self-reported 
cigarette smoking during the work shift (yes/no) and 2,5-dimethylfuran in blood (µg/l). 
USAF base and relative humidity were included as covariates in all models. A model was 
fit for each of the VOCs measured in blood.  
Mean air temperature, self-service at a gas station, age and body mass index of 
participant were also considered as possible covariates. These covariates were not 
significant predictors of blood VOCs in either regression model and were not included in 
the final models. We considered conducting a post-hoc analysis to include exposure to 
other chemicals endorsed on the post-shift survey as possible covariates in our regression 
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models. However, the sample size was small for those reporting the additional exposures 
(n≤5) and therefore not performed. All statistical analyses were conducted using SAS 
statistical software version 9.2 (SAS Institute, Cary, NC, USA).  
 
RESULTS  
Table 2.1 shows demographics for the 69 study participants. On average, the 
USAF personnel participating in this study were 25.3 years old and had spent 5.3 years in 
the USAF. The majority of participants were white males in the lower enlisted ranks. 
Significantly more males than females reported work shift JP-8 exposure. Significantly 
more JP-8 exposed individuals reported smoking during the work shift (χ2 = 5.71 (1 df), P 
= 0.02). Work shift exposure to JP-8 did not differ by other demographic factors.  
Table 2.2 shows post-shift VOC concentrations in blood by self-reported JP-8 
exposure and shift cigarette smoking. 2,5-dimethylfuran, a biomarker for cigarette 
smoking, was detected in 91% of the samples for persons who reported smoking during 
the work shift. The geometric mean (GM) concentrations of 2,5-dimethylfuran (P < 
0.0001), toluene (P = 0.0001), o-xylene (P = 0.005), and m/p-xylene (P = 0.0006) in 
blood were significantly higher among participants who reported smoking during the 
work shift. Similarly, the GM concentrations of toluene (P = 0.003), o-xylene (P = 
0.0003), and m/p-xylene (P <0.0001) in blood were significantly higher among 
participants who reported exposure to JP-8.  
Concentrations of THC in personal air samples were significantly higher among 
participants who self-reported jet fuel exposure (GM = 4.40 mg/m3) than among those 
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who did not (GM = 0.46 mg/m3) (P < 0.0001). In this sample of workers, personal air 
THC concentrations were strongly correlated with blood levels of o-xylene (r = 0.7) and 
m/p-xylene (r = 0.7), moderately correlated with blood concentrations of toluene (r = 
0.5), and weakly correlated with ethylbenzene (r = 0.3) (Figure 2.1). When participants 
smoked, they removed their personal air-sampling pumps. Consequently, the correlations 
between 8-h TWA THC levels and blood levels of 2,5-dimethylfuran were negligible (r = 
0.2).  
Table 2.3 presents regression models evaluating predictors of ethylbenzene, 
toluene, o-xylene, and m/p-xylene in blood. Model 1 examined self-reported work shift 
exposure to JP-8 as a predictor of the individual blood VOCs, while controlling for self-
reported shift cigarette smoking, USAF base (Base A [reference], Base B, or Base C), 
and mean relative humidity. Work shift jet fuel exposure was a significant predictor for 
o-xylene, and m/p-xylene in blood. There was a positive association between work shift 
JP-8 exposure and ethylbenzene and toluene, but the association did not reach statistical 
significance. Smoking during the shift was a significant predictor for all analyzed blood 
VOCs, and participants at USAF Base B had significantly higher blood VOC 
concentrations compared with participants from the other USAF bases (Table 2.3, Model 
1).  
Model 2 was used to evaluate THC in personal air samples as a predictor of 
individual blood VOCs, while controlling for cigarette smoking using the blood 
biomarker 2,5-dimethylfuran, USAF base, and mean relative humidity (Table 2.3). THC 
in personal air was a significant predictor for ethylbenzene, toluene, o-xylene, and m/p-
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xylene in blood. The measure of cigarette smoking, blood levels of 2,5-dimethylfuran, 
remained significant in all models, with the exception of o-xylene. Model 2 explained a 
larger portion of the variance in the blood VOCs than did Model 1, with adjusted R2 
values ranging from 63% (toluene) to 82% (ethylbenzene). 
To further evaluate confounding from cigarette smoking, Model 2 was re-run only 
among USAF personnel who did not smoke during the work shift (n = 46), and 2,5-
dimethylfuran was excluded as a covariate (data not shown). For each of the JP-8 
components, parameter estimates for 8-h TWA THC and adjusted R2 were consistent 
with results in Table 2.3. 
 
DISCUSSION  
VOCs in blood can serve as biomarkers of JP-8 exposure over a work shift in 
USAF personnel. Specifically, of the VOCs measured, o-xylene and m/p-xylene appear to 
be the most appropriate blood biomarkers of JP-8 exposure. This is based on their strong 
correlations with THC in personal air, and results of the regression model which 
indicated that THC concentration was a significant predictor of o-xylene and m/p-xylene. 
Also, results showed that self-reported work shift jet fuel exposure was a good predictor 
of o-xylene and m/p-xylene. Because the half-life of VOCs in blood is on the time course 
of several hours, we used an exposure measure self-reported during the same work shift 
as the collection of the blood sample. THC concentration in the personal breathing zone 
measured over a work shift was a better predictor of ethylbenzene and toluene than self-
reported exposure, potentially indicating another source of VOC exposure other than jet 
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fuel.  
We explored the role of several potential confounders, particularly cigarette 
smoke. Significantly more individuals exposed to JP-8 during the day 5 work shift also 
smoked during that shift. We used two different variables to control for the effect of 
smoking on VOC levels in blood: self-reported smoking during the work shift and 
concentration of 2,5-dimethylfuran in blood. Self-reported smoking during the work shift 
corresponded well with smoking biomarker 2,5-dimethylfuran. Among the 23 
participants who smoked during their work shift, 21 (91%) had detectable levels of 2,5-
dimethylfuran and 20 (87%) had a blood concentration of 2,5-dimethylfuran ≥ 0.014 µg/l, 
the CDC cut-off for classifying a daily smoker smoking the equivalent of one cigarette 
per day (Chambers et al. 2011). Blood levels of 2,5-dimethylfuran can be affected by 
several factors not captured by our questionnaires, including environmental tobacco 
smoke (ETS), brand style of cigarette, time since last cigarette, and cigarettes smoked per 
day. In our study, cigarette usage was categorized to the nearest fractional pack, rather 
than cigarettes per day, to simplify the estimation of cigarettes smoked during shift by 
participants and to utilize an inherent categorization established by smokers. Information 
regarding brand and style of cigarette smoked or exact time since the previous cigarette 
was not obtained. 
 The USAF base at which personnel worked was also a significant predictor of 
VOCs in blood. Participating personnel at USAF Base B had significantly higher levels 
of all the analyzed blood VOCs compared with those at other USAF base locations. 
There could be multiple factors contributing to the differences in VOC exposure by 
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location. First, JP-8 composition can vary based on batch and can also be altered based 
on performance needs and type of aircraft maintained at a particular location (Ritchie et 
al. 2003). Second, exposure could be affected by specific job task being performed and 
differences in use of personal protective equipment (PPE) (e.g., tasks requiring 
respirators). Certain tasks may require the use of other solvents and chemicals. We could 
not analyze exposure to other chemicals because of small sample size endorsing their use 
during the work shift (n≤5). Lastly, personal air levels of THC capture occupational 
exposure to VOCs via inhalation; however, air sampling pumps were turned off while 
respirators were in use. Respirator use decreases inhalation exposure, but past studies 
have found that dermal exposure can also be an important route of VOC exposure (Chao 
et al. 2005; Kim et al. 2006). Blood biomarkers can provide a measure for both inhalation 
and dermal exposure. 
 
CONCLUSION 
 This study demonstrates that VOCs in blood reflect occupational exposure to JP-8 
during a work shift. USAF personnel who reported occupational exposure to JP-8 had 
higher concentrations of blood VOCs than did personnel who did not report occupational 
contact with JP-8. Higher concentrations of THC in personal air samples were 
significantly associated with higher levels of VOCs in blood, even after controlling for 
smoking and other potential confounders. Although more invasive, detection of VOCs in 
blood offers an estimate of absorbed dose from multiple routes of exposure and a direct 
measure of body burden compared to detection of these compounds in personal breathing 
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zone samples. These observations support the use of blood VOCs as a biomarker of 
occupational exposure to fuels such as JP-8.		
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Table 2.1. Demographics of participating US Air Force (USAF) personnel tested for 
volatile organic compounds in blood (n = 69) 
Continuous variables Mean  
(Standard 
deviation) 
Range 
Age, years 25.3 (6.0)  18.6–43.0 
Body mass index 26.1 (3.4)  17.8–34.4 
Years active USAF service 5.31 (5.2)  0.5–20.0 
Categorical variables No.  (%) 
Cigarette(s) smoked during shift   
Yes 23 (33.3) 
No 46 (66.7) 
Day 5 work shift jet fuel exposure   
Yes 37 (53.6) 
No 32  (46.4) 
USAF base   
Base A 20 (29.0) 
Base B 17 (24.6) 
Base C 32  (46.4) 
Rank   
Airmen (lower enlisted ranks) 45 (65.2) 
Non-commissioned officers (higher 
enlisted ranks) 
24 (34.8) 
Sex   
Male 58 (84.1) 
Female 11 (15.9) 
Ethnicity   
White 49 (71.0) 
Nonwhite 20 (29.0) 
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Table 2.2. Volatile organic compound (VOC) blood concentrations for sampled US Air Force (USAF) personnel (n = 69) 
Analyte (µg/l) LOD 
Cigarette(s) smoked during shift Day 5 work shift JP-8 exposure 
Yes (n = 23) No (n = 46) Yes (n = 37) No (n = 32) 
% 
Detect 
GM 
(GSD) 
Range % 
Detect 
GM 
(GSD) 
Range % 
Detect 
GM 
(GSD) 
Range % 
Detect 
GM 
(GSD) 
Range 
2,5-dimethylfuran  0.0112 91 0.04 
(2.6) 
 
<LOD–
0.2 
7 0.01 
(1.6) 
 
<LOD–
0.06 
46 0.02 
(2.8) 
 
<LOD–
0.26 
22 0.01 
(2.5) 
 
<LOD–
0.15 
Octane  0.1 30 0.11 
(2.1) 
 
<LOD–
0.55 
11 0.08 
(1.5) 
 
<LOD–
0.44 
30 0.10 
(2.0) 
 
<LOD–
0.55 
3 0.10 
(1.1) 
<LOD–
0.15 
Isopropylbenzene  0.04 30 0.04 
(1.8) 
 
<LOD–
0.22 
11 0.03 
(1.5) 
 
<LOD–
0.13 
30 0.04 
(1.8) 
 
<LOD–
0.22 
3 0.03 
(1.2) 
<LOD–
0.08 
Benzene  0.024 96 0.11 
(2.1) 
 
<LOD–
0.41 
22 0.02 
(1.9) 
 
<LOD–
0.12 
65 0.05 
(2.7) 
 
<LOD–
0.41 
25 0.03 
(2.3) 
 
<LOD–
0.25 
Ethylbenzene  0.024 96 0.19 
(3.8) 
 
<LOD–
1.65 
70 0.11 
(5.1) 
 
<LOD–
1.81 
86 0.17 
(4.8) 
 
<LOD–
1.81 
69 0.10 
(4.4) 
 
<LOD–
1.21 
Toluene  0.025 96 0.33 
(2.6) 
 
0.02–
1.15 
91 0.09 
(3.6) 
 
<LOD–
2.76 
97 0.22 
(3.4) 
 
<LOD–
2.76 
88 0.09 
(3.4) 
 
<LOD–
0.68 
o-xylene  0.024 96 0.11 
(3.0) 
 
<LOD–
1.16 
80 0.05 
(2.7) 
 
<LOD–
0.63 
92 0.10 
(3.4) 
 
<LOD–
1.16 
78 0.04 
(2.0) 
 
<LOD–
0.30 
m-/p-xylene  0.0335 96 0.35 
(3.0) 
 
0.02–3.1 94 0.13 
(3.0) 
 
<LOD–
1.62 
100 0.30 
(3.3) 
 
0.05–
3.11 
88 0.10 
(2.4) 
 
<LOD–
0.80 
Definitions: GM = geometric mean; GSD = geometric standard deviation; JP-8 = jet propulsion fuel 8; LOD = limit of 
detection; ND = not detected. 
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Table 2.3. Models* evaluating predictors of volatile organic compound (VOC) blood levels in sampled US Air Force (USAF) 
personnel (n = 69) 
Model/Variables Ethylbenzene (µg/l)** Toluene (µg/l)** o-xylene (µg/l)** m-/p-xylene (µg/l)** 
β  (SE) P-value β  (SE) P-value β  (SE) P-value β  (SE) P-value 
Model 1         
Intercept -4.28 (0.42) <0.0001 -3.83 (0.49) <0.0001 -5.18 (0.41) <0.0001 -4.40 (0.42) <0.0001 
JP-8 exposure (yes/no) 0.31 (0.22) 0.16 0.43 (0.26) 0.10 0.52 (0.22) 0.02 0.58 (0.22) 0.01 
Shift cigarette smoking (yes/no) 0.43 (0.21) 0.05 1.13 (0.25) <0.0001 0.48 (0.21) 0.03 0.73 (0.21) 0.001 
USAF base A Ref  Ref  Ref  Ref  
USAF base B 3.44 (0.26) <0.0001 1.65 (0.31) <0.0001 1.45 (0.25) <0.0001 1.59 (0.26) <0.0001 
USAF base C -0.05 (0.58) 0.93 -0.97 (0.68) 0.16 -0.41 (0.57) 0.47 -1.04 (0.59) 0.08 
Mean relative humidity 0.03 (0.02) 0.09 0.03 (0.02) 0.09 0.04 (0.02) 0.006 0.05 (0.02) 0.001 
Summary Adjusted R2 0.74  0.50  0.51  0.55  
Model 2         
Intercept -3.57 (0.37 <0.0001 -3.24 (0.45) <0.0001 -4.26 (0.34) <0.0001 -3.54 (0.38) <0.0001 
8-h TWA THC (mg/m3) 0.04 (0.01) <0.0001 0.03 (0.01) <0.0001 0.04 (0.01) <0.0001 0.04 (0.01) <0.0001 
2,5-dimethylfuran (µg/L) 3.76 (1.78) 0.04 13.32 (2.17) <0.0001 0.45 (1.67) 0.79 4.65 (1.86) 0.02 
USAF base A Ref  Ref  Ref  Ref  
USAF base B 3.36 (0.22) <0.0001 1.55 (0.26) <0.0001 1.38 (0.20) <0.0001 1.50 (0.23) <0.0001 
USAF base C 0.44 (0.46) 0.34 -0.77 (0.56) 0.17 0.12 (0.43) 0.79 -0.64 (0.48) 0.19 
Mean relative humidity 0.003 (0.01) 0.81 0.02 (0.02) 0.13 0.02 (0.01) 0.13 0.03 (0.01) 0.03 
Summary Adjusted R2 0.82  0.63  0.69  0.67  
Abbreviations: JP-8 = jet propulsion fuel 8; Ref = referent; SE = standard error; THC = total hydrocarbons; TWA = time-
weighted average. 
* Multiple linear regression 
** Natural log-transformed. 
Model 1: With self-reported cigarette use (shift cigarette smoking (yes/no)) and Day 5 JP-8 exposure (yes/no) 
Model 2: With measured JP-8 (8-h TWA THC (mg/m3)) and cigarette smoke exposure (2,5-dimethylfuran (µg/L)) 
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Figure 2.1. Correlation on log-scale between concentrations of personal air total hydrocarbons and blood volatile organic 
compounds in sampled US Air Force personnel (n = 69) 
	
	
	 	
	
	
 
Definitions: r = Pearson’s correlation coefficient; THC = total hydrocarbons; TWA = time-weighted average. 
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ABSTRACT 
Objective: To determine whether acute jet propulsion fuel 8 (JP-8) exposure is 
associated with balance task measurements in JP-8 exposed Air Force personnel. 
Methods: As part of a larger neuroepidemiology study, balance tasks were completed by 
JP-8 exposed individuals (n=37). Acute JP-8 exposure was measured using personal 
breathing zone levels and urinary biomarkers. Multivariate linear regression analyses 
were conducted to examine the relationship between workday JP-8 exposure and postural 
sway. 
Results: Balance control decreased as the balance task became more challenging. 
Workday exposure to JP-8, either measured by personal air or urinary metabolite levels, 
was not significantly related to postural sway. Increases in workday postural sway were 
associated with demographic variables, including younger age, being a current smoker, 
and higher body mass index. 
Conclusions: Results suggest that acute workday JP-8 exposure does not significantly 
contribute to diminished balance control.  
 
INTRODUCTION 
Jet-propulsion fuel 8 (JP-8) is currently the exclusive jet fuel used by the United 
States Air Force (USAF) for the fueling of its aircraft, ground vehicles and support 
equipment and is widely used in other branches of the US Armed Forces and NATO 
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country militaries (NRC 2003). JP-8, which replaced JP-4 as the primary propulsion fuel, 
is a kerosene-based fuel that contains a mixture of over 200 aliphatic and aromatic 
hydrocarbons (NRC 2003; Smith et al. 1997). The percent volume of hydrocarbons, 
including naphthalene, toluene, and benzene, present in a JP-8 fuel supply can vary and 
depends on the fuel manufacturer, fuel lot, and performance objectives (Ritchie et al. 
2003). The USAF and other militaries consume an estimated 5 billion gallons of JP-8 
every year, making JP-8 the single largest chemical exposure in the USAF (Carlton and 
Smith 2000; Ritchie et al. 2003). 
Because of its widespread use, all Air Force (AF) personnel may be exposed to 
JP-8 through inhalation of fuel combustion exhaust (Ritchie et al. 2003). However, 
personnel working in aircraft fuel-cell maintenance, fuels-specialty, and fuels-
transportation shops are also likely to be exposed to raw fuel and vapor phase via dermal 
contact, inhalation, and incidental ingestion (NRC 2003; Ritchie et al. 2003). There is a 
large body of research characterizing JP-8 exposure among AF personnel and several 
techniques have been employed to determine these exposure levels. These methods 
include the measurement of exposure through breathing zone samples, dermal skin 
samples, analysis of exhaled breath, and urinary biomarkers (Carlton and Smith 2000; 
Chao et al. 2005; Chao et al. 2006; Pleil et al. 2000; Puhala et al. 1997; Serdar et al. 2003; 
Serdar et al. 2004; Smith et al. 2010; Smith et al. 2012; Tu et al. 2004). Urinary 
biomarkers may provide a surrogate measure for combined dermal and inhalation JP-8 
exposure using aromatic hydrocarbons that are readily absorbed into the bloodstream and 
metabolized (Chao et al. 2006; Serdar et al. 2003; Serdar et al. 2004). Studies have shown 
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that levels of naphthalene metabolites (1- and 2-naphthol) in urine samples are 
significantly associated with both dermal and breathing zone sample measurements and 
may be a valid biomarker for total absorbed dose (Chao et al. 2006). In addition, study 
results have demonstrated that urinary 1- and 2-naphthol concentrations significantly 
correspond with a priori classification of low, moderate, and high occupational exposure 
categories (Serdar et al. 2003; Serdar et al. 2004; Smith et al. 2012). 
A smaller number of studies have examined potential neurological health effects 
of JP-8 exposure. Dizziness, headache, nausea, fatigue, slurred speech, mental confusion 
and staggered gait are all symptoms noted after acute JP-8 exposure (Carlton and Smith 
2000; Smith et al. 1997). Similar acute symptoms have been documented among 
individuals who have been exposed to solvents contained in JP-8 (Herpin et al. 2009; 
Hodgkinson and Prasher 2006; Kraut et al. 1988; Vouriot et al. 2005). Research has also 
demonstrated that individuals who are chronically exposed to organic solvents (e.g., n-
hexane, and toluene) show neuropsychological and neurophysiological changes over 
longer periods of time (Kuriwaka et al. 2002; Taylor 1985; White and Proctor 1997; Xiao 
and Levin 2000). Posturography, a technique for measuring postural sway, has been 
utilized as a non-invasive way to measure neurotoxic effects of chemicals and solvents on 
the functional aspects of the central nervous system (CNS). Balance control involves both 
the CNS and the peripheral nervous system, and postural sway measurement quantifies 
the displacement of the body’s center of mass during balance control tasks (Hegeman et 
al. 2007; Kuo et al. 1996). Less efficient balance, or increased postural sway, has been 
noted in workers in many occupational settings involving solvent exposure: adhesive 
	37	
manufacturers, serigraphy plant, leather factory, shipbuilding, shipyard, and sewage 
treatment workers (Herpin et a. 2009; Kuo et al. 1996; Kuriwaka et al. 2002; Ledin et al. 
1989; Vouriot et al. 2005; Yokoyama et al. 1997).  Two studies to date have used 
posturography to examine the possible neurotoxic effects of JP-8 exposure in AF 
personnel (Bhattacharya 2001; Smith et al. 1997). Marginally significant differences in 
postural sway on specific balance tasks were observed for JP-8 exposed personnel, 
demonstrating some functional changes in those chronically exposed to JP-8 compared to 
non-military, healthy controls (Smith et al. 1997). 
The primary aim of this study was to characterize the relationship between acute 
JP-8 exposure and postural sway among a group of AF personnel with varying levels of 
exposure to JP-8 based on job task activities. JP-8 exposure was evaluated using both 
personal breathing zone air levels (naphthalene and total hydrocarbon) and urinary 
biomarkers of exposure (1- and 2-naphthol). We hypothesized that decreased balance 
control, quantified by increased postural sway measurements, would be associated with 
higher acute JP-8 exposure.  
 
METHODS 
Subjects 
A group of male and female Active Duty AF personnel (n=37) participated in a 
postural sway evaluation. These individuals were a part of a larger neuroepidemiology 
study (n=74) in which participants were invited to participate based on the degree to 
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which they were exposed to JP-8 during their current job tasks (Proctor et al. 2011). The 
evaluation of balance control included 23 persons working in current jobs with higher 
levels of JP-8 exposure and 14 persons from jobs involving little to no exposure to JP-8. 
Each participant completed a questionnaire to ascertain demographic information (e.g., 
age, gender, education level), work history (e.g., current job, length of AF service) and 
other lifestyle and physical characteristics (e.g., smoking history, use of alcohol, height, 
weight). 
 
Assessment of Postural Sway 
The Sway StarTM Balance System was used for the postural sway evaluation. The 
Sway StarTM Balance System consists of a belt mounted device that rests against the 
subject’s lower back and contains two digitally based angular velocity transducers that 
measure pitch (anterior/posterior movement) and roll (lateral movement). Measurements 
of angular velocity were collected and calculated as described by Gill et al. (2001). The 
postural sway evaluation protocol involved four stance tasks: (1) standing on two legs 
with eyes open (EO), (2) standing on two legs eyes closed (EC), (3) standing on two legs 
with eyes open on foam support (FO), and (4) standing on two legs with eyes closed on 
foam support (FC). The tasks conducted without the foam support took place on a smooth 
bare surface. The foam support surface was 10 cm thick and 40 cm wide by 50 cm long. 
All tasks were completed without footwear.  
The postural sway evaluation occurred pre-shift and post-shift. The participants 
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performed two trials of each of the four stance tasks, for a total of 8 consecutively 
recorded trials, at both the pre- and post-shift data collection periods. The Sway Star™ 
software computed the total angular area (TAA: deg2), which is the total area 
encompassed by both pitch and roll movements of an individual over a complete trial, 
and the mean path velocity (MPV: deg/s), which is the mean velocity of both pitch and 
roll movements over each completed trial. During the balance control evaluation trials, 
individual movements over a larger total area and with a faster velocity (higher values for 
TAA and MPV, respectively) were generally considered indicative of reduced balance 
control. 
Before starting the series of stance tasks participants were instructed to stand in a 
normal, comfortable position with their arms at their sides. The location of their feet was 
marked with tape so that they stood in approximately the same position for all of the 
trials. During the pre-shift data collection period, before each new stance task, 
participants completed a practice run to become accustomed to the length of the trial and 
the task. Balance data for each pre- and post-shift trial were recorded for 30 seconds. A 
spotter watched the participants throughout all trials for loss of balance defined as the 
participant falling or stepping off the foot tape markings. Additionally, an investigator 
monitored the participants for any voluntary movements, such as hand movements, and 
noted them in a study log. If voluntary movements were excessive (e.g., sneezing), 
recorded data from that trial was excluded from analysis.   
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JP-8 Exposure Measures 
Breathing zone sampling was conducted using a Casella Apex Pro IS (Casella 
USA, Amherst, NH) personal air sampling pump worn by participants conducting work 
tasks throughout an entire work-shift. The personal air sampling pump was turned off 
during breaks from job tasks in which the participant left the work area (e.g., lunch, 
cigarette break). Personal air sampling and analytical methods have been described in 
Merchant-Borna et al. (2012). Work-shift breathing zone samples were collected on four 
consecutive workdays, including the same day as the postural sway evaluation. Air 
samples were collected and extracted in accordance with OSHA Method 35 for 
naphthalene and NIOSH Methods 1550 for THC (NIOSH 1994; OSHA 1982). Breathing 
zone samples were analyzed using gas chromatography mass spectrometry (GC/MS) in 
selective ion monitoring (SIM) mode for naphthalene and THC. Samples determined to 
be below the limit of detection (LOD – calculated as 3 times the standard deviation of the 
field blanks) were replaced with a value half the LOD. Air concentrations are presented 
as mg/m3 for THC and as µg/m3 for naphthalene.  
In addition, pre- and post-shift urine samples were collected on the same day as 
the postural sway evaluation. Samples were collected in 15-mL polyethylene cups and 
stored frozen until sent to the Center for Disease Control laboratory for analysis. Urine 
samples were analyzed for urinary metabolites of naphthalene (1- and 2-naphthol), using 
gas chromatography/mass spectrometry and for creatinine levels (Smith et al. 2012). 
Samples determined to be below the limit of detection (LOD – calculated as 3 times the 
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standard deviation of the field blanks) were noted as <LOD. No samples in this subgroup 
analysis were <LOD. 
 
Data Analysis 
For analyses of the postural sway data, the duration of each trial was truncated 
from 30 seconds to 20 seconds. Five seconds from the beginning and end of the data 
recording were not included in the analyses to ensure stability of data (Gill et al. 2001). 
The average TAA and MPV for the two trials were used in the analysis.  In cases where a 
trial was excluded (n=3) from the analysis due to excessive movement (e.g., sneezing), 
data from the non-excluded trial from the same subject was used in the place of an 
averaged measurement.  Analyses were performed for the EO task which is best utilized 
as a screening for gross balance problems and for the three balance task scenarios that are 
most sensitive to subtle balance deficits (i.e. EC, FO, FC) (Allum et al. 2001; Allum and 
Carpenter 2005). No participants lost their balance during any of the study trials.  
For analyses examining the relationship between acute JP-8 exposure and 
balance, the 8-hour time-weighted averages (8-hr TWA) for breathing zone air samples 
on the day of balance testing were determined. Urinary biomarkers of exposure were used 
as an additional measure of acute JP-8 exposure. Data analyses were conducted 
separately, using both creatinine-adjusted and unadjusted naphthol levels, but since 
differences in results were minimal, we have only reported the creatinine-adjusted urinary 
1- and 2-naphthol (µg/g creatinine).  
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Demographic data of the a priori high and low exposure groups were compared 
using Student t test for continuous variables or chi-square statistics for categorical 
variables. A comparison of means was used to compare the mean postural sway variables 
from this study with age-matched, non-clinical reference values embedded in the Sway 
StarTM software (Allum and Honegger 2009; Gill et al. 2001).  
Multiple linear regression analyses were used to examine potential associations 
between JP-8 exposure and postural sway outcomes. Post-shift TAA and MPV were the 
dependent variables of interest to quantify postural sway. Postural sway variables were 
natural log transformed to reduce skewness for regression analyses. For each independent 
exposure variables of interest, three separate models were run for each of the dependent 
variables (TAA and MPV) reflecting the four stance tasks (EO, EC, FO, and FC). In 
those models examining acute breathing zone exposure, the independent variables were 
8-hr TWA THC and 8-hr TWA naphthalene (each examined in separate models). In 
models examining urinary biomarker of exposure, the independent variables were post-
shift 1-naphthol and 2-naphthol (examined in separate models).  
Covariates considered included age (continuous), current smoking status (yes/no), 
and body mass index (BMI – kg/m2) computed based on self-reported height and weight 
information. In all models, the pre-shift postural sway variables were included to account 
for pre-shift performance levels. In all models, the exposure measure was forced to 
remain in the model in a regression step following the stepwise entry of the covariates (p-
value ≤ 0.15 for inclusion and p-value ≥ 0.20 for exclusion).  
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Three sets of post hoc analyses were conducted. First, we evaluated the influence 
of age on balance performance. Specifically, t-tests were conducted to determine if 
individuals aged 25 or younger presented a different pattern of postural sway 
performance compared to individuals older than 25. We also examined the role of current 
alcohol use (yes/no) on the regression results. Additionally, to examine whether long-
term or chronic exposure to JP-8 was a significant predictor of balance performance, 
years of AF service was included in the regression models. Since age was highly 
correlated with years of AF service (r = 0.91), age was omitted as a covariate for these 
latter post hoc analyses.  
A Bonferroni correction was used to account for multiple comparisons (4 models 
for each postural sway outcome), with a p-value ≤ 0.013 indicating significant results in 
the multiple linear regression models. SPSS Statistics Version 19.0 software (IBM SPSS 
Statistics 19, IBM Corporation, Somers, NY) was used for all data analyses.  
 
RESULTS 
Participant characteristics of those in the neuroepidemiology study and balance 
study subgroup are presented in Table 3.1. As in the overall study, those in the balance 
study subgroup ranged in age from 18.6 to 43 years. Also, the majority of participants 
were in the lower enlisted ranks, white (Caucasian) and married. There were significantly 
more males in the high JP-8 exposure group compared to the low JP-8 exposure group 
(100% vs. 71.4%; p=0.015).  Compared with the larger neuroepidemiology study group, 
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the balance study participants were slightly older, had more years of active AF service, 
and included a higher proportion of individuals with a history of previous overseas 
deployment. 
In general, increased sway, quantified by increases in both MPV and TAA, was 
observed as the support-surface changed (no foam versus foam) and as the stance task 
became more challenging (Table 3.2). This trend was observed during pre-shift and post-
shift task performance. Among both the a priori high and low exposure groups, the 
largest sway values were observed during the eyes closed on foam (FC) support stance 
task. Results from the comparison of overall study postural sway data with reference 
norms from Sway StarTM found that regardless of exposure group, the AF personnel 
performed better, sometimes significantly so, in each stance task at both pre- and post-
shift testing points (Table 3.2). AF personnel demonstrated similar performance 
compared to reference MPV and TAA values on the eyes closed (EC) stance task. 
However, their performance on the more challenging tasks (eyes open on foam (FO) and 
eyes closed on foam (FC)) was significantly better than those from the reference 
population. No significant differences between the a priori exposure groups were 
observed for either the pre-shift MPV or TAA postural sway measurements or post-shift 
postural sway measurements (Table 3.2).  
Work-shift breathing zone air samples were significantly higher among the a 
priori high exposure group compared to the low exposure group for both THC (geometric 
mean (GM)high = 4.4 mg/m3, GMlow = 0.9 mg/m3, p = 0.023) and naphthalene (GMhigh = 
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4.8 µg/m3, GMlow = 0.7 µg/m3, p = 0.008). Creatinine-adjusted urinary naphthol levels 
increased in both a priori exposure groups during the work-shift (Figure 3.1). In both 
exposure groups, pre-shift measured levels of 2-naphthol (GMhigh = 3.27 µg/g creatinine, 
GMlow = 4.33 µg/g creatinine, p = 0.21) were higher than pre-shift measured levels of 1-
naphthol (GMhigh = 2.91 µg/g creatinine, GMlow = 1.47 µg/g creatinine, p = 0.14). The 
same trend was observed for post-shift levels of 1-naphthol (GMhigh = 4.04 µg/g 
creatinine, GMlow = 2.44 µg/g creatinine, p = 0.25) and 2-naphthol (GMhigh = 4.25 µg/g 
creatinine, GMlow = 4.45 µg/g creatinine, p = 0.73).  
In regression analyses, acute JP-8 exposure, as measured by 8hr TWA THC 
personal breathing zone air samples, was not significantly associated with increased sway 
velocity (MPV) or increased angular area (TAA) (Table 3.3). Though 8hr TWA THC 
was not a significant predictor, the multivariate models that included the combination of 
acute THC exposure, pre-shift balance performance, and demographic covariates 
accounted for 45.2 – 65.9% of the variance in post-shift MPV and 39.3 – 62.2% of 
variance in post-shift TAA. The pre-shift measures of these balance outcomes were 
significant predictors in each MPV and TAA model run for each balance task. Younger 
age was a significant predictor of balance control in FC task models. In all cases, higher 
r2 values were observed in the models where MPV was the outcome of interest compared 
to models where TAA was the outcome of interest. Similar results were observed for 8hr 
TWA naphthalene (Table 3.4). Naphthalene 8hr-TWA exposure measure was not 
significantly associated with increased postural sway (MPV or TAA), and no additional 
variance in postural sway performance was explained by this exposure measure 
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compared to that with THC exposure.  
Biomarkers of acute JP-8 exposure, quantified by creatinine adjusted 1-naphthol 
and 2-naphthol levels, were not significantly associated with either MPV or TAA (Tables 
3.5 and 3.6). In models with 1-naphthol as the exposure measure, the strongest predictor 
for the post-shift measurements of MPV and TAA for all four of the balance tasks was 
the pre-shift measurement of MPV or TAA (Table 3.5). All models were significant with 
the combination of variables included and accounted for 40–60% of the variance in the 
balance outcomes (MPV R2 = 0.529 – 0.678; TAA R2 = 0.449 – 0.607; Table 3.5). 
Similar results were seen when creatinine adjusted 2-naphthol was entered into the model 
as the exposure covariate (Table 3.6). Models were all significant, with a range of MPV 
R2 = 0.521 – 0.672 and TAA R2 = 0.426 – 0.608. Again, the highest R2 values were 
observed in the MPV regression models.  Pre-shift measures of MPV and TAA remained 
the most significant predictor of post-shift outcomes in all four balance tasks, and age 
was a significant negative predictor in the FC task models.  
In the post hoc analyses, although there was a somewhat wider variance in both 
sway area and velocity outcomes among those aged 25 years or younger compared to 
those older than 25 years, particularly on the eyes closed on foam task, no statistically 
significant differences were observed for any of the balance measures. Recent alcohol use 
was not found to be a significant predictor of MPV or TAA. Similar to the findings 
observed for age, years of AF service was a significant negative predictor of MPV and 
TAA in the most difficult balance task, FC. 
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DISCUSSION 
In this study, no significant associations between balance performance and 
workday exposure to JP-8 using either work-shift breathing zone area levels of THC and 
naphthalene or urinary 1- and 2-naphthol were observed. We did observe that as the 
difficulty of the balance task increased (comparing EO to EC to FO to FC tasks) postural 
sway performances were adversely influenced, as observed by increased (wider) sway 
areas (TAA) with accompanying faster sway velocities (MPV).  
In a sample of AF personnel, Bhattacharya (2001) observed a significant 
association between acute, passive naphthalene exposure and increased sway. However, 
this association was only seen during the EC balance task, and JP-8 exposure estimated 
from area measurements rather than a personal measure of JP-8 exposure. Our findings 
do coincide with the results of acute JP-8 exposure models reported by Smith et al. 
(1997). Using 8-hour personal breathing zone samples of benzene, toluene, and xylene as 
the measurement of acute JP-8 exposure, Smith et al. (1997) found no significant 
relationship between acute JP-8 exposure and postural sway performance. In terms of 
covariates, Smith et al. (1997) found age and weight to height ratio contributed 
significantly to increased postural sway measurements. While we observed similar results 
with BMI, in several of our regression models (particularly on FC tasks) age was 
negatively associated with post-shift balance performance. The commonly reported 
relationships between age and balance performance indicate postural control decreases in 
older individuals and remains steady in young and middle aged populations (age range 25 
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– 65) (Gill et al. 2001; Hegeman et al. 2007). Approximately half of our study population 
was aged 25 or younger, and it has been observed that postural sway is increased in those 
in the 5 – 25 year old range (Hegeman et al. 2007). Presumably, as a result of our young, 
healthy, and physically active study population, we surmise that the negative associations 
we observe between age and balance performance measures in this study are most likely 
due to the generally young age and healthy fitness level of our study population and do 
not demonstrate a practical or clinical difference related to age.  
All personal exposure levels for THC were below the ACGIH threshold limit 
value for jet fuels (200 mg/m3) which also serves as the occupational exposure limit for 
the USAF (Smith et al. 2010). The absence of a significant relationship between the acute 
exposure measure and post-shift balance performance could be related to lower observed 
JP-8 exposure concentrations in our AF population compared to previously published 
studies of AF personnel (Merchant-Borna et al. 2012). Carlton and Smith (2000) reported 
full-shift mean THC levels of 14.2 mg/m3 and Puhala et al. (1997) reported full-shift 
mean naphthalene levels of 10 mg/m3. These full-shift mean levels are higher than levels 
found in our a priori high exposure category. Chao et al. (2006) reported post-shift levels 
of unadjusted 1-naphthol and 2-naphthol at 28 ng/ml and 38 ng/ml, respectively. These 
reported post-shift levels of both urinary naphthols were 4–5 times higher than levels 
found in our high JP-8 exposed group (unadjusted 1-naphthol = 7.7 ng/ml and 2-naphthol 
= 8.1 ng/ml). Similarly, Serdar et al. (2003), reported 1- and 2-naphthol geometric means 
for low, moderate, and high exposed JP-8 smokers and nonsmokers. The pre- and post-
shift levels measured in our AF personnel population were either similar or lower than 
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those reported by Serdar et al. (2003). In this study, compared to earlier studies, the lower 
observed exposure levels may be related to a lack of handling fire-suppressant foam 
required for certain aircraft, which often becomes saturated with JP-8 (Smith et al. 2012).  
A larger percentage of smokers in the low exposure group and the relationship 
between cigarette smoke and urinary naphthols may explain why our low exposed group 
had slightly higher levels of 2-naphthol compared to the high exposed group (Figure 3.1). 
Serdar et al. (2004) reported different rates of naphthol production in smokers and 
nonsmokers depending on JP-8 exposure level. Among individuals exposed to low levels 
of JP-8, smokers had a higher rate of 2-naphthol production compared to nonsmokers. 
The rate of 2-naphthol production was lower in high exposed individuals and did not vary 
by smoking status (Serdar et al. 2004). These results suggest different metabolic 
pathways for absorbed naphthalene depending on the primary source, cigarette smoke 
versus JP-8, of naphthalene. 
In addition to relatively low exposure levels observed in this study, the modest 
sample size, while adequate to enable identification of clinically-relevant (15–25%) 
differences, may have further limited the ability to detect sub-clinical differences in 
postural sway outcomes associated with low-level JP-8 exposure.  
This study had several notable strengths. First, in contrast with other studies that 
have examined neurological health effects of JP-8 exposure in the military our study 
participants were all Active Duty AF personnel (Smith et al. 1997). Therefore, with the 
exception of their level of JP-8 exposure, a priori low and high JP-8 exposure groups 
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were similar on demographic and non-exposure work experience variables. An 
unexposed healthy comparison group from the general (non-military) population does not 
necessarily provide an adequate comparison with regards to important demographic and 
non-exposure military work experience variables.  Second, the ability to include 
measurement of personal JP-8 exposure using both individual breathing zone samples 
and urinary biomarkers provided a more complete objective documentation of individual 
JP-8 exposure than reliance on self-reported JP-8 exposure or job task categories 
(Merchant-Borna et al. 2012). Moreover, the use of the Sway Star™ instrumentation 
allowed for non-invasive but objective measurement of postural sway control. Also, 
because we measured postural sway at two time points (pre- and post-shift) we were able 
to control for pre-shift postural sway performance. In terms of study design, we observed 
minimal differences in descriptive characteristics between participants in the higher and 
lower exposure groups, thus confounding and misclassification of exposure and outcome 
status are not major concerns for the study (Proctor et al. 2011). 
 
CONCLUSION 
This study was designed to focus on measurement of acute workday and 
workweek JP-8 exposure, which we found had no significant relationship with post-shift 
balance performance. In contrast to our study, Smith et al. (1997) did demonstrate a 
significant relationship between an estimated cumulative JP-8 exposure and increased 
postural sway in a group of AF personnel that were both older (35 years compared to 27 
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years old in this study) and with more years of service (12 years compared to 7 years in 
this study). This finding may support a continued interest in studying chronic 
occupational exposure to JP-8 and its relationship to balance and other neurological 
outcomes. 		
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Table 3.1. Participant Demographics and Pre-shift Measurements 
 
Variable 
 
Mean (SD) 
[Range] 
Overall 
Study 
Group 
(n=74) 
 
 Balance 
Study 
Subgroup 
(n=37) 
 
High 
exposure+ 
(n=23) 
Low 
exposure+ 
(n=14) 
Age 25.8 (6.3) 
[18.6‒43.0] 
 26.8 (6.7) 
[18.6‒43.0] 
26.9 (6.8) 
[18.6‒40.8] 
26.6 (6.9) 
[19.4‒43.0] 
Education 12.5 (1.4) 
[12‒20] 
 12.5 (1.0) 
[12‒16] 
12.5 (1.0) 
[12‒16] 
12.5 (0.9) 
[12‒14] 
Years Active AF Service 5.8 (5.4) 
[0.5‒20.0] 
 6.6 (5.6) 
[0.5‒-20.0] 
6.5 (5.5) 
[0.5‒17.0] 
6.8 (6.0) 
[0.8‒20.0] 
BMI 26.2 (3.5) 
[17.8‒34.4] 
 25.6 (3.2) 
[21.5‒34.4] 
26.4 (3.2) 
[21.5‒34.4] 
24.4 (3.0) 
[21.7‒31.1] 
N (%)      
Rank 
    E2 – E4  
    E5 – E8 
 
45 (60.8) 
29 (39.2) 
  
19 (51.4) 
19 (48.6) 
 
12 (52.2) 
11 (47.8) 
 
 7 (50.0) 
 7 (50.0) 
Ethnicity 
     White (Caucasian) 
     Non-White 
 
53 (71.6) 
21 (28.4) 
  
27 (73.0) 
10 (27.0) 
 
17 (73.9) 
 6 (26.1) 
 
10 (71.4) 
 4 (28.6) 
Male 62 (83.8)  33 (89.2) 23 (100.0) 10 (71.4)* 
Married 40 (54.1)  21 (56.8) 13 (56.5)  8 (57.1) 
Deployed overseas > 30 
days 
39 (52.7)  24 (64.9) 15 (65.2)   9 (64.3) 
Currently Smoke 32 (43.2)  18 (48.6) 11 (47.8)  7 (50.0) 
Currently drink alcohol 51 (68.9)  28 (75.7) 18 (78.3) 10 (71.4) 
+ High and low exposure groups from a priori categorizations based on job-type 
activities 
*p<0.05 (Comparison between high and low exposure groups in the balance study)		
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Table 3.2. Summary of postural sway variables 
 Eyes Open (EO) 
Mean (SD) 
Eyes Open on Foam (FO) 
Mean (SD) 
Exposure High 
(n=23) 
Low 
(n=14) 
Overall 
(n=37) 
High  (n=23) Low (n=14) Overall 
(n=37) 
MPV(deg/s) 
  Pre-shift 
  Post-shift 
 
0.376(0.21) 
0.351(0.13) 
 
0.365(0.13) 
0.370(0.11) 
 
0.372(0.18) 
0.358 (0.12) 
 
0.427(0.20) 
0.398(0.17) 
 
0.467(0.18) 
0.437(0.16) 
 
0.442(0.19) 
0.413(0.16)* 
TAA (deg2) 
  Pre-shift 
  Post-shift 
 
0.339(0.53) 
0.236(0.20) 
 
0.224(0.20) 
0.235(0.17) 
 
0.295(0.44) 
0.236(0.19)* 
 
0.453(0.42) 
0.362(0.30) 
 
0.312(0.20) 
0.327(0.15) 
 
0.400(0.36) 
0.349(0.25)* 
 Eyes Closed (EC) 
Mean (SD) 
EC on Foam (FC) 
Mean (SD) 
Exposure High 
(n=23) 
Low 
(n=14) 
Overall 
(n=37) 
High  (n=23) Low (n=14) Overall 
(n=37) 
MPV(deg/s) 
  Pre-shift 
  Post-shift 
 
0.413(0.16) 
0.420(0.18) 
 
0.418(0.12) 
0.419(0.15) 
 
0.415(0.15) 
0.420(0.17) 
 
0.526(0.18) 
0.535(0.17) 
 
0.603(0.27) 
0.583(0.21) 
 
0.555(0.22) 
0.553(0.18)* 
TAA (deg2) 
  Pre-shift 
  Post-shift 
 
0.290(0.20) 
0.354(0.26) 
 
0.273(0.18) 
0.274(0.15) 
 
0.284(0.19) 
0.324(0.23)* 
 
0.542(0.35) 
0.713(0.42) 
 
0.564(0.40) 
0.675(0.62) 
 
0.550(0.36) 
0.700(0.50)* 
 
 [SwayStar™ reference values: MPV/EO=0.385(0.10); MPV/EC=0.444(0.13); 
MPV/FO=0.624(0.19); MPV/FC=0.845(0.31); TAA/EO=0.386(0.31); 
TAA/EC=0.486(0.43); TAA/FO=0.995(1.0); TAA/FC=1.76(1.2). MPV, mean path 
velocity; TAA, total angular area] 
Bolded text - SwayStar™ reference values were compared to overall post-shift postural 
sway performance (*p<0.05) 
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Table 3.3. Regression Model with 8hr TWA Total Hydrocarbons (THC) as Exposure Measure (n=37) 
Dependent Variable     
 Eyes Open (EO) Eyes Closed (EC) Eyes Open on Foam 
(FO) 
EC on Foam (FC) 
 
Post-shift MPV(deg/s)+ 
Intercept 
8hr TWA THC (mg/m3) 
Pre-shift MPV (deg/s) 
Current Smoker 
BMI 
Age 
 
Model R2 
 
Post-shift TAA(deg2)+ 
Intercept 
8hr TWA THC (mg/m3) 
Pre-shift TAA (deg2) 
Current Smoker 
BMI 
Age 
 
Model R2 
 
βǂ (95%CI) 
-0.307 (-0.646, 0.032) 
-0.002 (-0.006, 0.003) 
0.500 (0.335, 0.665)* 
0.236 (0.097, 0.375)* 
- 
-0.012 (-0.023, -0.002) 
 
0.659 
 
 
0.238 (-0.480, 0.955) 
-0.006 (-0.016, 0.004) 
0.602 (0.414, 0.790)* 
- 
- 
-0.033 (-0.056, -0.010)* 
 
0.622 
 
β (95%CI) 
-0.788 (-1.49, -0.084) 
0.002 (-0.004, 0.007) 
0.655 (0.408, 0.902)* 
0.200 (0.032, 0.367) 
0.028 (0.000, 0.055) 
-0.013 (-0.027, 0.000) 
 
0.614 
 
 
-0.549 (-1.05, -0.050) 
0.002 (-0.010, 0.015) 
0.685 (0.388, 0.982)* 
0.343 (-0.039, 0.725) 
- 
- 
 
0.436 
 
β (95%CI) 
-0.451 (-0.679, -0.221) 
0.001 (-0.005, 0.007)  
0.556 (0.339, 0.773)* 
- 
- 
- 
 
0.452 
 
 
0.259 (-0.562, 1.08) 
-0.008 (-0.020, 0.004) 
0.468 (0.253, 0.682)* 
- 
- 
-0.033 (-0.060, -0.005) 
 
0.446 
 
β (95%CI) 
0.328 (-0.007, 0.663) 
-0.001 (-0.006, 0.003) 
0.600 (0.402, 0.798)* 
- 
- 
-0.021 (-0.032, -0.011)* 
 
0.603 
 
 
0.964 (0.121, 1.8) 
-0.004 (-0.017, 0.008) 
0.525 (0.232, 0.818)* 
- 
- 
-0.041 (-0.069, -0.012)* 
 
0.393 
+Dependent variables are natural log transformed.  
ǂ Unstandardized β coefficient 
* p<0.017 
[In all models, the exposure measure was forced to remain in the model in a regression step following the stepwise entry of the 
covariates (p-value ≤ 0.15 for inclusion and p-value ≥ 0.20 for exclusion). 8hr TWA, 8-hour time-weighted average; MPV, 
mean path velocity; TAA, total angular area] 
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Table 3.4. Regression Model with 8hr TWA Naphthalene (NAP) as Exposure Measure (n=37) 
Dependent Variable     
 Eyes Open (EO) Eyes Closed (EC) Eyes Open on Foam 
(FO) 
EC on Foam (FC) 
 
Post-shift MPV(deg/s)+ 
Intercept 
8hr TWA NAP (µg/m3) 
Pre-shift MPV (deg/s) 
Current Smoker 
BMI 
Age 
 
Model r2 
 
Post-shift TAA(deg2)+ 
Intercept 
8hr TWA NAP (µg/m3) 
Pre-shift TAA (deg2) 
Current Smoker 
BMI 
Age 
 
Model r2 
 
β (95%CI) 
-0.303 (-0.633, 0.027) 
-0.004 (-0.011, 0.003) 
0.494 (0.331, 0.657)* 
0.237 (0.103, 0.372)* 
- 
-0.013 (-0.023, -0.003) 
 
0.667 
 
 
0.207 (-0.496, 0.910) 
-0.009 (-0.025, 0.007) 
0.594 (0.407, 0.781)* 
- 
- 
-0.032 (-0.056, -0.009)* 
 
0.622 
 
β (95%CI) 
-0.747 (-1.6, -0.034) 
0.003 (-0.005, 0.012) 
0.666 (0.418, 0.915)* 
0.201 (0.036, 0.365) 
0.026 (-0.002, 0.055) 
-0.013 (-0.027, 0.000) 
 
0.616 
 
 
-0.554 (-1.05, -0.059) 
0.007 (-0.012, -0.026) 
0.693 (0.396, 0.989)* 
0.338 (0.245, 1.85) 
- 
-  
 
0.442 
 
β (95%CI) 
-0.445 (-0.666, -0.225) 
0.000 (-0.009, 0.010) 
0.559 (0.344, 0.775)* 
- 
- 
- 
 
0.451 
 
 
0.220 (-0.581, 1.02) 
-0.012 (-0.031, 0.006) 
0.452 (0.239, 0.664)* 
- 
- 
-0.032 (-0.059, -0.005) 
 
0.448 
 
β (95%CI) 
0.328 (0.000, 0.656) 
-0.003 (-0.010, 0.004) 
0.596 (0.399, 0.793)* 
- 
- 
-0.021 (-0.031, -0.011)* 
 
0.606 
 
 
0.932 (0.097, 1.77) 
-0.005 (-0.024, 0.014) 
0.524 (0.230, 0.818)* 
- 
- 
-0.040 (-0.068, -0.012)* 
 
0.389 
+Dependent variables are natural log transformed.  
ǂ Unstandardized β coefficient 
* p<0.017 
[In all models, the exposure measure was forced to remain in the model in a regression step following the stepwise entry of the 
covariates (p-value ≤ 0.15 for inclusion and p-value ≥ 0.20 for exclusion). 8hr TWA, 8-hour time-weighted average; MPV, 
mean path velocity; TAA, total angular area] 
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Table 3.5. Regression Model with 1-Naphthol (1-NAP) as Exposure Measure (n=37) 
Dependent Variable     
 Eyes Open (EO) Eyes Closed (EC) Eyes Open on Foam 
(FO) 
EC on Foam (FC) 
 
Post-shift MPV(deg/s)+ 
Intercept 
1-NAP (mg/g creatinine) 
Pre-shift MPV (deg/s) 
Current Smoker 
BMI 
Age 
 
Model r2 
 
Post-shift TAA(deg2)+ 
Intercept 
1-NAP (mg/g creatinine) 
Pre-shift TAA (deg2) 
Current Smoker 
BMI 
Age 
 
Model r2 
 
β (95%CI) 
-0.272 (-0.615, 0.071) 
-0.004 (-0.011, 0.003) 
0.514 (0.343, 0.686)* 
0.231 (0.095, 0.368)* 
- 
-0.013 (-0.023, -0.002) 
 
0.663 
 
 
0.147 (-0.593, 0.886) 
-0.002 (-0.017, 0.014) 
0.590 (0.391, 0.789)* 
- 
- 
-0.032 (-0.056, -0.007)* 
 
0.606 
 
β (95%CI) 
-0.394 (-0.685, -0.103) 
0.000 (-0.009, 0.008) 
0.681 (0.411, 0.952)* 
0.202 (0.025, 0.379) 
- 
- 
 
0.517 
 
 
-0.544 (-1.07, -0.039) 
0.005 (-0.013, 0.023) 
0.688 (0.386, 0.990)* 
0.345 (-0.036, 0.727) 
- 
- 
 
0.438 
 
β (95%CI) 
-0.433 (-0.661, -0.206) 
-0.001 (-0.010, 0.008) 
0.567 (0.345, 0.788)* 
- 
- 
- 
 
0.451 
 
 
0.085 (-0.749, 0.918) 
-0.001 (-0.019, 0.017) 
0.450 (0.222, 0.678)* 
- 
- 
-0.030 (-0.019, 0.017) 
 
0.415 
 
β (95%CI) 
0.311 (-0.022, 0.644) 
-0.001 (-0.008, 0.006) 
0.593 (0.385, 0.800)* 
- 
- 
-0.021 (-0.031, -0.010)* 
 
0.599 
 
 
0.899 (0.045, 1.75) 
-0.003 (-0.022, 0.015) 
0.523 (0.221, 0.825)* 
- 
- 
-0.039 (-0.068, -0.010)* 
 
0.385 
+Dependent variables are natural log transformed. 
ǂ Unstandardized β coefficient  
* p<0.017 
[In all models, the exposure measure was forced to remain in the model in a regression step following the stepwise entry of the 
covariates (p-value ≤ 0.15 for inclusion and p-value ≥ 0.20 for exclusion). 8hr TWA, 8-hour time-weighted average; MPV, 
mean path velocity; TAA, total angular area] 
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Table 3.6. Regression Model with 2-Naphthol (2-NAP) as Exposure Measure (n=37) 
Dependent Variable     
 Eyes Open (EO) Eyes Closed (EC) Eyes Open on Foam 
(FO) 
EC on Foam (FC) 
 
Post-shift MPV(deg/s)+ 
Intercept 
2-NAP (mg/g creatinine)  
Pre-shift MPV (deg/s) 
Current Smoker 
BMI 
Age 
 
Model r2 
 
Post-shift TAA(deg2)+ 
Intercept 
2-NAP (mg/g creatinine)  
Pre-shift TAA (deg2) 
Current Smoker 
BMI 
Age 
 
Model r2 
 
β (95%CI) 
-0.261 (-0.604, 0.081) 
-0.007 (-0.017, 0.003) 
0.501 (0.334, 0.667)* 
0.232 (0.097, 0.367)* 
- 
-0.013 (-0.023, -0.003) 
 
0.668 
 
 
0.194 (-0.553, 0.940) 
-0.007 (-0.031, 0.017) 
0.589 (0.394, 0.784)* 
- 
- 
-0.032 (-0.057, -0.008)* 
 
0.610 
 
β (95%CI) 
-0.386 (-0.678, -0.093) 
-0.002 (-0.015, 0.011) 
0.679 (0.409, 0.949) 
0.205 (0.029, 0.382) 
- 
- 
 
0.519 
 
 
-0.533 (-1.06, -0.010) 
-0.001 (-0.029, 0.028) 
0.684 (0.380, 0.989)* 
0.360 (-0.022, 0.743) 
- 
- 
 
0.433 
 
β (95%CI) 
-0.413 (-0.644, -0.182) 
-0.005 (-0.018, 0.009) 
0.565 (0.345, 0.785)* 
- 
- 
- 
 
0.458 
 
 
0.128 (-0.719, 0.974) 
-0.006 (-0.035, 0.022) 
0.441 (0.210, 0.672)* 
- 
- 
-0.030 (-0.059, -0.002) 
 
0.418 
 
β (95%CI) 
0.326 (-0.010, 0.662) 
-0.003 (-0.014, 0.007) 
0.586 (0.379, 0.793)* 
- 
- 
-0.021 (-0.032, -0.011)* 
 
0.603 
 
 
0.906 (0.037, 1.78) 
-0.005 (-0.034, 0.024) 
0.520 (0.214, 0.825)* 
- 
- 
-0.039 (-0.068, -0.010)* 
 
0.385 
+Dependent variables are natural log transformed. 
ǂ Unstandardized β coefficient  
* p<0.017 
[In all models, the exposure measure was forced to remain in the model in a regression step following the stepwise entry of the 
covariates (p-value ≤ 0.15 for inclusion and p-value ≥ 0.20 for exclusion). 8hr TWA, 8-hour time-weighted average; MPV, 
mean path velocity; TAA, total angular area] 
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Figure 3.1. Creatinine Adjusted Urinary Biomarkers during Work-shift 
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ABSTRACT 
Objectives: Across diverse groups of Gulf War (GW) veterans reports of pain, cognitive 
dysfunction, fatigue, and gastrointestinal issues are common. GW illness (GWI) is a 
condition resulting from GW service in veterans who report critical numbers of these 
symptoms. This study integrated the GW literature using meta-analytic methods to 
characterize the most significant symptoms occurring among GW veterans and to better 
understand the spectrum of GWI. 
Design: Meta-analysis 
Primary measures: Data were extracted from published studies to determine pooled 
prevalence and combined odds ratios of health symptoms comparing deployed GW and 
GW-era control veterans. 
Results: GW veterans had higher odds of reporting all 56 analyzed symptoms compared 
to GW-era control veterans, with the largest excess prevalence reported for fatigue, 
memory problems, difficulty concentrating, forgetfulness, and joint pain. Odds of 
reporting irritability, feeling detached, muscle weakness, diarrhea, and rash were more 
than 3 times higher among GW veterans compared to GW-era controls. 
Conclusions: Mood-cognition, fatigue, musculoskeletal, gastrointestinal and 
dermatological symptom domains are critical when assessing GW veteran health status 
and GWI. 
Keywords: meta-analysis, Gulf War veterans, health symptoms, deployment health, Gulf 
War Illness 
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INTRODUCTION 
From 1990 through early 1991, approximately 700,000 troops from the United 
States (US), along with military personnel from over 30 coalition countries, were 
deployed to the Persian Gulf in support of Operation Desert Shield and Operation Desert 
Storm, collectively known as the Gulf War (GW) (RAC-GWVI 2008). After returning 
from the Persian Gulf, US GW veterans reported greater deployment-related health 
problems when compared with veterans of the same era who did not deploy to the Gulf or 
who were deployed elsewhere (e.g. Bosnia, Germany) (CDC 1995; Doebbeling et al. 
2000; Fukuda et al. 1998; Gray et al. 2002; Iannacchione et al. 2011; The Iowa Persian 
Gulf Study Group 1997; Kang et al. 2000; Knoke et al. 2000; Proctor et al. 1998; Shapiro 
et al. 2002; Sostek et al. 1996; Steele 2000; Stretch et al. 1995). Similar reports of 
increased ill health were seen in GW veterans from other countries, including the United 
Kingdom (UK), Australia, Denmark, Canada, and France (Cherry et al. 2001a; Goss 
Gilroy Inc. 1998; Ishoy et al. 1999; Kelsall et al. 2004b; Murphy et al. 2006; Salamon et 
al. 2006; Simmons et al. 2004; Unwin et al. 1999; Unwin et al. 2002). Research indicates 
that these excess health symptoms in GW veterans, known as Gulf War Illness (GWI), 
have remained chronic with no improvement over time (Dursa et al. 2016; Hotopf et al. 
2003; Ozakinci et al. 2006; Proctor et al. 1998; Wolfe et al. 2002).  
GWI is prevalent in 25–32% of US and UK GW veterans and is characterized in 
individual veterans by one of more of the following symptoms: chronic pain, fatigue, 
cognitive dysfunction, gastrointestinal complaints, respiratory symptoms, and skin rashes 
(Fukuda et al. 1998; IOM 2014; RAC-GWVI 2008; RAC-GWVI 2014; Steele 2000). 
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Although some critics have claimed that GWI is not a unique syndrome, this central 
group of symptoms has consistently been used to determine case criteria for the illness 
(Doebbeling et al. 2000; Ismail et al. 1999). Two case definitions for GWI have received 
endorsement for use by the Institute of Medicine, the Centers for Disease Control and 
Prevention (CDC) chronic multisymptom illness (CMI) and the Kansas GWI definition 
(Fukuda et al. 1998; IOM 2014; Steele 2000). According to the CDC CMI case 
definition, a veteran is diagnosed with GWI if s/he reports one or more symptoms that 
last for at least six months in two of three categories: fatigue, musculoskeletal pain, and 
mood/cognition (Fukuda et al. 1998). The Kansas definition requires moderate levels of 
self-reported symptoms in at least three out of six symptom categories: fatigue/sleep, 
pain, neurological/cognitive/mood, respiratory, gastrointestinal and skin (Steele 2000). A 
third set of symptoms used to define GWI are the Haley criteria (Haley et al. 1997). 
These include three syndromes characterized by different symptom clusters. Syndrome 1 
(Impaired cognition) requires reported attention, memory, sleep and depression 
symptoms. Syndrome 2 (Confusion/ataxia) requires reported problems with thinking and 
balance symptoms. Syndrome 3 (Neuropathic pain) requires self-reported joint and 
muscle pain (Haley et al. 1997).  
Uncertainty remains about the sensitivity and specificity of these case definitions. 
The Kansas definition is associated with a more consistent rate of GWI across multiple 
GW populations (34% prevalence in GW veterans) but excludes veterans with certain 
concomitant medical or psychiatric conditions who may also have GWI (IOM 2014; 
Steele 2000; Steele et al. 2012; White et al. 2016). In contrast, depending on the 
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population studied, the CDC case definition includes between 29–60% of GW veterans 
and is considered the most inclusive but the least specific of the case criteria (IOM 2014). 
Finally, the Haley criteria provide a more restrictive characterization of GWI (Haley and 
Tuite 2013). The syndromes were originally devised by assessing a specific military unit 
of US Navy Seabees who showed a 20% rate of GWI (Haley et al. 1997). More current 
estimates in a larger population-based cohort showed that the combined Haley syndromes 
include about 14% of GW veterans (Iannacchione et al. 2011).   
The epidemiological literature on health symptoms among GW veterans has 
identified environmental exposures unique to deployment to the Persian Gulf as etiologic 
agents in the development of specific health outcomes and the occurrence of GWI (RAC-
GWVI 2008; RAC-GWVI 2014; White et al. 2016). Exposures that have been linked to 
health effects in this veteran population include oil well fires, pesticides, pyridostigmine 
bromide pills, and chemical nerve gas agents, with pesticides and pyridostigmine 
bromide exposures most consistently linked to GWI (Haley et al. 1997; Kelsall et al. 
2004b; Proctor et al. 1998; RAC-GWVI 2008; Shapiro et al. 2002; Steele et al. 2012; 
Unwin et al. 1999; Wolfe et al. 2002). However, deployment experiences and exposures 
were not uniform across all troops deployed to the GW (Ismail et al. 2000; Spencer et al. 
2001). Some studies have utilized unit-level characteristics as surrogates of deployment 
exposures and found that illness rates in GW veterans were associated with deployment 
location and time frame of deployment (i.e., Operation Desert Shield, Operation Desert 
Storm) (Gray et al. 2002; The Iowa Persian Gulf Study Group 1997; Ismail et al. 2000; 
Nisenbaum et al. 2000; Steele 2000; Steele et al. 2012). 
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Collectively, prior studies have used several analytical techniques in separate 
cohorts to identify symptom prevalence rates and a common complex of symptoms 
among different groups of GW veterans including cluster analysis, correlation analysis, 
and factor analysis (Cherry et al. 2001a; Doebbeling et al. 2000; Everitt et al. 2002; 
Forbes et al. 2004; Fukuda et al. 1998; Haley et al. 1997; Hallman et al. 2003; Kang et al. 
2002; Knoke et al. 2000; Nisenbaum et al. 2004; Shapiro et al. 2002; Steele 2000). Some 
GW researchers have suggested that development of a new case definition using the data 
now available on the disorder could provide greater clarity and lead to better 
comparability of studies in GWI research (IOM 2014; RAC-GWVI 2014).  
The present study is the first, to our knowledge, to pool published health symptom 
data from different populations of GW veterans and their controls. It uses meta-analytic 
statistical methods to: (1) determine the combined total and excess prevalence of 
individual self-reported symptoms, (2) identify symptoms most commonly reported in the 
GWI literature, and (3) examine the differences in symptom reporting between 
population-based GW cohort studies and GW cohorts recruited from specific military 
units. 
 
METHODS 
Data search 
Two members of the research team (ALM, MKY) used the literature search 
strategy in Figure 4.1 to identify studies examining self-reported health symptoms in 
deployed GW veterans and a relevant veteran comparison group (defined below in Step 
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3). This process was performed in duplicate to ensure that all relevant, peer-reviewed 
GW health symptom studies were identified and reviewed for possible inclusion. 
Step 1, a Medline and Google Scholar database search was filtered for papers 
published between January 1990 and May 2015, and “Human Subjects” and “English” 
language studies. Following the database search, study titles, abstracts, and full 
manuscripts were reviewed for eligibility criteria using a 4-step process. Exclusion 
criteria included the following: (1) the study population included veterans of other wars 
or civilians in conflict zones; (2) the study data were collected in-theater; (3) duplicate 
titles were found or the paper was an editorial commentary. 
Step 2, studies were eliminated if the study’s outcome of interest was not health 
symptoms or health status. From Step 2 forward, if it was unclear whether the study met 
the inclusion/exclusion criteria by reviewing the study title and abstract, full articles were 
reviewed. 
In Step 3, studies were removed if the investigation: (1) had no relevant veteran 
comparison group; (2) was a follow-up survey to an original cohort; (3) did not include 
self-reported health symptoms/conditions. A relevant comparison group was defined as 
non-deployed veterans or veterans who deployed to areas other than the Gulf (e.g., 
Germany, Bosnia) serving in the military during the 1990–1991 GW period; referred to 
as “GW-era controls” throughout the rest of the manuscript.   
In Step 4, studies were eliminated for (1) overlapping GW veteran populations; 
(2) no usable data.  
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Data extraction 
When studies were found to have used survey results from the same veteran 
population (e.g., survey data completed by 4 Air Force units were published by both 
CDC MMWR (1995) and Fukuda et al. (1998)), the prevalence data were extracted from 
the paper that presented results for the greatest number of self-reported health symptoms. 
If different symptoms were reported in the second paper from the same veteran 
population, those specific symptoms were extracted from the second paper. One of the 
eligibility criteria for Step 4 was the availability of usable data. If manuscripts published 
descriptive statistics other than symptom frequency (e.g., mean symptom severity score, 
factor loading score), the corresponding author was contacted with a request for 
frequency data. If a follow-up request went unanswered, the study was eliminated. 
The symptom checklists and wording of specific symptoms differed between 
studies. To determine which health symptoms matched across studies, members of the 
study team (ALM, PAJ, KAS, MHK) completed a qualitative comparison. For example, 
the Knoke et al. (2000) health symptom checklist includes “chest pains” while Simmons 
et al. (2004) used “chest pains and tightness”, and a consensus was reached that these 
symptoms were comparable and both included in analysis of “chest pain.” Once the final 
list of health symptoms that matched across studies was determined, the quantitative data 
were extracted if the symptom was reported in three or more studies. We extracted total 
n, symptomatic n, frequency, standard error, and unadjusted odds ratio for both the 
deployed GW veteran and GW-era controls. If any of the statistics listed above were not 
included, they were calculated using data that could be extracted.  
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Data analysis 
To calculate the pooled prevalence rate of each symptom in both the deployed 
GW veteran and GW-era controls, each symptom frequency from the individual studies 
was transformed using an arcsin transformation (Barendregt et al. 2013). To account for 
heterogeneity between studies, a random-effects maximum likelihood model was used to 
calculate the summary arcsin transformed proportion. The pooled transformed prevalence 
and its 95% confidence limits were back-transformed to a proportion using equations 
published in Barendregt et al. (2013). Excess prevalence was calculated for each 
symptom by subtracting the pooled transformed prevalence of the GW-era controls from 
the pooled transformed prevalence of the deployed GW veterans group.  
 For each health symptom, a summary odds ratio was estimated using a random-
effects binomial-normal model. This two-level model accounts for the binomial 
distribution of proportions and the normal distribution of the study specific odds ratios 
around the summary odds ratio (µ) with a variance term, τ2 (Nyaga et al. 2014). The 
starting values for µ and τ2 were set using the summary log odds estimate from the fixed-
effects model and the variance term from the maximum likelihood random-effects model, 
respectively (Nyaga et al. 2014). Additionally, an offset term (log nGW veterans/nGW-Era 
veterans) was included to account for different sample sizes of GW veterans and GW-era 
controls. 
 
Confounding and bias assessment 
 In a meta-analysis, study characteristics are explored as potential confounders 
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since individual level data are not available. We explored each study’s participant cohort 
sampling strategy as a possible confounder. Studies either had participants who were 
recruited from specific military unit cohorts or participants who were sampled from a 
population-based cohort of deployed GW and GW-era controls. We performed a 
stratified analysis to explore the effect of participant cohort sampling strategy on the 
symptom odds ratios. If the symptom was reported by three or more studies in each 
stratum, the summary odds ratio was estimated for each stratum using the binomial-
normal model described above.  
To assess publication bias on the summary odds ratios, we used a method 
described in Levy et al. (2001). For the studies that did not report an odds ratio for a 
health symptom, the odds ratio for that health symptom was assigned the null (OR = 1.0) 
and the standard error was assumed to be the same as the minimum standard error 
amongst the reported studies. The summary odds ratio was estimated using a maximum 
likelihood random-effects model. We could not use the binomial-normal model for the 
bias assessment because it relies on counts rather than odds ratios for the binomial level 
of the model and for the offset term. Although these models yield slightly different 
results for summary odds ratio estimates, they provide comparable estimates of the 
standard errors. 
 
RESULTS 
The literature search identified 37 peer-reviewed studies examining self-reported 
health symptoms in deployed GW veterans and GW-era control veterans. Fifteen of these 
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studies were excluded because their study populations overlapped with another identified 
study and reported no additional health symptoms that were different from the study with 
an overlapping population. Of the remaining papers, we extracted primary data directly 
from 19 of the studies. We contacted the authors of three additional papers to obtain 
primary data and received data for two of these studies (Cherry et al. 2001a; 
Iannacchione et al. 2011). We did not receive primary data for the third study, which was 
not included in the analysis (Pierce 1997). Table 4.1 gives an overview of the final 
studies used in the meta-analysis, which include data from over 129,000 deployed GW 
veterans and GW-era controls from four different countries, all branches of the military, 
and both Active Duty and Reserve components of the US military. Eleven of the studies 
sampled participants from specific military units (e.g., US Navy Seabees) and 15 were 
population-based studies (Table 4.1). 
A total of 56 distinct health symptoms were reported in three or more studies and 
included in the meta-analysis. Table 4.2 shows the pooled prevalence of each symptom in 
GW veterans and GW-era control veterans. The combined data from these studies show 
that GW veterans have a higher reported frequency of each of these symptoms compared 
to GW-era controls (Table 4.2). The excess prevalence was largest for some of the mood-
cognition symptoms (memory problems: excess prevalence (EP) = 24.2%; forgetfulness: 
EP = 20.4%; difficulty concentrating: EP = 20.1%); pain (joint pain: EP = 20.2%) and 
fatigue (fatigue: EP = 24.9%). 
Table 4.3 presents the results of the summary odds ratios of reporting symptoms 
in GW veterans compared to GW-era controls veterans. Of the 56 symptoms, the most 
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data were available for the analysis of headaches, joint pain, diarrhea/loose stools, 
fatigue, feeling depressed, irritability, rash, and unrefreshing sleep. GW veterans had 
significantly higher odds of reporting all the analyzed symptoms. The odds of reporting 
mood-cognition (feeling detached: OR = 3.59; irritability: OR = 3.21), musculoskeletal 
(muscle weakness/loss of strength: OR = 3.19), gastrointestinal (diarrhea/loose stools: 
OR = 3.24), and dermatological (rash: OR = 3.18) symptoms were over three times 
higher in GW veterans compared to GW-era controls.  
The bias assessment demonstrates that GW veterans continue to have higher odds 
of reporting all the analyzed symptoms compared to GW-era control veterans, and the 
majority of the odds ratios shown in Table 4.3 remain significant after assigning the 
missing studies an OR=1 and the minimum standard error of the reported studies. 
However, the summary measure of effect for loss of balance/coordination, feeling 
detached, lacking energy, joint swelling, flatulence or burping, vomiting, itching, 
sweating, pain during intercourse, asthma, bleeding gums, lump in throat, swollen glands, 
and weight gain were no longer significant (i.e., 95% CI for the OR included null) when 
accounting for possible publication bias (Table 4.3). 
In the meta-analysis stratified by sampling strategy (military unit versus 
population based studies), a total of 19 distinct health symptoms were reported in three or 
more studies in both strata and were included in the analysis. The results of the stratified 
meta-analysis show that odds ratios move further from the null compared to the 
unadjusted meta-analysis in studies with participants recruited from specific military 
units, for all but 2 of the 19 analyzed outcomes (Table 4.4). For self-reported dizziness, 
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irritability, fatigue, and several musculoskeletal, gastrointestinal, and dermatological 
symptoms, the adjusted OR is more than a 10% change away from the null compared to 
the unadjusted symptom OR (Table 4.4). 
 
DISCUSSION 
 Using meta-analytic models, we combined data from 21 studies reporting on 
health symptoms endorsed by over 129,000 deployed GW veterans and GW-era control 
veterans. These 21 studies represented GW veterans from 18 unique veteran populations, 
four different countries, and all branches of the military. Results of the meta-analysis 
showed GW veterans reported all the analyzed symptoms more frequently than GW-era 
controls, indicating that the health problems associated with GW deployment include 
widespread, multiple body symptoms. The largest differences in symptom reporting (i.e., 
20–24% excess prevalence) between the two veteran groups were for the mood-
cognition, pain, and fatigue symptoms. Furthermore, the odds of GW veterans’ reporting 
several mood-cognition, musculoskeletal, gastrointestinal, and dermatological symptoms 
were more than three times higher than GW-era controls. Additionally, in the unadjusted 
meta-analysis, the group of symptoms with the highest combined prevalence (fatigue, 
memory problems, forgetful, joint pain) and the largest summary odds ratios (irritability, 
feeling detached, muscle weakness, diarrhea, and rash) are consistent with the cluster of 
symptoms reported by GW veterans with GWI (Fukuda et al. 1998; Haley et al. 1997; 
Steele 2000). Although it was not possible in this meta-analysis to compare overlapping 
symptom reporting at the individual level across studies, Smith et al. (2013) recently 
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reported that nearly half of all respondents in their population-weighted sample endorsed 
symptoms in all three CDC criteria categories (fatigue, mood-cognition, 
musculoskeletal), with 96% of GWI cases reporting mood-cognition symptoms. 
We also characterized studies based on their cohort sampling strategy and 
performed a stratified meta-analysis comparing population based studies to military-unit 
based studies, using military-unit as a surrogate for deployment exposures. The stratified 
analysis showed evidence of confounding by sampling strategy. In studies where 
participants were sampled from specific military units, the adjusted summary odds ratios 
were higher compared to the unadjusted summary odds ratios. These results agree with 
previous studies that found GW veteran health problems were associated with 
deployment/operational time frame and location and may be reflective of specific 
deployment exposures experienced by different military-units in the GW theater (Gray et 
al. 2002; Haley et al. 1997; Haley and Tuite 2013; Ismail et al. 2000; Nisenbaum et al. 
2000; Spencer et al. 2001; Steele 2000; Steele et al. 2012). In our stratified analysis, 
several of the symptoms with higher adjusted odds ratios in the military-unit cohort 
studies have been associated with GW exposures in previous research. For example, in 
the Fort Devens cohort, Proctor et al. (1998) found that musculoskeletal symptom 
reporting was associated with pesticide and chemical warfare agent exposure, while 
neurological and psychological symptoms were linked to self-reported exposure to debris 
from SCUDS and chemical warfare agents. Similarly, McCauley et al. (2001) found that 
self-reported exposure to chemical warfare agents was associated with fatigue and 
gastrointestinal symptoms, and Cherry et al. (2001b) found that exposure to pesticides 
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was related to neurological, dermatological and musculoskeletal symptoms. 
A major strength of this meta-analysis is the method used to estimate the 
summary measures of effect. The binomial-normal model is recommended for rare 
events, which made the analysis of some of the lesser reported health symptoms more 
robust. Moreover, both the Freeman-Tukey transformation of proportions and the 
binomial-normal model are designed to analyze binary outcomes and take into account 
the non-normal distribution of the prevalence and odds ratio effect estimate, in contrast to 
the fixed-effects of maximum likelihood random-effects model, which assumes normal 
distributions and is the traditional meta-analytic approach. 
As mentioned previously, a limitation of a meta-analysis is the lack of individual 
level data. Consequently, we were not able to assess the effect of some covariates 
relevant to health symptom reporting (e.g., PTSD and specific deployment exposures). 
While some of the primary studies published adjusted odds ratios, we extracted or 
calculated unadjusted odds ratios in this meta-analysis because effect measures were not 
adjusted for the same covariates across all studies (Gray et al. 2002; The Iowa Persian 
Gulf Study Group 1997; Kelsall et al. 2004b; Murphy et al. 2006; Proctor et al. 1998; 
Simmons et al. 2004; Steele 2000; Unwin et al. 1999; Unwin et al. 2002). This limits 
comparability of the combined study data and increases the heterogeneity across studies. 
Another limitation of the meta-analytic approach is the effect of publication bias 
on results. Publication bias occurs when studies with positive findings are more likely to 
be published than studies with null and/or negative findings. In this analysis we were 
limited to peer-reviewed, published literature on GWI and then further limited by the 
		74 
number of health symptoms reported by each study. To address the latter issue, we 
performed a bias analysis where individual study odds ratios were assigned the null value 
for a symptom that was unreported. The meta-analysis was re-run with the null odds 
ratios, and 42 out of the 56 summary odds ratios remained significant (Table 4.3), 
demonstrating that the significant associations between GW veteran status and self-
reported health symptoms cannot be attributed solely to publication bias. Lastly, studies 
were evaluated using a hypothesis validity checklist outlined by Wampold et al. (1990), 
however, we used other methods to assess the risk of bias on our results. 
 
CONCLUSION 
 Results of this meta-analysis of 21 health symptom studies provides the first 
comprehensive reference of pooled health symptom data from 129,000 deployed GW and 
GW-era control veterans representing four different countries and all branches of the 
military.  The excess prevalence and odds ratios found in this meta-analysis indicate that 
the mood-cognition, fatigue, musculoskeletal, gastrointestinal, and dermatological 
symptom domains should be considered in attempts to derive a new consensus case 
definition of GWI. They should also continue to be utilized in symptom surveys when 
assessing GW veterans for illness biomarkers or treatment trial efficacy (IOM 2014; 
RAC-GWVI 2008; RAC-GWVI 2014). The stratified analysis demonstrated important 
differences by study sampling strategy, with higher symptoms odds ratios in studies of 
specific military-unit cohorts, potentially reflecting symptoms that are associated with 
specific deployment-related exposures that warrant further study.  
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DATA SHARING STATEMENT 
All of the data, with the exception of Iannacchione et al. (2011) and Cherry et al. 
(2001a), was extracted from published, peer-reviewed journal articles. Corresponding 
authors from Iannacchione et al. (2011) and Cherry et al. (2001a) were contacted for the 
primary data relevant to this meta-analysis. 
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TABLE 4.1. Overview of 21 peer-reviewed studies used in health symptom meta-
analysis 
Author 
Year 
Published 
GWV 
(N) 
NGV 
(N) 
Sampling 
Strategy 
Country Date of Collection 
CDC MMWR – Unit A* 1995 313 364 
Military 
unit 
US January – March 1995 
CDC MMWR – Unit B* 1995 119 421 
Military 
unit 
US January – March 1995 
CDC MMWR – Unit C* 1995 262 581 
Military 
unit 
US January – March 1995 
CDC MMWR – Unit D* 1995 470 1397 
Military 
unit 
US January – March 1995 
Cherry 2001 8014 3900 Population UK 
December 1997 – September 
1999 
Doebbeling† 2000 1896 1799 Population US September 1995 – May 1996 
Fukuda* 1998 1163 2538 
Military 
unit 
US January – March 1995 
Gray 2002 3831 3104 
Military 
unit 
US May 1997 – July 1999 
Iannacchione 2011 6480 1522 Population US May 2007 – April 2009 
Iowa – Active Duty† 1997 985 968 Population US September 1995 – May 1996 
Iowa – NG/Reserve† 1997 911 831 Population US September 1995 – May 1996 
Ishoy 1999 686 231 Population Denmark 
January 1997 – January 
1998 
Kang 2000 11441 9476 Population US 
1995 – No end date 
mentioned 
Kelsall 2004b 1430 1533 Population Australia August 2000 – April 2002 
Knoke 2000 524 935 
Military 
unit 
US Late 1994 – early 1995 
Murphy 2006 149 622 Population UK 2002 – 2003 
Nisenbaum‡ 2004 3454 2577 Population UK 
November 1997 – 
November 1998 
Proctor# 1998 186 48 
Military 
unit 
US Spring 1994 – Fall 1996 
Shapiro 2002 610 516 Population US October 1998 – April 1999 
Simmons 2004 23358 17730 Population UK August 1998 – March 2001 
Sostek 1996 57 44 
Military 
unit 
US 
1994 – No end date 
mentioned but published 
Dec 1996 
Steele 2000 1435 409 Population US February – August 1998 
Stretch – Active Duty 1995 715 1576 
Military 
unit 
US 
No mention but published in 
1995 
Stretch – Reserves 1995 766 948 
Military 
unit 
US 
No mention but published in 
1995 
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Unwin – Male‡ 1999 3284 2408 Population UK 
August 1997 – November 
1998 
Unwin – Female‡ 2002 236 192 Population UK 
August 1997 – November 
1998 
GWV: deployed Gulf War veterans; NGV: Gulf War era control veterans; CDC MMWR: Centers 
for Disease Control and Prevention Morbidity and Mortality Weekly Report; US: United States; 
UK: United Kingdom; NG: National Guard  
* Overlapping populations; for Fukuda (1998) only used symptoms that were not reported in 
CDC MMWR (1995) 
† Overlapping populations, for Doebbeling (2000) only used symptoms that were not reported in 
Iowa (1997) 
# NGV group for Proctor (1998) was GW-Era personnel deployed to Germany; all other control 
groups were non-deployed GW-Era veterans 
‡ Overlapping populations, for Nisenbaum (2004) only used symptoms that were not reported in 
Unwin (1999, 2002) 
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TABLE 4.2. Frequency of self-reported symptoms in Gulf War veteran (GWV) and Gulf 
War era control veteran (NGV) populations 
 
 
Self-reported symptom 
GWV 
Frequency (%) 
(95% CI) 
NGV 
Frequency (%) 
(95% CI) 
Excess 
Prevalence 
Fatigue 41.3 (32.3, 50.6) 16.4 (10.3, 23.4) 24.9 
Memory problems 39.8 (31.0, 49.0) 15.6 (9.1, 23.5) 24.2 
Forgetful 35.2 (29.5, 40.8) 14.7 (7.6, 23.5) 20.4 
Joint pain 35.1 (29.5, 40.8) 14.9 (11.4, 18.8) 20.2 
Difficulty concentrating 33.7 (27.2, 40.4) 13.6 (9.2, 18.7) 20.1 
Unrefreshing sleep 43.3 (33.4, 53.4) 23.4 (14.6, 33.6) 19.8 
Lacking energy 47.0 (36.9, 57.2) 27.4 (18.6, 37.1) 19.6 
Irritability 31.2 (22.4, 40.8) 11.6 (6.1, 18.6) 19.6 
Difficulty sleeping, falling or 
staying asleep 38.9 (33.5, 44.5) 20.9 (15.4, 26.9) 18.0 
Joint stiffness 31.3 (28.1, 34.7) 14.0 (9.7, 18.9) 17.4 
Feeling detached 24.1 (18.5, 30.1) 6.7 (3.4, 11.0) 17.4 
Sleepiness 29.7 (17.1, 44.0) 12.4 (4.0, 24.1) 17.3 
Headaches 43.4 (35.5, 51.4) 26.2 (18.9, 34.2) 17.2 
Rash 24.8 (20.3, 29.6) 8.1 (5.2, 11.6) 16.7 
Sinus congestion 40.4 (35.4, 45.6) 25.1 (20.6, 30.0) 15.3 
Diarrhea/loose stools 21.8 (15.6, 28.8) 6.7 (4.2, 9.8) 15.1 
Flatulence or burping 44.6 (32.6, 56.9) 30.1 (16.5, 45.6) 14.5 
Recurrent headaches 25.5 (19.7, 31.8) 11.0 (6.1, 17.1) 14.5 
Itching 29.7 (17.1, 44.1) 15.5 (7.2, 26.1) 14.3 
Trouble finding words 23.4 (15.9, 31.8) 9.2 (4.1, 16.0) 14.2 
Muscle aches/pain 25.1 (19.7, 33.3) 11.7 (6.5, 18.1) 13.4 
Bleeding gums 17.4 (4.3, 35.7) 5.7 (0.0, 17.2) 11.7 
Ringing in ears 26.8 (21.1, 32.9) 15.2 (10.3, 21.0) 11.6 
Dizziness 19.8 (15.4, 24.6) 8.2 (5.6, 11.3) 11.6 
Night sweats 15.7 (10.9, 21.3) 4.4 (2.4, 6.8) 11.4 
Weight gain 20.3 (16.2, 24.8) 9.0 (7.6, 10.5) 11.3 
Numbness and tingling in body 
parts 20.7 (13.0, 29.5) 9.4 (5.6, 11.3) 11.2 
Sweating 28.8 (15.8, 43.8) 17.7 (8.4, 29.4) 11.1 
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TABLE 4.2 (continued). Frequency of self-reported symptoms in Gulf War veteran 
(GWV) and Gulf War era control veteran (NGV) populations 
 
 
Self-reported symptom 
GWV 
Frequency (%) 
(95% CI) 
NGV 
Frequency (%) 
(95% CI) 
Excess 
Prevalence 
Abdominal pain and cramps 19.7 (14.0, 26.1) 8.9 (5.7, 12.8) 10.8 
Back pain 36.2 (30.1, 42.6) 25.5 (18.3, 33.5) 10.7 
Loss of appetite 15.5 (6.3, 27.6) 5.1 (1.8, 9.7) 10.5 
Muscle weakness/loss of 
strength 15.1 (10.3, 20.6) 4.7 (2.8, 7.2) 10.3 
Coughing 19.8 (14.1, 26.2) 9.7 (6.3, 13.7) 10.1 
Feeling depressed 18.1 (13.5, 23.1) 8.0 (5.6, 10.8) 10.0 
Shortness of breath 15.2 (11.3, 19.5) 5.4 (3.3, 7.9) 9.8 
Chest pain 17.1 (9.3, 26.7) 7.4 (3.4, 12.7) 9.7 
Loss of balance/coordination 17.0 (10.1, 25.2) 7.5 (3.8, 12.2) 9.6 
Sore throat 21.1 (15.0, 28.0) 11.7 (7.2, 17.1) 9.5 
Wheezing 18.3 (9.7, 28.8) 9.2 (3.9, 16.3) 9.1 
Nausea 15.4 (11.4, 20.0) 6.7 (3.6, 10.5) 8.8 
Nightmares 13.1 (6.1, 22.1) 4.7 (1.2, 10.1) 8.4 
Feeling anxious/anxiety 12.2 (5.3, 21.3) 4.3 (1.0, 9.5) 7.9 
Irregular heart beat 17.8 (5.9, 33.6) 10.0 (3.1, 19.7) 7.8 
Loss of interest in sex 14.0 (4.6, 26.9) 6.4 (1.4, 14.1) 7.6 
Hair loss 12.6 (6.9, 19.7) 5.0 (1.8, 9.6) 7.6 
Chemical sensitivity 14.7 (8.2, 22.7) 7.2 (3.4, 12.3) 7.5 
Tremors and/or shaking in 
body parts 11.0 (10.6, 11.4) 4.0 (3.7, 4.4) 6.9 
Joint swelling 11.0 (5.4, 18.2) 4.6 (1.3, 9.5) 6.4 
Constipation 10.8 (7.4, 14.8) 4.9 (2.5, 8.0) 6.0 
Swollen glands 10.7 (5.5, 17.3) 5.0 (2.0, 9.2) 5.7 
Fever 9.7 (4.5, 16.4) 4.2 (1.4, 8.1) 5.5 
Lump in throat 7.8 (7.0, 8.6) 3.2 (2.7, 3.8) 4.6 
Rapid/racing heart beat 12.4 (7.0, 19.1) 8.1 (6.9, 9.4) 4.3 
Vomiting 7.1 (4.2, 10.8) 3.0 (0.7, 6.6) 4.2 
Asthma 5.0 (3.2, 7.1) 3.5 (2.4, 4.9) 1.4 
Pain during intercourse 2.7 (1.4, 4.3) 1.9 (1.6, 2.1) 0.8 
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TABLE 4.3. Meta-analysis of self-reported health symptoms in Gulf War veterans 
compared to Gulf War era controls 
Full unadjusted meta-analysis results 
Symptom 
# of studies in 
analysis OR 
95% CI 
Neurological      
Tremors and/or shaking in body parts 4 2.68 (2.53, 2.84) 
Dizziness 10 2.34 (2.06, 2.67) 
Recurrent Headache 4 2.34 (1.74, 3.15) 
Numbness and tingling in body parts 8 2.32 (1.96, 2.74) 
Loss of balance/coordination 3 2.18 (1.83, 2.59)* 
Headaches 18 1.78 (1.49, 2.12) 
 Mood-Cognition    
Feeling detached 3 3.59 (1.83, 7.03)* 
Irritability 14 3.21 (2.28, 4.52) 
Nightmares 5 2.92 (1.98, 4.30) 
Feeling anxious/anxiety 8 2.68 (2.10, 3.43) 
Memory Problems 7 2.63 (2.10, 3.30) 
Trouble finding words 7 2.62 (1.92, 3.57) 
Forgetful 6 2.52 (1.80, 3.52) 
Difficulty concentrating 11 2.47 (2.06, 2.96) 
Feeling depressed 14 2.26 (1.88, 2.71) 
Sleep, Fatigue   
 
 
Fatigue 15 2.74 (2.11, 3.57) 
Sleepiness 5 2.49 (1.79, 3.48) 
Difficulty sleeping, falling or staying asleep 11 1.91 (1.67, 2.19) 
Unrefreshing sleep 12 1.91 (1.59, 2.30) 
Lacking energy 3 1.73 (1.52, 1.97)* 
Musculoskeletal   
 
 
Muscle weakness/loss of strength 5 3.19 (2.73, 3.74) 
Joint pain 17 2.36 (1.99, 2.80) 
Muscle aches/pain 13 2.36 (1.91, 2.92) 
Joint swelling 3 2.35 (1.67, 3.30)* 
Joint stiffness 10 2.28 (1.79, 2.90) 
Back pain 9 1.47 (1.27, 1.70) 
Gastrointestinal   
 
 
Diarrhea/loose stools 15 3.24 (2.51, 4.17) 
Loss of appetite 5 2.58 (1.90, 3.51) 
Constipation 6 2.20 (1.77, 2.74) 
Nausea 6 2.20 (1.61, 3.02) 
Abdominal pain and cramps 11 2.08 (1.79, 2.42) 
Vomiting 5 1.60 (1.45, 1.76)* 
Flatulence or burping 4 1.45 (1.15, 1.84)* 
OR: Odds ratio, CI: confidence interval 
*OR no longer significant in bias analysis; 95% CI contains null using minimum standard error  
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TABLE 4.3 (continued). Meta-analysis of self-reported health symptoms in Gulf War 
veterans compared to Gulf War era controls 
Full unadjusted meta-analysis results 
Symptom 
# of studies in 
analysis OR 
95% CI 
Dermatological   
 
 
Rash 14 3.18 (2.47, 4.09) 
Hair loss 9 2.60 (1.85, 3.67) 
Itching 3 1.90 (1.59, 2.27)* 
Sweating 3 1.67 (1.34, 2.07)* 
Cardiac   
 
 
Chest pain 7 2.24 (1.92, 2.61) 
Rapid/racing heart beat 3 2.04 (1.97, 2.11) 
Irregular heart beat 3 1.78 (1.70, 1.87) 
Genitourinary   
 
 
Pain during intercourse 3 2.39 (2.12, 2.70)* 
Loss of interest in sex 5 2.34 (1.80, 3.05) 
Pulmonary   
 
 
Shortness of breath 6 2.81 (2.35, 3.35) 
Coughing 11 2.02 (1.72, 2.38) 
Wheezing 5 1.92 (1.66, 2.22) 
Sinus congestion 9 1.63 (1.46, 1.81) 
Asthma 7 1.38 (1.20, 1.58)* 
Miscellaneous   
 
 
Night sweats 5 3.42 (2.73, 4.29) 
Bleeding gums 4 2.99 (1.73, 5.17)* 
Fever 6 2.30 (1.75, 3.03) 
Lump in throat 3 2.26 (1.62, 3.17)* 
Weight gain 3 2.16 (1.93, 2.41)* 
Swollen glands 4 1.98 (1.68, 2.34)* 
Chemical sensitivity 4 1.95 (1.60, 2.38) 
Sore throat 10 1.82 (1.56, 2.12) 
Ringing in ears 6 1.69 (1.42, 2.01) 
OR: Odds ratio, CI: confidence interval 
*OR no longer significant in bias analysis; 95% CI contains null using minimum standard error  
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TABLE 4.4. Meta-analysis of self-reported health symptoms in Gulf War veterans 
compared to Gulf War era controls stratified by cohort sampling strategy 
 
 
Military unit studies Population based studies 
Symptom 
# of 
studies 
in 
analysis OR (95% CI) 
# of 
studies 
in 
analysis OR (95% CI) 
Neurological         
Dizziness 3 2.96# (2.27, 3.86) 7 2.21 (1.82, 2.68) 
Headaches 10 1.72 (1.44, 2.05) 8 1.82 (1.34, 2.47) 
Neuropsychological, 
Psychological  
  
   
Irritability 6 3.56# (2.48, 5.10) 8 2.93 (1.67, 5.14) 
Feeling depressed 7 2.32 (1.86, 2.89) 7 2.22 (1.70, 2.89) 
Sleep, Fatigue       
Fatigue 8 3.11# (2.36, 4.10) 8 2.33* (1.53, 3.55) 
Difficulty sleeping, 
falling or staying asleep 3 
2.08 (1.71, 2.54) 
8 1.86 (1.57, 2.19) 
Musculoskeletal       
Joint stiffness 5 3.00# (2.74, 3.29) 5 1.69* (1.32, 2.17) 
Joint pain 8 2.99# (2.49, 3.60) 8 1.88* (1.57, 2.24) 
Muscle aches/pain 8 2.87# (2.27, 3.63) 8 2.09* (1.59, 2.75) 
Back pain 5 1.64# (1.32, 2.06) 5 1.37 (1.15, 1.63) 
Gastrointestinal       
Diarrhea/loose stools 8 4.42# (3.27, 5.99) 8 2.49* (1.91, 3.25) 
Constipation 3 2.98# (2.44, 3.63) 3 1.79* (1.57, 2.03) 
Abdominal pain and 
cramps 5 
2.15 (1.83, 2.52) 
5 2.05 (1.66, 2.54) 
Dermatological       
Rash 5 3.93# (3.18, 4.86) 5 2.21* (1.53, 3.20) 
Hair loss 6 3.84# (3.35, 4.41) 6 2.20* (1.50, 3.24) 
Cardiac       
Chest pain 4 2.39 (1.86, 3.06) 4 2.06 (1.77, 2.41) 
Pulmonary       
Coughing 5 2.10 (1.69, 2.61) 5 1.95 (1.54, 2.46) 
Sinus congestion 3 1.61 (1.42, 1.82) 3 1.71 (1.34, 2.18) 
Miscellaneous       
Sore throat 5 2.04# (1.71, 2.43) 5 1.55* (1.29, 1.86) 
*greater than 10% change towards the null (OR=1.0) 
#greater than 10% change away from the null (OR=1.0)
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Figure 4.1. Meta-analysis literature search strategy 
 
	
 
 
	
1. Database search filtered 
for “Human Subjects” and 
“English” language 
returned 2082 papers. 
2. 386 potentially relevant 
Gulf War study 
titles/abstracts reviewed. 
3. 128 potentially relevant 
Gulf War health study 
titles/abstracts reviewed. 
1696 excluded:  
- non-Gulf War subjects 
(e.g. OEF/OIF, civilians) 
- in theater studies 
- duplicates 
258 excluded: 
- did not mention health 
symptoms, health status, 
medical conditions, illness, 
medical diagnosis, etc. 
92 excluded: 
- no relevant comparison 
group 
- follow-up survey 
- medical evaluation only, 
no self-reported symptoms 
-	
4. 37 studies read for 
detailed assessment/validity 
check. 
16 excluded: 
- overlapping populations 
-no usable data 
-	
Data extracted from 21 
studies representing over 
129,000 respondents. 
Search terms: (Gulf War OR Desert Storm OR Desert Shield OR Gulf Syndrome OR Gulf 
War Syndrome OR Gulf War Illness OR Persian Gulf War OR Persian Gulf Syndrome) AND 
(health OR symptom* OR health symptom*) 
(Note: * syntax indicates that all variations of the word were 
searched by the databases, e.g., symptom* searched for symptoms, 
symptomatology, etc.) 
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ABSTRACT 
Background: 1990–1991 Gulf War (GW) veterans encountered a combination of 
hazardous exposures during their deployment to the Persian Gulf theater that have been 
linked to several adverse health outcomes, including Gulf War Illness (GWI). Using a 
subset of the Fort Devens cohort, this study examines the relationship between GW-
specific exposures and health symptoms reported over a follow-up period of seven years 
and the sex differences between the exposure-symptom associations. 
Methods: Fifty-nine men and 58 women reported health symptoms on three surveys. 
Repeated logistic regression models stratified by sex were used to examine the 
association of GW-specific exposures and health symptoms over time. 
Results:  Men and women endorsed GW hazards at a high frequency. Men exposed to 
debris from SCUD missiles had increased odds of reporting feeling anxious (OR=2.62), 
trouble sleeping (OR=2.64), dizziness (OR=2.41), and muscle twitching (OR=5.02) 
compared to unexposed men. Among men, self-reported exposure to tent heaters, 
pesticides, and chemical alarms were also associated with significantly higher odds of 
reporting symptoms. Women exposed to debris from SCUD missiles had higher odds of 
reporting crying easily (OR=4.32), feeling anxious (OR=3.05), trouble sleeping 
(OR=2.74), lacking energy (OR=2.94), and shortness of breath (OR=4.29) compared to 
unexposed women. Among women, self-reported exposure to tent heaters and chemical 
alarms were also significantly associated with symptom reporting.   
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Conclusions: In men and women, specific GW exposures were associated with 
significantly higher odds of symptom reporting. The differences between men and 
women in the profile of symptoms associated with the same GW exposures highlight the 
need for more deployment health research focusing on sex-specific issues.  
 
INTRODUCTION 
US military personnel deployed to the Persian Gulf in support of the 1990–1991 
Gulf War (GW) were exposed to many unique environmental hazards in theater, 
including petrochemicals, debris from SCUD missiles, oil well fire smoke, depleted 
uranium, pesticides, pharmaceutical agents (e.g., anti-nerve gas pyridostigmine bromide 
(PB) pills) and chemical warfare agents (e.g., sarin and cyclosarin nerve gas). Several of 
these chemicals are neurotoxic, belonging to a class of chemicals known as 
acetylcholinesterase inhibitors (AChEi). AChEi’s inhibit the breakdown of acetylcholine 
(ACh) by inactivating the AChE enzyme, leading to build-up of ACh in the synapse 
(Grob and Harvey 1958; McDonough and Shih 1997). This causes overstimulation of 
muscarinic and nicotinic cholinergic receptors in organs and muscles containing these 
receptors which can lead to cognitive, muscle, and sleep dysfunction (Golomb 2008; 
National Academies of Sciences, Engineering, and Medicine 2016). Because cholinergic 
receptors are present outside of the central nervous system (CNS), hazardous chemicals 
that inactivate AChE can disrupt the autonomic nervous system and alter innate immune 
function, activating microglia and astrocytes in the brain and leading to enhanced 
expression of cytokines and chemokines and to chronic neuroinflammation (Abou-Donia 
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et al. 2016; Banks and Lein 2015; Golomb 2008; Milligan and Watkins 2009; Morris et 
al. 2015; O’Callaghan et al. 2015; Parihar et al. 2013; White et al. 2016).  
Studies have used the DoD sarin plume model and/or troop proximity to 
Khamisiyah, Iraq, to estimate sarin/cyclosarin exposure following demolition of an arms 
depot at that location. Exposed GW veterans were more likely to report problems with 
numbness and tingling, difficulty sleeping, fatigue, depression, and changes in cognition 
(McCauley et al. 2001; Proctor et al. 2006; Shapiro et al. 2002; White et al. 2016). 
The cross-sectional epidemiological literature suggests that GW veterans who 
self-report exposure to smoke from oil well fires, hearing chemical weapon alerts, use of 
PB pills, pesticide exposure, and debris from SCUD missiles were more likely to report 
cognitive dysfunction (e.g., changes in memory), depressive symptoms, and neurological 
complaints (e.g., headaches) compared to unexposed GW veterans (The Iowa Persian 
Gulf Study Group 1997; Kelsall et al. 2005; Proctor et al. 1998; Steele et al. 2012; White 
et al. 2001). Pulmonary symptoms (asthma, cough and shortness of breath) were more 
likely to be reported among GW veterans exposed to emissions from oil well fires and 
tent heaters compared to unexposed GW veterans (Petruccelli et al. 1999; Cowan et al. 
2002; Proctor et al. 1998). In addition to their links to individual health symptoms, 
consuming PB pills and exposure to pesticides have been consistently implicated as 
causal factors of Gulf War Illness (GWI), a disorder that affects approximately 30% of 
GW veterans and is characterized by a combination symptoms that include: fatigue, 
cognitive dysfunction, musculoskeletal pain, gastrointestinal complaints, respiratory 
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symptoms and skin rashes (Fukuda et al. 1998; RAC-GWVI 2008; RAC-GWVI 2014; 
Steele 2000; White et al. 2016).  
Prospective, longitudinal GW cohort studies provide evidence that the health 
problems experienced by returning GW veterans persist many years after deployment to 
the Gulf. Most investigations have found that the number and severity of symptoms 
remained stable over follow-up periods of varying lengths (4–18 years), indicating 
neither improvement nor progression of symptoms (Brewer et al. 2008; Dursa et al. 2016; 
Gwini et al. 2016; Hotopf et al. 2003; Kang et al. 2009; Li et al. 2011; Ozakinci et al. 
2006). However, few longitudinal studies have examined the relationship over time 
between GW exposures and health symptoms and disorders. In a follow-up survey of UK 
GW veterans, Hotopf et al. (2004) found that self-reported exposure to smoke from oil 
well fires and hearing chemical weapons alarms were significantly associated with 
continuing complaints of fatigue. This follow-up study concluded that GW exposures 
were important risk factors for the onset of illness; however, the severity of initial 
symptoms, rather than exposures, was the most important risk factor for the persistence 
of symptoms over a 4-year period (Unwin et al. 1999; Hotopf et al. 2004). 
The Fort Devens cohort is a population of former US Army Active, Reserve, and 
National Guard GW veterans who have been followed prospectively through a series of 
surveys since their return from deployment in the Persian Gulf in 1991 (Heaton et al. 
2006; Proctor et al. 1998; Proctor et al. 2006; White et al. 2001; Wolfe et al. 1998; Wolfe 
et al. 2002; Yee et al. 2016). In cross-sectional analyses, Fort Devens cohort members 
		89 
who reported exposure to debris from SCUDs and chemical warfare agents were more 
likely to endorse neurological and cognition-mood symptoms (Proctor et al. 1998). In the 
same study, individuals who reported pesticide use and chemical warfare agent exposure 
were more likely to report musculoskeletal symptoms; a similar relationship was found 
between tent heater exposure and cardiac/pulmonary symptoms (Proctor et al. 1998). At a 
later follow-up, individuals with self-reported exposure to smoke from oil well fires, tent 
heater emissions, and consuming PB pills had significantly higher odds of chronic multi-
symptom illness (CMI), which is a commonly used definition for GWI (Wolfe et al. 
2002; Fukuda et al. 1998).  
There is some evidence that women are at higher risk for deployment-related 
illness or more severe illness than their male counterparts, but many GW studies have 
been underpowered to look at sex-specific deployment issues because only 7% of GW 
veterans are women (Coughlin 2016; Fukuda et al. 1998; Pierce 1997; Smylie et al. 2013; 
Spencer et al. 2001; Steele 2000; Wolfe et al. 1998).  
The present study examined data from a subset of the Fort Devens cohort that was 
over-sampled for women so that sex-specific health issues could be better assessed 
(Proctor et al. 1998). Using longitudinal data from three health symptom surveys over a 
7-year period, our study further examined the relationship between modeled and self-
reported GW deployment exposures and health symptoms over time, with a particular 
focus on sex differences.  
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METHODS 
Participants and Surveys 
In the spring of 1991 (Baseline), Active Duty, Reserve, and National Guard Army 
personnel who returned from a deployment to the Persian Gulf through Fort Devens, MA, 
were recruited to participate in a survey to assess participants’ demographics, 
psychological health, and combat exposure. Follow-up questionnaires were designed to 
assess long-term health and psychological and functional well-being, as well as Gulf-
specific environmental and combat exposures (Proctor et al. 1998; Wolfe et al. 1998; 
Wolfe et al. 2002). Figure 5.1 illustrates the overall timeline of the Fort Devens cohort 
study. The sample at Follow-up 2 was much smaller because in depth in-person 
interviews and neuropsychological testing were completed. The Follow-up 2 study 
sample was oversampled for women; the full sampling strategy is outlined in Proctor et 
al. (1998). The current study uses the subset of Fort Devens cohort participants who 
completed Health Symptom Checklists at the three follow-up time points, there are a total 
of 117 participants for the current study (59 men and 58 women). 
 The health symptom checklist allowed participants to report whether they had 
experienced specific health symptoms from a pre-set list that was originally adapted from 
Bartone et al. (1989). Over the course of the Fort Devens cohort surveys, two different 
health symptom checklists were included in the survey questionnaires. At Follow-up 1, a 
20-item Health Symptom Checklist asked participants to indicate the frequency of 20 
symptoms over the past 4 weeks using a Likert-scale rating (0=none; 1=a little; 2=often; 
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3=very often) (Wolfe, 1998). Each response was dichotomized for the analysis; endorsing 
0 (none) was coded as 0=non-endorsement and checking 1 (a little), 2 (often) or 3 (very 
often) was coded as 1=endorsement of the health symptom. At Follow-ups 2 and 3, the 
questionnaire included a 52-item Expanded Health Checklist (Proctor et al. 1998; Wolfe 
et al. 2002). Respondents were asked to indicate the frequency with which they 
experienced each health symptom over the past 30 days using a Likert-scale rating (0=no 
symptom; 1=rarely (1–2 times in all); 2=some (1–2 times/week); 3=often (several 
times/week); 4=very often (almost every day)). Each response was again dichotomized so 
that checking 0 (no symptom) was considered non-endorsement (coded as 0) and other 
responses were considered as endorsing the symptom (coded as 1). 
 Based on the epidemiological literature examining GW exposures and reported 
health symptoms, we chose symptoms from the 20-item and 52-item Health Symptom 
Checklists that could be characterized as belonging to one of the following categories: 
mood-cognition, fatigue, neurological or physical symptoms. A total of 12 symptoms fit 
these categories and were included on all 3 follow-up surveys: difficulty concentrating, 
feeling depressed, crying easily, feeling anxious, trouble sleeping, lack of energy, 
dizziness, headache, muscle twitching/trembling, rapid heart rate, rash, and shortness of 
breath. 
 
Gulf War Exposure Characterization 
Participants were asked about environmental and combat exposures specific to GW 
deployment on the Follow-up 2 and 3 survey questionnaires. To minimize the length of 
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time between deployment and recall, exposures self-reported on the Follow-up 2 surveys 
were used in the present study’s models analyzing the relationship between GW-specific 
exposures and self-reported health symptoms. Exposures self-reported at Follow-up 3 
were used to determine the test-retest reliability of exposure recall. Participants were 
asked to recall consumption of PB pills and hearing formal chemical weapons alerts in a 
dichotomous, yes or no response. They were also asked whether they had experienced 
exposure to smoke from tent heaters or oil well fires, pesticides, and debris from SCUD 
missiles according to these categories: ‘not exposed’, ‘exposed but did not feel ill’, 
‘exposed and felt ill’. Answers for these four GW-specific exposures were dichotomized 
to 0=not exposed and 1=exposed but did not feel ill or exposed and felt ill. 
 Sarin nerve gas exposure was determined by exposure estimates from the 2000 
CIA/DoD exposure plume model developed by the Directorate of Health Risk 
Management, US Army Center for Health Promotion and Preventive Medicine to 
determine US troops who had been exposed to sarin and cyclosarin nerve gas as a result 
of the destruction of the Khamisiyah munitions facility in March 1991 (Winkenwerder 
2002a; Winkenwerder 2002b). Exposure models were combined with troop location data 
using a database of GW unit locations to determine which US troops were located in the 
modeled exposure plume. The identified individuals were notified about their possible 
exposure by mail. A list of which cohort members received notifications was provided by 
the DoD. 
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Data Analysis 
 Preliminary analyses demonstrated that the relationships between GW-specific 
exposures and health symptoms differed by sex in our dataset; therefore, we conducted 
stratified analyses to evaluate sex as an effect modifier. Study sample demographic 
characteristics were determined at each follow-up time point, along with the reporting 
frequency of GW-specific exposures and health symptoms. Kappa coefficients were 
calculated to estimate the level of agreement between Follow-up 2 and Follow-up 3 
exposure responses. 
Repeated logistic regression models were used to determine the unique 
associations between GW-specific exposures and health symptoms, controlling for age at 
deployment and military status during deployment, comparing Active Duty (reference) 
versus Army Reserve/National Guard. To evaluate the effect of time on health symptom 
reporting, we used dates of survey completion to determine the amount of time in years 
since the Baseline Survey was completed immediately upon return from the Persian Gulf. 
Odds ratios (OR) and 95% confidence intervals (CI) were calculated from the logistic 
regression models. To examine the effect of PTSD on the results, a sensitivity analysis 
was conducted in which individuals with a missing baseline PTSD scale score (n = 2, 1 
male and 1 female) or a Mississippi PTSD scale score greater than the clinical cutoff 
(>85) were excluded from the sex strata (n = 8, 2 males and 6 females). All analyses were 
performed using SAS 9.3/9.4 (SAS, Cary, NC). 
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RESULTS 
Table 5.1 shows the demographic characteristics of the men and women in our 
study sample compared to the full Fort Devens cohort. Compared to their male 
counterparts, women in our study sample were younger, less likely to be white, more 
likely to be Active Duty, and more often have a high score on the Mississippi PTSD scale 
at the Baseline Survey. 
On average, the number of years since deployment for the first follow-up survey 
was 1.26 years (sd = 0.3 years) and 3.99 years (sd = 0.8 years) and 5.94 years (sd = 0.2 
years), for Follow-ups 2 and 3, respectively. The time since deployment did not differ 
significantly between the men and women in our study sample for any of the follow-up 
periods. Table 5.2 shows the differences between symptom reporting in males and 
females at each time point. Generally, women reported symptoms at a higher frequency 
than men, with the one exception that men had higher reports of trouble sleeping than 
women. Trends of symptom reporting over time were examined in the repeated logistic 
regression models, but in both men and women the frequency of symptom reporting most 
often remained stable or decreased over time. 
Twenty-five men (42.4%) from the study sample were notified that they had 
likely exposure to sarin nerve gas based on modeled estimates of the Khamisiyah 
detonation. Of the GW exposures examined in this analysis, the most frequent self-
reported GW exposure among men was smoke from oil well fires (n = 52, 88.1%), 
followed by hearing chemical alerts (n = 40, 67.8%), tent heaters (n = 34, 57.6%), taking 
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PB pills (n = 28, 47.5%), debris from SCUDs (n = 26, 44.1%), and pesticide use (n = 23, 
38.9%). Twenty-seven women (46.6%) from the study sample were notified that they had 
likely exposure to sarin nerve gas based on modeled estimates of the Khamisiyah 
demolition. The most commonly self-reported GW exposure among women was hearing 
chemical alerts (n = 52, 89.7%), followed closely by smoke from oil well fires (n = 48, 
82.8%) and tent heaters (n = 43, 74.1%). Thirty-nine (67.2%) women self-reported 
consuming PB pills, thirty-two (55.2%) reported exposure to debris from SCUD missiles, 
and twenty-nine (50.0%) reported pesticide use. 
Comparing Follow-up 2 and 3 responses, consumption of PB pills was recalled 
with a high level of agreement, κ = 0.73 for males and κ = 0.82 for females, and hearing 
chemical weapons alerts was also recalled with high reliability, κ = 0.65 for males and κ 
= 0.70 for females. Exposure to smoke from tent heaters was recalled with moderate 
agreement, κ = 0.50 for males and κ = 0.55 for females.  
 
Longitudinal associations between GW exposure and health 
Table 5.3a shows the relationship between GW exposures and the mood-cognition 
and fatigue symptoms that were asked on all three health symptom surveys. Among male 
participants, those reporting exposure to tent heaters, pesticides, PB pills, and debris from 
SCUD missiles had higher odds of reporting each of the mood-cognition and fatigue 
symptoms. Compared to unexposed individuals, tent heater exposure was significantly 
associated with feeling depressed (OR = 3.28, 95% CI: 1.41, 7.59), anxious (OR = 2.39, 
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95% CI: 1.08, 5.32), and having trouble sleeping (OR = 4.81, 95% CI: 1.97, 11.78). 
Exposure to debris from SCUD missiles was significantly associated with higher odds of 
reporting feeling anxious (OR = 2.62, 95% CI: 1.17, 5.86) and having trouble sleeping 
(OR = 2.64, 95% CI: 1.10, 6.35) compared to unexposed individuals.  
Among women, debris from SCUD missiles was the only exposure consistently 
associated with higher odds of reporting each mood-cognition and fatigue symptom 
(Table 5.3a). Compared to unexposed women, women reporting exposure to debris from 
SCUD missiles had significantly higher odds of reporting crying easily (OR = 4.32, 95% 
CI: 1.90, 9.84), feeling anxious (OR = 3.05, 95% CI: 1.30, 7.15), trouble sleeping (OR = 
2.74, 95% CI: 1.28, 5.86), and lack of energy (OR = 2.94, 95% CI: 1.21, 7.18).  
In women, an increase in the number of years since deployment was associated 
with significantly lower symptom reporting in some cases (Table 5.3a). In the models of 
exposure to sarin based on the DoD model and of self-reported exposures to tent heaters, 
hearing chemical alerts, and smoke from oil well fires, odds of reporting feeling 
depressed significantly decreased as the number of years from deployment increased. 
Similarly, models investigating exposure to sarin based on the DoD model and self-
reported exposures to tent heaters, pesticides, hearing chemical alerts, smoke from oil 
well fires, and debris from SCUD missiles, showed that the odds of reporting feeling 
anxious significantly decreased as the number of years from deployment increased.  
The relationship between GW exposures and neurological and other physical 
symptoms are shown in Table 5.3b. Men reporting exposure to tent heaters, pesticides, 
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hearing chemical alerts, and debris from SCUD missiles had higher odds of endorsing 
each of these symptoms on the three symptom surveys. Compared to unexposed men, 
those reporting exposure to tent heaters had significantly higher odds of reporting 
headaches (OR = 3.19, 95% CI: 1.39, 7.29), muscle twitching and/or trembling (OR = 
8.54, 95% CI: 3.06, 23.85), and skin rashes (OR = 3.16, 95% CI: 1.07, 9.28). Men 
reporting pesticide exposure had significantly higher odds of endorsing headaches (OR = 
2.67, 95% CI: 1.11, 6.42) and muscle twitching and/or trembling (OR = 4.36, 95% CI: 
1.68, 11.30) compared to unexposed men. Significantly higher odds of muscle twitching 
and/or trembling (OR = 3.88, 95% CI: 1.2, 11.41) and skin rash (OR = 3.42, 95% CI: 
1.04, 11.19) were seen among men who reported hearing chemical alerts compared to 
unexposed men. Men who endorsed being exposed to debris from SCUD missiles had 
significantly higher odds of reporting dizziness (OR = 2.41, 95% CI: 1.03, 5.66) and 
muscle twitching and/or trembling (OR = 5.02, 95% CI: 2.05, 12.31) compared to the 
unexposed men.  
For the models in Table 5.3b, there were some significant associations between 
the length of time since deployment and symptom reporting among men. In the models 
using the DoD-determined sarin exposure and those examining self-reported exposures to 
tent heaters, hearing chemical alerts, smoke from oil well fires, and debris from SCUD 
missiles, odds of reporting headaches significantly decreased as the years from 
deployment increased. The opposite effect was seen for time since deployment and self-
reported muscle twitching/trembling and skin rash. Among men with DoD-reported sarin 
exposure and those with self-reported exposures to tent heaters, pesticides, hearing 
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chemical alerts, taking PB pills, smoke from oil well fires, and debris from SCUD 
missiles, odds of reporting rashes significantly increased as time since deployment 
increased. With the exception of the model investigating consumption of PB pills, 
increased time since deployment was significantly associated with increased reporting of 
muscle twitching/trembling for the self-reported GW exposure models.  
Among women, there were fewer GW exposures that were consistently associated 
with higher odds of symptom reporting. Women reporting exposure to tent heaters and 
debris from SCUD missiles had higher odds of reporting each of the neurological and 
physical symptoms, but only one of those associations reached the level of significance 
(Table 5.3b). Compared to unexposed women, women who reported exposure to debris 
from SCUD missiles had significantly higher odds of reporting shortness of breath (OR = 
4.29, 95% CI: 1.54, 11.96).  
Among women, the direction of the significant associations between years since 
deployment and symptom reporting varied between the exposure-symptom models. In the 
models testing the association between sarin exposure based on the DoD model and self-
reported exposures to tent heaters, pesticides, hearing chemical alerts, taking PB pills, 
smoke from oil well fires, and debris from SCUD missiles, odds of reporting headaches 
significantly decreased as the years from deployment increased (Table 5.3b). But among 
women in the model investigating sarin exposure based on the DoD model, odds of 
reporting dizziness significantly increased as the years from deployment increased.  
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Sensitivity Analysis Removing Participants with Baseline PTSD 
 Three males were removed from the primary analysis omitting persons with 
PTSD, 1 male with missing PTSD data and 2 with a score greater than 85 on the 
Mississippi PTSD scale score on the Baseline Survey. Among men, the results of the 
exposure-symptom relationships noted above remained mostly unchanged. The 
relationships between self-reported tent heater exposure and feeling anxious and between 
self-reported pesticide exposure and headache were no longer significant. Seven females 
were removed from this analysis, 1 female with missing PTSD data and 6 with a score 
greater than 85 on the Mississippi PTSD scale score on the Baseline Survey. Among 
women, the significant association seen between DoD-modeled sarin exposure and the 
mood/fatigue symptoms was no longer significant. The relationships between hearing 
chemical alerts and crying easily, debris from SCUD missiles and feeling anxious, and 
debris from SCUD missiles and shortness of breath were also no longer significant. 
 
DISCUSSION 
In a longitudinal analysis stratified by sex, several self-reported GW-specific 
exposures (tent heater exhaust, pesticide use, hearing chemical alerts, and debris from 
SCUD missiles), were significantly associated with higher symptom reporting. However, 
the most noteworthy results were the differences in exposure-symptom relationships 
between the sexes. We found a larger number of significant associations between GW 
exposures and health symptom reporting in men compared to their female counterparts. 
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Among men, self-reported exposure to tent heaters and exposure to debris from SCUD 
missiles were the GW hazards most frequently associated with significantly higher odds 
of health symptoms in each of the categories of interest: feeling depressed, anxious, 
trouble sleeping, headache, muscle twitching/trembling, and rash. In men, self-reported 
exposure to pesticides and hearing chemical alerts were also significantly associated with 
higher odds of reporting of dizziness, headache, muscle twitching/trembling, and rash.  
These results are similar to associations found in previous cross-sectional studies of GW 
veterans, and to chronic symptoms associated with organophosphate pesticide exposure 
in agricultural workers and pesticide applicators (Cherry et al. 2001b; Hanssen et al. 
2015; The Iowa Persian Gulf Study Group 1997; Kamel et al. 2005; Kamel et al. 2007; 
Kelsall et al. 2005; McCauley et al 2001; Payán-Rentería et al. 2012; Proctor et al. 1998; 
Steele et al. 2012). Furthermore, the significant findings among men correspond with 
symptom clusters from the most widely accepted case definitions of GWI: mood-
cognition, fatigue, neurological and dermatological (Fukuda et al. 1998; IOM 2014; 
Steele 2000). 
 In this study, women endorsed deployment exposures and symptoms, sometimes 
with greater frequency than their male counterparts, but we did not see as many 
significant exposure-symptom relationships, suggesting that there might be other factors 
influencing their self-perceived health. Of the covariates explored in this analysis, women 
in the Reserve/National Guard and women who were older when they deployed had 
higher odds of reporting symptoms. This contrasts with the findings of Pierce et al. 
(1997), who showed Active Duty US Air Force (USAF) women reported more general 
		101 
health problems than women in the USAF Reserve. In that study and a study of female 
GW veterans in the UK, headache, fatigue, trouble sleeping, depression, and irritability 
were reported with the highest frequency (Pierce 1997; Unwin et al. 2002). Neither study 
looked at the relationship between health symptoms and deployment exposures. Although 
women were only 7% of the deployed force during the GW, they constituted the largest 
group of women deployed to a war-zone at that time; therefore, these results highlight the 
importance of continuing to look at sex-specific issues in deployment health research 
(Coughlin 2016; Smylie et al. 2013). 
Some of the exposures assessed on the survey questionnaires were reported by 
most participants, with only 7 men and 10 women reporting no exposure to smoke from 
oil well fires and only 6 women reporting hearing no formal chemical alerts. The skewed 
distribution of exposure resulted in a limited number of unexposed, symptom-positive 
subjects. Without an adequate representation of each exposure-symptom combination, the 
results for the logistic regression models become less reliable. Indeed, among male 
participants we had 2 models that failed to converge, the model analyzing the association 
between smoke from oil fires and rapid heart rate and the model analyzing the association 
between smoke from oil fires and shortness of breath. In cross-sectional analyses these 
exposures have been linked to cognitive dysfunction, depressive symptoms, neurological 
complaints, and pulmonary issues; unfortunately we did not have sufficient power to 
assess the longitudinal effects associated with exposure to smoke from oil well fires and 
hearing chemical alerts. 
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Previous research indicates that symptom reporting remains relatively stable in 
GW veterans over time. However, in this stratified, longitudinal analysis, there were 
some significant associations between time since deployment and symptom trajectories. 
In both men and women, across all exposure models, we found a decrease in odds of 
reporting headache over time. Among females, there was also a decrease in the reporting 
of feeling depressed and anxious over time.  Lastly, in men, we saw increasing odds of 
reporting muscle twitching/trembling and rash as time from deployment increased.  The 
changes in symptom trajectories over the 7-year follow-up period could indicate 
emerging symptoms as time since deployment increases; on the other hand, it could 
indicate differences in the ability of the medical community to treat certain symptoms 
that are commonly experienced by GW veterans. There is another Fort Devens cohort 
follow-up survey underway (data collection ends in 2017); this will enable us to examine 
a much longer symptom trajectory. 
 
Limitations and Strengths 
 Our study sample is a small subset of the full Fort Devens cohort; however, to 
analyze this sample longitudinally we limited our study sample to Fort Devens cohort 
members who had completed health symptom surveys on three follow-up survey 
questionnaires. This may limit the generalizability of our results to the greater Fort 
Devens cohort and the population of GW veterans as a whole. 
 We tested many exposure-symptom relationships, so it is possible that some of 
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the significant associations we found are due to chance. However, using an alpha level of 
0.05, we would expect approximately 5% of our significant associations could be by 
chance alone (approximately 4 exposure-symptom relationships per sex strata). In both 
the male and female groups, the number of significant exposure-symptoms relationships 
was greater than what we would expect by chance, giving us confidence in results which 
demonstrate that some GW-specific exposures are significantly related to health symptom 
reporting in this sample of GW veterans. 
An important challenge to studying the effects of GW exposures on veteran health 
is a lack of records or measurements quantifying chemical exposures during deployment. 
For this study, we relied mostly on self-reported exposures. To determine the effect of 
possible recall bias on our results we calculated a kappa statistic, a measure of agreement, 
for exposures that were self-reported at Follow-up 2 and 3. Similar levels of agreement 
were found in other GW cohort studies, mean κ for GW exposures = 0.74 (Gray et al. 
2002); κ(consuming PB pills) = 0.86 (McCauley et al. 1999); κ(chemical weapons 
alarms) = 0.64 (McCauley et al. 1999); κ(chemical weapons alarms) = 0.49 (Wessely et 
al. 2003). The high but not perfect level of agreement of exposure recall between follow-
up surveys indicates that while exposure misclassification likely exists in this study, the 
magnitude of the exposure misclassification would not change the significant results 
found in this study.  
Selection bias, in which individuals with more health problems are more likely to 
remain in the study than healthy individuals, can affect the results of longitudinal studies. 
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At Follow-up 1, individuals were flagged as high or low symptom reporters and the study 
sample at that time point was randomized to yield a balance of high symptom reporters 
and low symptom reporters. Using this flag variable, we determined that the balance of 
high and low symptom reporters remained steady for our study sample, so we can be 
confident that our results are not due to sicker individuals from the cohort participating in 
the surveys at a higher rate than healthy individuals. We also saw relatively few changes 
to our results when removing individuals with PTSD from the primary analysis. These 
results add to the literature demonstrating that GW veteran ill health is being driven by 
specific exposures encountered in the Gulf region and not psychological conditions. We 
did see more results change in the sensitivity analysis in our female participants; 
however, these changes could be due to small sample size and removing additional 
participants decreases the precision of exposure-symptom associations. 
 
CONCLUSION 
In this longitudinal analysis, results showed higher odds of symptom reporting 
associated with specific deployed-related exposures in a group of male and female GW 
veterans. Understanding sex-specific symptom trajectories and the relationship between 
GW exposures and outcomes is critical as the research focus shifts to developing 
effective treatments for persistent health issues experienced by GW veterans. 
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Table 5.1. Demographics of study sample (n=117) compared to full Fort Devens cohort 
(n=2949) 
 
 
Full Fort Devens 
cohort (n=2949) 
Male Study Sample 
(n=59) 
Female Study Sample 
(n=58) 
Age 30.2 (8.4) [18–65] 35.5 (10.0) [20–56] 30.2 (7.9) [19–55] 
Mississippi PTSD scale-
score 
61.9 (13.4) [35–131] 61.5 (11.0) [42–95] 67.6 (16.1) [45–116] 
n (%) Caucasian 2702 (91.6%) 58 (98.3%) 51 (87.9%) 
n (%) Active Duty 823 (27.9%) 4 (6.8%) 8 (13.8%) 
n (%) above clinical 
cutoff on Mississippi 
scale-score 
116 (3.9%) 2 (3.4%) 6 (10.3%) 
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Table 5.2. Symptom frequencies at follow-up surveys: mood-cognition and fatigue symptoms 
 Follow-up 1 Follow-up 2 Follow-up 3 
 Male Female Male Female Male Female 
Difficulty concentrating 
Yes 
No 
Missing 
 
27 (45.8%) 
32 (54.2%) 
0 
 
33 (56.9%) 
25 (43.1%) 
0 
 
30 (50.8%) 
26 (44.1%) 
3 (5.1%) 
 
37 (64.8%) 
17 (28.8%) 
4 
 
22 (37.3%) 
36 (61.0%) 
1 (1.7%) 
 
22 (37.9%) 
36 (62.1%) 
0 
Feeling depressed 
Yes 
No 
Missing 
 
27 (45.8%) 
32 (54.2%) 
0 
 
29 (50.0%) 
29 (50.0%) 
0 
 
20 (33.9%) 
38 (64.4%) 
1 (1.7%) 
 
27 (46.6%) 
31 (53.4%) 
0 
 
19 (32.2%) 
38 (64.4%) 
2 (3.4%) 
 
22 (37.9%) 
36 (62.1%) 
0 
Cry easily 
Yes 
No 
Missing 
 
8 (13.6%) 
51 (86.4%) 
0 
 
28 (48.3%) 
30 (51.7%) 
0 
 
8 (13.6%) 
50 (84.7%) 
1 (1.7%) 
 
25 (43.1%) 
32 (55.2%) 
1 (1.7%) 
 
11 (18.6%) 
45 (76.3%) 
3 (5.1%) 
 
21 (36.2%) 
36 (62.1%) 
1 (1.7%) 
Feeling anxious 
Yes 
No 
Missing 
 
26 (44.1%) 
32 (54.2%) 
1 (1.7%) 
 
35 (60.3%) 
23 (39.7%) 
0 
 
20 (33.9%) 
39 (66.1%) 
0 
 
27 (46.6%) 
31 (53.5%) 
0  
 
18 (30.5%) 
40 (67.8%) 
1 (1.7%) 
 
21 (36.2%) 
37 (63.8%) 
0 
Trouble sleeping 
Yes 
No 
Missing 
 
28 (47.5%) 
31 (52.5%) 
0 
 
26 (44.8%) 
32 (55.2%) 
0 
 
36 (61.0%) 
23 (39.0%) 
0 
 
31 (53.4%) 
26 (44.8%) 
1 (1.7%) 
 
29 (49.2%) 
29 (49.2%) 
1 (1.7%) 
 
26 (44.8%) 
32 (55.2%) 
0 
Lack of energy 
Yes 
No 
Missing 
 
30 (50.9%) 
29 (49.1%) 
0 
 
35 (60.3%) 
23 (39.7%) 
0 
 
29 (49.2%) 
29 (49.2%) 
1 (1.7%) 
 
41 (70.7%) 
16 (27.6%) 
1 (1.7%) 
 
28 (47.5%) 
30 (50.8%) 
1 (1.7%) 
 
37 (63.8%) 
21 (36.2%) 
0 
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Table 5.2 (continued). Symptom frequencies at follow-up surveys: neurological and physical symptoms 
 Follow-up 1 Follow-up 2 Follow-up 3 
 Male Female Male Female Male Female 
Dizziness 
Yes 
No 
Missing 
 
10 (17.0%) 
49 (83.0%) 
0 
 
12 (20.7%) 
46 (79.3%) 
0 
 
14 (23.7%) 
43 (72.9%) 
2 (3.4%) 
 
26 (44.8%) 
31 (53.4%) 
1 (1.7%) 
 
10 (17.0%) 
48 (81.3%) 
1 (1.7%) 
 
20 (34.5%) 
38 (65.5%) 
0 
Headache 
Yes 
No 
Missing 
 
37(62.7%) 
22 (37.3%) 
0 
 
44 (75.9%) 
14 (24.1%) 
0 
 
33 (55.9%) 
26 (44.1%) 
0 
 
49 (84.5%) 
9 (15.5%) 
0 
 
28 (47.5%) 
31 (52.5%) 
0 
 
28 (48.3%) 
30 (51.7%) 
0 
Muscle twitching/trembling 
Yes 
No 
Missing 
 
14 (23.7%) 
45 (76.3%) 
0 
 
17 (29.3%) 
41 (70.7%) 
0 
 
13 (22.0%) 
43 (72.9%) 
3 (5.1%) 
 
23 (39.7%) 
35 (60.3%) 
0 
 
21 (35.6%) 
37 (62.7%) 
1 (1.7%) 
 
20 (34.5%) 
38 (65.5%) 
0 
Rapid heart rate 
Yes 
No 
Missing 
 
10 (17.0%) 
49 (83.0%) 
0 
 
16 (27.6%) 
41 (70.7%) 
1 (1.7%) 
 
8 (13.6%) 
51 (86.4%) 
0 
 
14 (24.1%) 
43 (74.1%) 
1 (1.7%) 
 
7 (11.9%) 
52 (88.1%) 
0 
 
11 (19.0%) 
47 (81.0%) 
0 
Rash 
Yes 
No 
Missing 
 
11 (18.6%) 
48 (81.4%) 
0 
 
17 (29.3%) 
41 (70.7%) 
0 
 
16 (27.1%) 
42 (71.2%) 
1 (1.7%) 
 
17 (29.3%) 
41 (70.7%) 
0 
 
20 (33.9%) 
38 (64.4%) 
1 (1.7%) 
 
22 (37.9%) 
36 (62.1%) 
0 
Shortness of breath 
Yes 
No 
Missing 
 
12 (20.3%) 
47 (79.7%) 
0 
 
16 (27.6%) 
41 (70.7%) 
1 (1.7%) 
 
11 (18.6%) 
48 (81.4%) 
0 
 
16 (27.6%) 
42 (72.4%) 
0 
 
15 (25.4%) 
43 (72.9%) 
1 (1.7%) 
 
15 (25.9%) 
43 (74.1%) 
0 
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Table 5.3a. Longitudinal associations between GW exposure and health: mood-cognition 
and fatigue symptoms 
 Difficulty 
concentrating 
Feeling depressed Cry easily 
Model 1 – sarin nerve gas exposed (modeled) 
Males   Exposed 
         Years from deployment         
-0.45 (-1.2, 0.3) 
-0.07 (-0.19, 0.1) 
-0.42 (-1.2, 0.4) 
-0.11 (-0.3, 0.03) 
0.35 (-0.7, 1.4) 
0.12 (-0.1, 0.3) 
Females   Exposed 
         Years from deployment 
-0.43 (-1.3, 0.4) 
-0.10 (-0.2, 0.05) 
-1.33 (-2.2, -0.4)* 
-0.15 (-0.3, -0.005)* 
-0.21 (-1.0, 0.6) 
-0.09 (-0.2, 0.05) 
Model 2 – tent heater (self-reported) 
Males   Exposed 
         Years from deployment         
0.44 (-0.3, 1.2) 
-0.06 (-0.2, 0.1) 
1.19 (-0.4, 2.0)* 
-0.11 (-0.3, 0.04) 
0.50 (-0.6, 1.6) 
0.12 (-0.1, 0.3) 
Females   Exposed 
         Years from deployment 
0.61 (-0.2, 1.5) 
-0.11 (-0.3, 0.03) 
0.44 (-0.6, 1.5) 
-0.15 (-0.3, -0.02)* 
1.46 (0.4, 2.5)* 
-0.10 (-0.3, 0.1) 
Model 3 – pesticides (self-reported) 
Males   Exposed 
         Years from deployment         
0.31 (-0.4, 1.1) 
-0.07 (-0.2, 0.1) 
0.41 (-0.4, 1.2) 
-0.10 (-0.3, 0.04) 
0.65 (-0.4, 1.7) 
0.09 (-0.1, 0.3) 
Females   Exposed 
         Years from deployment 
0.69 (-0.1, 1.5) 
-0.11 (-0.3, 0.03) 
-0.05 (-0.9, 0.8) 
-0.12 (-0.3, 0.02) 
0.68 (-0.2, 1.5) 
-0.11 (-0.3, 0.05) 
Model 4 – hearing chemical alerts (self-reported) 
Males   Exposed 
         Years from deployment         
0.30 (-0.5, 1.1) 
-0.07 (-0.2, 0.1) 
-0.55 (-1.5, 0.4) 
-0.11 (-0.3, 0.03) 
0.30 (-1.1, 1.7) 
0.12 (-0.1, 0.3) 
Females   Exposed 
         Years from deployment 
-0.40 (-1.8, 1.0) 
-0.10 (-0.2, 0.04) 
-0.62 (-1.9, 0.6) 
-0.15 (-0.3, -0.02) 
1.48 (0.1, 2.8)* 
-0.10 (-0.2, 0.05) 
Model 5 – consuming PB pills (self-reported) 
Males   Exposed 
         Years from deployment         
0.42 (-0.4, 1.3) 
-0.09 (-0.2, 0.04) 
0.25 (-0.7, 1.2) 
-0.14 (-0.3, 0.01) 
0.02 (-1.2, 1.2) 
0.08 (-0.1, 0.3) 
Females   Exposed 
         Years from deployment 
0.45 (0.6, 1.5) 
-0.13 (-0.3, 0.02) 
-0.23 (-1.2, 0.8) 
-0.18 (-0.3, -0.03)* 
0.84 (-0.02, 1.7) 
-0.15 (-0.3, 0.01) 
Model 6 – Smoke from oil well fires (self-reported) 
Males   Exposed 
         Years from deployment         
-0.14 (-1.3, 1.0) 
-0.05 (-0.2, 0.1) 
-0.14 (-1.2, 0.9) 
-0.09 (-0.2, 0.1) 
1.39 (-0.7, 3.5) 
0.12 (-0.1, 0.3) 
Females   Exposed 
         Years from deployment 
0.32 (-0.8, 1.4) 
-0.11 (-0.2, 0.03) 
-1.17 (-2.6, 0.2) 
-0.15 (-0.3, -0.01)* 
-0.48 (-1.5, 0.5) 
-0.09 (-0.2, 0.05) 
Model 7 – Debris from SCUDs (self-reported) 
Males   Exposed 
         Years from deployment         
0.35 (-0.4, 1.1) 
-0.08 (-0.2, 0.1) 
0.54 (-0.3, 1.4) 
-0.12 (-0.3, 0.02) 
0.55 (-0.5, 1.6) 
0.12 (-0.1, 0.3) 
Females   Exposed 
         Years from deployment 
0.62 (-0.2, 1.5) 
-0.11 (-0.3, 0.04) 
0.82 (-0.1, 1.7) 
-0.13 (-0.3, 0.01) 
1.46 (0.6, 2.3)* 
-0.13 (-0.3, 0.04) 
Note: Unexposed (reference); models adjusted for baseline age (continuous), baseline 
military status (0=Active Duty, 1=Reserve/Guard) 
* p<0.05 
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Table 5.3a (continued). Longitudinal associations between GW exposure and health: 
mood-cognition and fatigue symptoms 
 Anxious Trouble sleeping Lack of energy 
Model 1 – sarin nerve gas exposed (modeled) 
Males   Exposed 
         Years from deployment         
-0.33 (-1.1, 0.5) 
-0.11 (-0.3, 0.04) 
-0.31 (-1.2, 0.5) 
0.03 (-0.1, 0.1) 
-0.40 (-1.2, 0.4) 
-0.03 (-0.1, 0.1) 
Females   Exposed 
         Years from deployment 
-0.62 (-1.5, 0.3) 
-0.20 (-0.3, -0.1)* 
-0.98 (-1.8, -0.2)* 
-0.0004 (-0.1, 0.1) 
-1.02 (-2.0, -0.1)* 
0.03 (-0.1, 0.2) 
Model 2 – tent heater (self-reported) 
Males   Exposed 
         Years from deployment         
0.87 (0.1, 1.7)* 
-0.12 (-0.3, 0.04) 
1.57 (0.7, 2.5)* 
0.03 (-0.1, 0.2) 
0.76 (-0.1, 1.6) 
-0.03 (-0.1, 0.1) 
Females   Exposed 
         Years from deployment 
0.70 (-0.3, 1.7) 
-0.21 (-0.4, -0.1)* 
0.75 (-0.1, 1.6) 
0.002 (-0.1, 0.1) 
-0.15 (-1.2, 0.9) 
0.02 (-0.1, 0.2) 
Model 3 – pesticides (self-reported) 
Males   Exposed 
         Years from deployment         
0.71 (-0.1, 1.6) 
-0.10 (-0.3, 0.1) 
0.86 (-0.1, 1.8) 
0.03 (-0.1, 0.1) 
0.27 (-0.6, 1.2) 
-0.04 (-0.2, 0.1) 
Females   Exposed 
         Years from deployment 
0.14 (-0.7, 1.0) 
-0.22 (-0.3, -0.1) 
-0.02 (-0.8, 0.7) 
0.002 (-0.1, 0.1) 
0.48 (-0.4, 1.4) 
0.01 (-0.1, 0.2) 
Model 4 – hearing chemical alerts (self-reported) 
Males   Exposed 
         Years from deployment         
-0.09 (-1.0, 0.8) 
-0.11 (-0.3, 0.03) 
0.25 (-0.7, 1.2) 
0.03 (-0.1, 0.1) 
0.41 (-0.5, 1.3) 
-0.03 (-0.1, 0.1) 
Females   Exposed 
         Years from deployment 
-0.09 (-1.1, 0.9) 
-0.20 (-0.3, -0.1)* 
-0.04 (-1.4, 1.3) 
0.001 (-0.1, 0.1) 
-2.31 (-4.2, -0.4)* 
0.02 (-0.1, 0.2) 
Model 5 – consuming PB pills (self-reported) 
Males   Exposed 
         Years from deployment         
0.22 (-0.7, 1.1) 
-0.14 (-0.3, 0.02) 
0.23 (-0.7, 1.2) 
-0.005 (-0.1, 0.1) 
0.38 (-0.5, 1.3) 
-0.02 (-0.1, 0.1) 
Females   Exposed 
         Years from deployment 
0.41 (-0.4, 1.3) 
-0.22 (-0.4, -0.1)* 
0.36 (-0.6, 1.3) 
0.01 (-0.1, 0.1) 
-0.05 (-1.2, 1.1) 
0.01 (-0.1, 0.2) 
Model 6 – Smoke from oil well fires (self-reported) 
Males   Exposed 
         Years from deployment         
-0.21 (-1.3, 0.9) 
-0.10 (-0.3, 0.1) 
-0.18 (-1.4, 1.0) 
0.03 (-0.1, 0.1) 
-0.81 (-1.9, 0.3) 
-0.03 (-0.1, 0.1) 
Females   Exposed 
         Years from deployment 
-0.42 (-1.6, 0.7) 
-0.20 (-0.3, -0.1)* 
-0.41 (-1.4, 0.6) 
-0.002 (-0.1, 0.1) 
0.71 (-0.4, 1.8) 
0.02 (-0.1, 0.2) 
Model 7 – Debris from SCUDs (self-reported) 
Males   Exposed 
         Years from deployment         
0.96 (0.2, 1.8)* 
-0.13 (-0.3, 0.03) 
0.97 (0.1, 1.9)* 
0.005 (-0.1, 0.1) 
0.50 (-0.3, 1.4) 
-0.02 (-0.1, 0.1) 
Females   Exposed 
         Years from deployment 
1.11 (0.3, 2.0)* 
-0.25 (-0.4, -0.1)* 
1.01 (0.3, 1.8)* 
0.02 (-0.1, 0.2) 
1.08 (0.2, 2.0)* 
0.02 (-0.1, 0.2) 
Note: Unexposed (reference); models adjusted for baseline age (continuous), baseline 
military status (0=Active Duty, 1=Reserve/Guard) 
* p<0.05 
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Table 5.3b. Longitudinal associations between GW exposure and health: neurological 
and physical symptoms 
 Dizziness Headache Muscle 
twitching/ 
trembling 
Model 1 – Sarin nerve gas (modeled) 
Males   Exposed 
         Years from deployment         
-0.24 (-1.2, 0.7) 
0.01 (-0.2, 0.2) 
-0.31 (-1.1, 0.5) 
-0.13 (-0.2, -0.02)* 
0.46 (-0.4, 1.3) 
0.15 (0.02, 0.3)* 
Females   Exposed 
         Years from deployment 
-0.86 (-1.8, 0.1) 
0.18 (0.01, 0.4)* 
-0.59 (-1.5, 0.3) 
-0.26 (-0.4, -0.1)* 
-0.95 (-1.9, 0.04) 
0.06 (-0.1, 0.2) 
Model 2 – tent heater (self-reported) 
Males   Exposed 
         Years from deployment         
0.89 (-0.03, 1.8) 
0.02 (-0.2, 0.2) 
1.16 (0.3, 2.0)* 
-0.15 (-0.3, -0.02)* 
2.15 (1.1, 3.2)* 
0.17 (0.02, 0.3)* 
Females   Exposed 
         Years from deployment 
0.47 (-0.7, 1.6) 
0.09 (-0.1, 0.3) 
0.18 (-0.8, 1.1) 
-0.26 (-0.4, -0.1)* 
0.57 (-0.5, 1.6) 
0.06 (-0.1, 0.2) 
Model 3 – pesticides (self-reported) 
Males   Exposed 
         Years from deployment         
0.63 (-0.2, 1.5) 
0.03 (-0.2, 0.2) 
0.98 (0.1, 1.9)* 
-0.12 (-0.2, 0.01) 
1.47 (0.5, 2.4)* 
0.18 (0.04, 0.3)* 
Females   Exposed 
         Years from deployment 
0.82 (-0.1, 1.7) 
0.11 (-0.1, 0.3) 
-0.04 (-0.9, 0.8) 
-0.25 (-0.4, -0.1)* 
0.95 (0.03, 1.9) 
0.10 (-0.1, 0.3) 
Model 4 – hearing chemical alerts (self-reported) 
Males   Exposed 
         Years from deployment         
0.52 (-0.5, 1.5) 
0.01 (-0.2, 0.2) 
0.38 (-0.6, 1.4) 
-0.13 (-0.3, -0.02)* 
1.36 (0.3, 2.4)* 
0.16 (0.03, 0.3)* 
Females   Exposed 
         Years from deployment 
-1.13 (-2.6, 0.4) 
0.09 (-0.1, 0.3) 
-1.23 (-2.7, 0.2) 
-0.27 (-0.4, -0.1)* 
-1.22 (-2.6, 0.2) 
0.06 (-0.1, 0.2) 
Model 5 – consuming PB pills (self-reported) 
Males   Exposed 
         Years from deployment         
0.66 (-0.5, 1.8) 
0.03 (-0.2, 0.2) 
0.12 (-0.8, 1.1) 
-0.11 (-0.2, 0.004) 
0.96 (-0.02, 1.9) 
0.12 (-0.02, 0.3) 
Females   Exposed 
         Years from deployment 
-0.34 (-1.4, 0.8) 
0.04 (-0.1, 0.2) 
-0.46 (-1.5, 0.6) 
-0.24 (-0.4, -0.1) 
0.37 (-0.8, 1.6) 
0.08 (-0.1, 0.2) 
Model 6 – Smoke from oil well fires (self-reported) 
Males   Exposed 
         Years from deployment         
1.33 (-0.8, 3.4) 
0.02 (-0.2, 0.2) 
0.72 (-0.6, 2.1) 
-0.14 (-0.3, -0.02)* 
0.98 (-0.2, 2.2) 
0.16 (0.03, 0.3)* 
Females   Exposed 
         Years from deployment 
0.14 (-0.9, 1.2) 
0.09 (-0.1, 0.3) 
-0.38 (-1.5, 0.7) 
-0.27 (-0.4, -0.1)* 
0.64 (-0.3, 1.6) 
0.06 (-0.1, 0.2) 
Model 7 – Debris from SCUDs (self-reported) 
Males   Exposed 
         Years from deployment         
0.88 (0.03, 1.7)* 
0.02 (-0.2, 0.2) 
0.48 (-0.4, 1.3) 
-0.14 (-0.3, -0.01)* 
1.61 (0.7, 2.5)* 
0.17 (0.02, 0.3)* 
Females   Exposed 
         Years from deployment 
0.75 (-0.2, 1.7) 
0.09 (-0.1, 0.3) 
0.68 (-0.1, 1.5) 
-0.27 (-0.5, -0.1)* 
0.58 (-0.4, 1.6) 
0.10 (-0.1, 0.3) 
Note: Unexposed (reference); models adjusted for baseline age (continuous), baseline 
military status (0=Active Duty, 1=Reserve/Guard) 
* p<0.05 
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Table 5.3b (continued). Longitudinal associations between GW exposure and health: 
neurological and physical symptoms 
 Rapid heart rate Rash Shortness of breath 
Model 1 – Sarin nerve gas (modeled) 
Males   Exposed 
         Years from deployment         
0.39 (-0.6, 1.4) 
-0.08 (-0.3, 0.1) 
-0.26 (-1.2, 0.7) 
0.18 (0.05, 0.3)* 
-0.37 (-1.4, 0.7) 
0.08 (-0.1, 0.2) 
Females   Exposed 
         Years from deployment 
-0.44 (-1.5, 0.6) 
-0.07 (-0.2, 0.1) 
-0.75 (-1.6, 0.1) 
0.11 (-0.1, 0.3) 
-0.17 (-1.1, 0.8) 
-0.01 (-0.2, 0.1) 
Model 2 – tent heater (self-reported) 
Males   Exposed 
         Years from deployment         
1.06 (-0.04, 2.2) 
-0.08 (-0.3, 0.1) 
1.15 (0.1, 2.2)* 
0.19 (0.05, 0.3)* 
1.19 (-0.1, 2.4) 
0.07 (-0.1, 0.2) 
Females   Exposed 
         Years from deployment 
1.23 (-0.4, 2.8) 
-0.07 (-0.2, 0.1) 
0.25 (-0.8, 1.3) 
0.10 (-0.1, 0.3) 
0.90 (-0.4, 2.2) 
-0.02 (-0.2, 0.1) 
Model 3 – pesticides (self-reported) 
Males   Exposed 
         Years from deployment         
0.78 (-0.2, 1.8) 
-0.08 (-0.3, 0.1) 
0.95 (-0.1, 2.0) 
0.17 (0.03, 0.3)* 
0.95 (-0.1, 2.0) 
0.08 (-0.1, 0.2) 
Females   Exposed 
         Years from deployment 
0.88 (-0.2, 2.0) 
-0.04 (-0.2, 0.1) 
0.16 (-0.02, 0.3) 
0.14 (-0.02, 0.3) 
0.85 (-0.1, 1.8) 
0.02 (-0.2, 0.2) 
Model 4 – hearing chemical alerts (self-reported) 
Males   Exposed 
         Years from deployment         
0.43 (-0.7, 1.5) 
-0.08 (-0.3, 0.1) 
1.23 (0.04, 2.4)* 
0.19 (0.05, 0.3)* 
0.63 (-0.6, 1.8) 
0.08 (-0.1, 0.2) 
Females   Exposed 
         Years from deployment 
0.02 (-1.7, 1.7) 
-0.07 (-0.2, 0.1) 
-0.68 (-1.9, 0.5) 
0.11 (-0.1, 0.3) 
-0.79 (-2.0, 0.4) 
-0.01 (-0.2, 0.1) 
Model 5 – consuming PB pills (self-reported) 
Males   Exposed 
         Years from deployment         
0.36 (-0.8, 1.6) 
-0.07 (-0.3, 0.2) 
-0.43 (-1.5, 0.6) 
0.18 (0.04, 0.3)* 
0.38 (-0.8, 1.6) 
0.04 (-0.1, 0.2) 
Females   Exposed 
         Years from deployment 
0.30 (-0.9, 1.5) 
-0.12 (-0.3, 0.05) 
-0.28 (-1.2, 0.7) 
0.07 (-0.1, 0.2) 
-0.004 (-1.0, 1.0) 
-0.01 (-0.2, 0.2) 
Model 6 – Smoke from oil well fires (self-reported) 
Males   Exposed 
         Years from deployment         ------- 
1.36 (-0.9, 3.6) 
0.20 (0.1, 0.3)* ------- 
Females   Exposed 
         Years from deployment 
0.14 (-0.9, 1.1) 
-0.07 (-0.2, 0.1) 
0.02 (-1.1, 1.1) 
0.10 (-0.1, 0.3) 
0.65 (-0.5, 1.8) 
-0.02 (-0.2, 0.1) 
Model 7 – Debris from SCUDs (self-reported) 
Males   Exposed 
         Years from deployment         
0.80 (-0.2, 1.8) 
-0.07 (-0.3, 0.1) 
0.89 (-0.1, 1.9) 
0.19 (0.04, 0.3)* 
0.36 (-0.7, 1.4) 
0.09 (-0.04, 0.2) 
Females   Exposed 
         Years from deployment 
0.73 (-0.4, 1.8) 
-0.05 (-0.2, 0.1) 
0.57 (-0.4, 1.5) 
0.13 (-0.03, 0.3) 
1.01 (0.3, 1.8)* 
0.005 (-0.2, 0.2) 
Note: Unexposed (reference); models adjusted for baseline age (continuous), baseline 
military status (0=Active Duty, 1=Reserve/Guard) 
* p<0.05
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Figure 5.1. Fort Devens cohort survey timeline 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Baseline Survey (n=2949) 
Spring 1991 
No health symptom questionnaire	
Follow-up 1 (n=2313) 
Winter 1992-Spring 1993 
20-item symptom questionnaire	
Follow-up 2 (n=220) 
Spring 1994-Fall 1996 
52-item symptom questionnaire	
Follow-up 3 (n=1290) 
Spring 1997-Spring 1998 
52-item symptom questionnaire 
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CHAPTER SIX. CONCLUSION 
 The research summarized in this dissertation explores occupational exposures in 
two distinct groups of military personnel, Air Force personnel with exposure to toxicants 
found in jet fuel and Gulf War (GW) veterans, some of whom experienced ill health 
and/or a syndrome known as GW illness (GWI) following their deployment in 1990–
1991. In the first two studies that are summarized here, we assessed USAF personnel 
exposed to JP-8 jet fuel in garrison using a standard, explicit exposure-related disease 
conceptual model. The next two investigations evaluated GW veterans exposed to a 
mixture of chemicals in operational theater. Given the challenges of health research 
among military personnel who become ill after return from active duty in a combat 
theater, the use of retrospective research methods were required for this effort.   
 The investigation summarized in Chapter 2 addressed the validity of biomarkers 
of JP-8 exposure. The results showed that VOCs in blood can serve as biomarkers to 
assess exposure to JP-8, a complex mixture of aliphatic and aromatic hydrocarbons 
(Maule et al. 2016). These results follow on evidence of other investigators that VOC 
levels measured in the personal breathing zone, exhaled breath, and urine are higher in 
USAF personnel self-reporting occupational exposure to JP-8 (Egeghy et al. 2003; 
Merchant-Borna et al. 2012; Pleil et al. 2000; Puhala et al. 1997; Smith et al. 2010; Smith 
et al. 2012; Tu et al. 2004). Our study adds to that literature by providing evidence that 
USAF personnel self-reporting occupational exposure to JP-8 also have higher VOC 
concentrations in blood. Of the VOCs examined in that study, we concluded that the 
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xylenes (o-xylene, m/p-xylene) are the most appropriate biomarkers of occupational JP-8 
exposure. Levels of THC measured in personal breathing zone air correlated best with 
xylenes and in regression models significantly predicted VOCs in blood. To most 
accurately assess the contribution of occupational JP-8 exposure to absorbed VOC dose, 
we controlled for the effect of cigarette smoking using blood levels of the biomarker 2,5-
dimethylfuran and for USAF base of the military personnel participants to control for 
differences in JP-8 composition, job tasks, and environmental conditions. Although 
collecting blood is more invasive for participants than collecting urine samples or air 
samples around the breathing zone, this approach directly quantifies the concentration of 
JP-8 constituents in blood that could reach target tissues (e.g., brain, liver, adipose tissue) 
while also representing cumulative exposure from multiple sources and routes (i.e., 
dermal, inhalation). 
 Chapter 3 describes research that addresses the relationship between occupational 
JP-8 exposure and potential adverse effects on nervous system function in the same group 
of USAF personnel that participated in the Chapter 2 work (Maule et al. 2013). 
Components of JP-8 are neurotoxic and previous studies provided inconsistent evidence 
concerning whether JP-8 exposure is associated with diminished balance control, a 
measure of nervous system function, following work-shift exposures (Bhattacharya 2001; 
Smith et al. 1997; White and Proctor 1997). In our study, the postural sway evaluation 
included four balance tasks performed before and after the work shift: (1) standing with 
eyes open, (2) standing with eyes closed, (3) standing on foam support with eyes open, 
and (4) standing on foam support with eyes closed. Diminished balance control was 
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quantified as increases in postural sway velocity (i.e., faster movements) and postural 
sway area (i.e., larger movements) during in each of the four balance tasks (Gill et al. 
2001; Hegeman et al. 2007). Participants’ pre- and post-shift postural sway 
measurements increased as the balance task grew more difficult (i.e., removal of visual 
stimuli and addition of uneven standing surface). Work shift JP-8 exposure, quantified by 
breathing zone levels of THC and naphthalene and urinary naphthol concentrations, was 
not associated with diminished balance control on any of the balance tasks. Results 
suggested that pre-shift balance performance and age were the most significant predictors 
of post-shift postural sway measurements. We concluded that short-term exposure to JP-8 
during the work-shift did not impair postural sway performance.   
 Chapter 4 describes work exploring the symptoms of ill health reported by 
military personnel following deployment to the Persian Gulf during the 1990–1991 GW. 
The existing literature on this military population has concluded that multiple symptoms 
of ill health were experienced by about 25–30% of GW veterans, a phenomenon that is 
known as GWI (RAC-GWVI 2008; RAC-GWVI 2014). To better understand the health 
complaints of GW veterans who were deployed to the Gulf theater, the aim of this work 
was to characterize the most significant symptoms occurring after deployment. We used 
meta-analytic techniques to integrate health symptom data contained in the literature 
from 18 distinct veteran populations, representing over 129,000 deployed GW veterans 
and GW-era veterans who were not deployed or who were deployed to areas other than 
the Gulf (e.g., Bosnia or Germany). The sample included veterans from the GW-era in all 
branches of the US and allied militaries and from four different countries (CDC MMWR 
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1995; Cherry et al. 2001; Doebbeling et al. 2000; Fukuda et al. 1998; Gray et al. 2002; 
Iannacchione et al. 2011; Iowa Study Group 1997; Ishoy et al. 1999; Kang et al. 2000; 
Kelsall et al. 2004b; Knoke et al. 2000; Murphy et al. 2006; Nisenbaum et al. 2004; 
Proctor et al. 1998; Shapiro et al. 2002; Sostek et al. 1996; Steele 2000; Stretch et al. 
1995; Unwin et al. 1999; Unwin et al. 2002). Deployed GW veterans had higher odds of 
reporting all of the analyzed health symptoms compared to GW-era control veterans, 
even after controlling for the effects of publication bias on the results. For several mood-
cognition, musculoskeletal, gastrointestinal, and dermatological symptoms, the odds were 
more than three times higher for deployed GW veterans compared to controls. These 
findings suggest that symptoms assessing these particular domains are especially critical 
when assessing GW veteran health status and for diagnosing GWI. A secondary analysis 
revealed important differences in symptom reporting by study sampling strategy. Studies 
of specific military-unit cohorts showed higher odds ratios for symptoms compared to 
population-based studies. It is possible the high likelihood of symptom occurrence is 
related to specific exposures experienced by different military-units in the GW theater; 
however, we did not have access to individual level health outcome or exposure data to 
explore this hypothesis. 
 Chapter 5 describes an investigation that employed a subset of the Fort Devens 
cohort, a population of former US Army Active, Reserve, and National Guard GW 
veterans who have been followed prospectively through a series of surveys since their 
return from deployment in the GW in 1991. This work assessed the longitudinal 
relationship between GW-specific exposures and health symptoms. Our results were 
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similar to those described in prior research on GW veterans, showing significant 
associations between self-reported exposures and experiences (tent heater exhaust, 
pesticide use, hearing chemical alerts, and debris from SCUD missiles) and reports of 
greater numbers of symptoms. In addition, our results indicated that there were gender-
specific differences in the relationships between predictor variables and symptom 
reporting. Among men compared to women, the results indicated a larger number of 
significant associations between specific self-reported GW exposures and mood-
cognition, fatigue, neurological, and physical symptoms. The data from female veterans 
revealed that demographic variables were the most significant indicators of health 
symptom reporting. Women who were older when they deployed and those serving in the 
Army Reserves/National Guard had increased odds of symptom reporting. These results 
highlight the importance of understanding sex-specific symptom trajectories and 
relationships between GW exposures and outcomes. 
 
Research Limitations 
The research limitations specific to each study were outlined in Chapters 2–5 and 
will be summarized here.  
JP-8 is a mixture of 200 aliphatic and aromatic hydrocarbons. At this time there is 
no standard industrial hygiene method for measuring occupational exposure to JP-8 
limiting researchers’ ability to measure occupational exposure to jet fuel and total 
absorbed dose attributable to occupational exposure to jet fuel. Exposure assessment 
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studies, including our examination of VOC concentrations in blood, measure constituents 
of JP-8 as surrogates of occupational JP-8 exposure. The BTEX (i.e., benzene, toluene, 
ethylbenzene, xylenes) concentration in breath samples taken from JP-8 exposed USAF 
personnel ranged from 14–50% of the total JP-8 fingerprint, so researchers are using 
measurements of these constituents in air, breath, skin, urine and blood to approximate 
total absorbed dose of JP-8 (Pleil 2001). 
The JP-8 constituents we evaluated to determine occupational exposure to jet fuel 
are abundant in other products, including gasoline and cigarette smoke (Ashley et al. 
1994; Chambers et al. 2011; NRC 2003; Polzin et al. 2007). Non-occupational exposure 
to components found in JP-8 and occupational exposure to other chemicals and solvents 
can affect levels of VOCs measured in blood and urine. First, we used two different 
approaches to control for potential confounding by cigarette smoke in our jet fuel studies. 
In the research summarized in Chapter 2, we controlled for 2,5-dimethylfuran, a 
biomarker of daily cigarette smoking in blood, to control for the effect of smoking on 
VOC levels in blood (Ashley et al. 1996; Chamber et al. 2011). For the work in Chapter 
3, we controlled for current smoking using a binary categorical variable (current smoker 
– yes/no). Separately, we characterized self-service at a gas station and other 
occupational exposures to chemicals (e.g., organic solvents, cutting or lubricating oils, 
coolants or anti-freeze, and/or degreasers). However, because the sample size was small 
for those reporting these additional exposures, we were unable to control for them in our 
statistical models. These exposures could be explored in a larger study.  
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The research examining the relationship between occupational JP-8 exposure and 
diminished balance control was powered to detect clinically relevant changes in postural 
sway measurements (i.e., 15–25% change in performance); however, our study had 
limited power to detect subclinical decrements in performance. Our study was also 
limited in its ability to assess the health impact of chronic occupational JP-8 exposure in 
jet fuel workers because it examined only an 8-hour period of exposure (Maule et al. 
2013). In our study, USAF personnel with high JP-8 exposure had worked, on average, 
for 6.5 years in the AF (range 0.5–17 years). In another study investigating postural sway 
in USAF personnel, workers exposed to jet fuel had worked an average of 12.0 years in 
the AF (range 0.8–30 years) (Smith et al. 1997). Smith et al. (1997) estimated cumulative 
exposure to JP-8 using work shift levels of JP-8 constituents measured in personal air and 
the length of each participant’s USAF career. Using the same postural sway evaluation as 
the study in Chapter 3, Smith et al. (1997) found a significant association between 
increased cumulative benzene and xylene levels and diminished balance control. These 
results support a need to study long-term occupational JP-8 exposure and potential 
adverse effects on nervous system function.    
In the third and fourth studies, which focused on veterans of the 1990–1991 GW, 
different forms of selection bias were a potential concern. Publication bias and non-
reporting bias is a limitation of conducting a meta-analysis on data published in peer-
reviewed literature. Publication bias arises when studies with null or negative finding are 
less likely to be published than studies with positive findings. Non-reporting bias occurs 
when researchers include only positive or significant findings in their studies, omitting 
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null or negative findings. To address this issue in the meta-analysis summarized in 
Chapter 4, we used a method described in Levy et al. (2001), assigning studies with 
missing symptom data a null finding.  The impact of selection bias on the results of the 7-
year longitudinal assessment described in Chapter 5 was also a concern. The results can 
be affected when individuals with more health problems are more likely to remain in the 
study than healthy individuals. At the first follow-up, participants in the Fort Devens 
Cohort were flagged as high- or low-symptom reporters based on the number of 
symptoms endorsed on the 20-item Health Symptom Checklist. The proportion of high 
and low symptom reporters did not change over the three follow-up periods, indicating 
that healthier individuals were participating at the same rate as sick individuals. 
A major limitation of researching exposure-related disease in GW veterans results 
from a lack of record-keeping, environmental monitoring, and personal exposure 
measurements during the operations in the Persian Gulf region leading to potential 
exposure misclassification. GW researchers have relied heavily of retrospective self-
reported exposure measures, which can be subject to recall bias, to examine causal links 
between deployment exposures and adverse health effects. In Chapter 5, we discussed the 
evidence of a moderate to good reliability of self-reported exposures on survey 
questionnaires at two different time points in our study sample and several other GW 
cohort studies. Results of two studies evaluating exposure recall in GW veterans showed 
that recall reliability did not differ between symptomatic and non-symptomatic GW 
veterans (McCauley, 1999; Brewer, 2008). This suggests that non-differential exposure 
misclassification would likely result from any exposure recall bias. 
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Public Health Impact  
The measured levels of VOCs in blood in Chapter 2 provide evidence of 
occupational exposure to JP-8 despite the use of protective equipment (e.g., gloves, 
coveralls, booties, and respirators). The evidence of occupational exposure even with 
these personal protective measures suggests that other strategies could be employed to 
further limit occupational exposure. For example, an individual entering a fuel cell for 
inspection or maintenance is required to wear a respirator, but his/her attendant standing 
directly at the opening of the fuel cell does not wear a respirator (Pleil et al. 2000). 
During fuel cell inspection/maintenance, area monitoring has shown that the highest 
levels of THC in air are inside the fuel cell, with the second highest air levels measured 
directly outside the fuel tank undergoing maintenance (Pleil et al. 2000). Occupational 
exposure to JP-8 may be further decreased if the attendant is also required to wear a 
respirator during inspection and maintenance activities. 
Our investigation of JP-8 exposure and health outcome research in a military 
population can also have direct applications to the civilian workforce. The commercial 
airline and civil aviation equivalents to JP-8 are Jet-A and Jet-A1, which have the same 
base formula as JP-8 without the military performance additives (Ritchie et al. 2003). In 
the US, the commercial consumption of jet fuel is expected to grow over the course of the 
next several decades. According to the Department of Energy, approximately 1.43 
million barrels of jet fuel was consumed in the US on a daily basis. That number is 
expected to increase to 1.52 million barrels per day in 2020, 1.60 million barrels per day 
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in 2030, and 1.66 million barrels per day by 2040 (ATSDR 2017). Jet fuel will continue 
to be an occupational exposure that impacts a large number of workers. According to the 
latest estimate used by the Agency for Toxicology and Disease Registry in their 
toxicological profile of jet fuels, including JP-8, over 1 million military and civilian 
workers are occupationally exposed to jet fuel on a yearly basis (ATSDR 2017).    
Unfortunately, some of the chemical hazards (e.g., chemical warfare agents and 
oil well fire smoke) associated with health problems experienced by GW veterans 
following their deployment to the Persian Gulf are now present in theater in current 
conflicts in Iraq and Syria. In addition to health concerns for local populations, there are 
US troops currently stationed in both of those countries. The international community 
widely accepts that Syrian forces have used chemical warfare agents (i.e., sarin and 
chlorine gas) in several attacks of rebel forces and civilian populations (Fields 2017; 
Loveluck 2017; Pita and Domingo 2014; Zarocostas 2017). In Iraq, Iraqi forces are 
fighting ISIS for control of the city of Mosul. During the summer of 2016, to create 
defensive barriers, ISIS fighters set fires to oil wells located south of Mosul. These fires, 
as well as a sulfur plant fire started in October 2016, have significantly affected the air 
quality in the area around Mosul (Malsin 2016). US troops stationed 50 miles south of 
Mosul at Camp Swift and Qayyarah Airfield as part of Combined Joint Task Force 
Operation Inherent Resolve have at certain points limited outdoor activity and worn 
personal protective equipment due to poor air quality (CJTF-OIR 2016). The results from 
the exposure-symptom associations explored in Chapter 5 can inform likely health 
outcomes among US troops and civilian populations encountering chemical hazards 
	123	
similar to those experienced by troops during the 1990–1991 GW. 
We recognize that environmental and occupational exposure assessment and 
monitoring is often not feasible in an operational or combat setting. The physical hazards 
of combat, battle injuries that threaten lives, and the completion of combat mission 
objectives will continue to be the top priority for US Armed Forces in deployment zones 
(Proctor 2008; Richards 2011). However, the evidence of chronic and persistent health 
effects experienced by GW veterans suggest that the research and medical community 
needs to continue to find ways to rapidly identify adverse health outcomes and their 
etiology post-deployment. When possible the Department of Defense should make efforts 
to implement environmental and occupational monitoring programs in the battlefield and 
should use this information to rapidly address health issues that arise in theater and once 
troops have returned from deployment.  
 
Future Research Directions 
The current American Conference of Governmental Industrial Hygienists 
(ACGIH) threshold limit value (TLV) for jet fuel vapor is 200 mg/m3, based on a 
measure of total hydrocarbons in personal air over an average of 8-hours (ATSDR 2017). 
The occupational TLV is based on a measure that only captures inhalation exposure 
despite evidence that dermal contact is an important exposure route. In the 2017 
Toxicological Profile of Jet Fuels, the ATSDR stated it could not set or recommend an 
occupational exposure limit because of lack of data. Future research could continue to 
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expand work on biomarkers of JP-8 exposure that capture dermal exposure so that an 
occupational exposure limit can be established. Furthermore, efforts could be made to use 
multiple biomarkers of exposure to characterize JP-8. Researchers are using several 
different statistical methods to study exposure to mixtures and their possible health 
effects (Taylor et al. 2016).  
While the focus of those studying the health of GW veterans and GWI is shifting 
to finding effective treatments for GWI and other GW-related health problems, 
epidemiology will continue to play a role in studying the long-term health of GW 
veterans. In 2014, the Fort Devens Cohort Study commenced data collection for a fifth 
follow-up survey. Data collection will end later this year. The survey asks questions 
about demographic and health information; military service and civilian work history; 
and occupational and non-occupational chemical exposures. A 34-item health symptom 
survey is included. Adding this health symptom information to the data evaluated in 
Chapter 5 will help characterize GW veteran health more than 20-years after deployment 
and will allow us to analyze a 20-year health symptom trajectory in relation to different 
GW and post-GW experiences.  
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